Details of Disease

General Information of Disease (ID: DISSRV2N)

• Disease Name: Schizophrenia
• Synonyms: schizoaffective disorder; schizophrenia with or without an affective disorder; SCZD; schizophrenia, susceptibility to; schizophrenia 12; schizophrenia (disease); schizophrenia; schizophrenia-1
• Disease Class: 6A20: Schizophrenia
• Definition: A major psychotic disorder characterized by abnormalities in the perception or expression of reality. It affects the cognitive and psychomotor functions. Common clinical signs and symptoms include delusions, hallucinations, disorganized thinking, and retreat from reality.
• Disease Hierarchy:
  DIS4UQOT: Psychotic disorder
  DISSRV2N: Schizophrenia
• ICD Code: ICD-11: ICD-11: 6A20
• Disease Identifiers:
  MONDO ID: MONDO_0005090
  MESH ID: D012559
  UMLS CUI: C0036341
  OMIM ID: 181500
  MedGen ID: 48574
  HPO ID: HP:0100753
  Orphanet ID: 3140
  SNOMED CT ID: 191526005

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 41 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Amisulpride	DMSJVAM	Approved	Small molecular drug	[1]
Aripiprazole	DM3NUMH	Approved	Small molecular drug	[2]
Asenapine	DMSQZE2	Approved	Small molecular drug	[3]
Benperidol	DMWQK9H	Approved	Small molecular drug	[4]
Bromperidol	DM24XYQ	Approved	Small molecular drug	[4]
Carphenazine	DMHTB31	Approved	Small molecular drug	[5]
Chlorpromazine	DMBGZI3	Approved	Small molecular drug	[6]
Clothiapine	DM6K1OA	Approved	Small molecular drug	[4]
Clozapine	DMFC71L	Approved	Small molecular drug	[7]
Flupentixol	DM0DJ9O	Approved	Small molecular drug	[8]
Fluspirilene	DMFO843	Approved	Small molecular drug	[9]
Gadobenate Dimeglumine	DM4VAOG	Approved	Small molecular drug	[10]
Haloperidol	DM96SE0	Approved	Small molecular drug	[11]
Iloperidone	DM6AUFY	Approved	Small molecular drug	[12]
L-Glutamic Acid	DM4PUDW	Approved	Small molecular drug	[13]
Loxapine	DM8AI9U	Approved	Small molecular drug	[4]
lumateperone tosylate	DMQ8HOJ	Approved	Small molecular drug	[14]
Lurasidone hydrochloride	DMCVPXO	Approved	Small molecular drug	[15]
Mesoridazine	DM2ZGAN	Approved	Small molecular drug	[16]
Molindone	DMAH70G	Approved	Small molecular drug	[17]
Nemonapride	DMY0EKH	Approved	Small molecular drug	[18]
Olanzapine	DMPFN6Y	Approved	Small molecular drug	[19]
Palbociclib	DMD7L94	Approved	Small molecular drug	[20]
Paliperidone	DM7NPJS	Approved	Small molecular drug	[21]
Penfluridol	DMG1DTE	Approved	Small molecular drug	[4]
Perphenazine	DMA4MRX	Approved	Small molecular drug	[22]
Pimozide	DMW83TP	Approved	Small molecular drug	[23]
Piperacetazine	DMGQU0Y	Approved	Small molecular drug	[4]
Pipotiazine	DMC68DF	Approved	Small molecular drug	[24]
Pitolisant	DM8RFNJ	Approved	Small molecular drug	[25]
Prolixin decanoate	DMMJ1IS	Approved	Small molecular drug	[26]
Quetiapine	DM1N62C	Approved	Small molecular drug	[20]
Risperidone	DMN6DXL	Approved	Small molecular drug	[27]
Sulpiride	DMF54ZG	Approved	Small molecular drug	[28]
Thioridazine	DM35M8J	Approved	Small molecular drug	[29]
Thiothixene	DMDINC4	Approved	Small molecular drug	[30]
Trifluoperazine	DMKBYWI	Approved	Small molecular drug	[4]
Triflupromazine	DMKFQJP	Approved	Small molecular drug	[4]
Ziprasidone	DMM58JY	Approved	Small molecular drug	[20]
Zuclopenthixol	DMKYD5N	Approved	Small molecular drug	[31]
Pregnenolone	DM6VFO1	Phase 4	Small molecular drug	[32]

This Disease is Treated as An Indication in 87 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
ALKS 3831	DMOB2R6	Phase 3	NA	[33]
AVP-786	DMV1SOR	Phase 3	NA	[33]
BI 425809	DMH3XDR	Phase 3	Small molecular drug	[34]
Blonanserin	DM36C17	Phase 3	Small molecular drug	[35]
CM-2395	DMASPWR	Phase 3	NA	[36]
EVP-6124	DMLQO7F	Phase 3	Small molecular drug	[37]
HP3070	DMEKHYF	Phase 3	NA	[33]
Iclepertin	DM83JCK	Phase 3	Small molecule	[38]
ITI-007	DMUQ1DO	Phase 3	Small molecular drug	[39]
KarXT	DM3XW3F	Phase 3	NA	[40]
LU AE58054	DMWGRQD	Phase 3	Small molecular drug	[41]
Lu AF35700	DMNAYUJ	Phase 3	NA	[33]
LY03004	DME5TUR	Phase 3	NA	[33]
LY404039	DMWZIRJ	Phase 3	Small molecular drug	[42]
MIN-101	DMCJY35	Phase 3	NA	[43]
R1678	DM4K9WH	Phase 3	Small molecular drug	[44]
RBP-7000	DMPJTZ1	Phase 3	NA	[33]
SEP-363856	DMG2QP4	Phase 3	NA	[45]
SR46349B	DM1ODMR	Phase 3	Small molecular drug	[20]
Zicronapine	DMP8ESD	Phase 3	Small molecular drug	[46]
AVN 211	DMVB4OS	Phase 2/3	NA	[33]
CX-516	DMSR7D2	Phase 2/3	Small molecular drug	[47]
NaBen	DM0O5HZ	Phase 2/3	NA	[48]
Sodium benzoate	DM3SGNS	Phase 2/3	NA	[33]
ABT-126	DM2OS51	Phase 2	NA	[49]
AMG 747	DMWPGB8	Phase 2	NA	[50]
Aplindore fumarate	DMGJ1X2	Phase 2	Small molecular drug	[20]
AZD2624	DMZLGQV	Phase 2	Small molecular drug	[51]
BI-409306	DMJFDS0	Phase 2	NA	[33]
BL-1020	DMVDO93	Phase 2	Small molecular drug	[20]
CTP-692	DMZ57Q0	Phase 2	Small molecular drug	[52]
Dexefaroxan	DMTY4KN	Phase 2	Small molecular drug	[20]
Evenamide	DMWB94K	Phase 2	Small molecular drug	[53]
FKF02SC	DMRJILU	Phase 2	NA	[33]
JNJ-37822681	DMV41P5	Phase 2	Small molecular drug	[54]
Lu AF11167	DMJOYNZ	Phase 2	Small molecular drug	[55]
MEM-3454	DMPNDYU	Phase 2	Small molecular drug	[20]
MK-8189	DMI8NXY	Phase 2	NA	[33]
MK-8998	DMERIP9	Phase 2	NA	[56]
N-DESMETHYLCLOZAPINE	DMVIRN3	Phase 2	Small molecular drug	[57]
NGX-267	DMJKBAY	Phase 2	Small molecular drug	[58]
NW-3509	DM2UJ1H	Phase 2	NA	[33]
Ocaperidone	DMP6B59	Phase 2	Small molecular drug	[59]
PF-02545920	DMJPE61	Phase 2	Small molecular drug	[60]
PF-04958242	DMRAFBK	Phase 2	NA	[61]
PF-3463275	DMO02LU	Phase 2	NA	[62]
R-209130	DM649K4	Phase 2	NA	[63]
RP-5000	DMQ63LS	Phase 2	NA	[64]
RP5063	DMKUE8O	Phase 2	NA	[65]
SAGE-718	DM9RC7D	Phase 2	Small molecular drug	[61]
SB773812	DMQGBQW	Phase 2	NA	[66]
SDZ-MAR-327	DM2YIOE	Phase 2	Small molecular drug	[20]
SGS742	DM5XYFH	Phase 2	Small molecular drug	[67]
TAK-063	DMP1873	Phase 2	NA	[68]
TAK-831	DMWPSJR	Phase 2	NA	[33]
Talnetant	DMQKZDT	Phase 2	Small molecular drug	[69]
TGOF02N	DMQ6ANE	Phase 2	NA	[70]
ITI-214	DM08TH3	Phase 1/2	NA	[71]
FRM-6308	DMNCOE1	Phase 1b	NA	[72]
(-)-3PPP, Maryland	DMG74BY	Phase 1	NA	[73]
1192U90	DM5IPHE	Phase 1	Small molecular drug	[20]
Abaperidone	DMYFB10	Phase 1	Small molecular drug	[74]
ALX-5407	DMLJWPN	Phase 1	Small molecular drug	[75]
AMG 579	DMRMC7U	Phase 1	NA	[76]
ATI-9242	DM6GKMU	Phase 1	NA	[33]
AZD-8418	DM9X20P	Phase 1	NA	[77]
B7-2/GM-CSF	DM0LKHV	Phase 1	Small molecular drug	[78]
CVN058	DMTSIYZ	Phase 1	Small molecular drug	[79]
DB103	DMJPQSI	Phase 1	NA	[33]
DCCCyB	DMQ8ACY	Phase 1	Small molecular drug	[80]
EVP-6308	DMHEN21	Phase 1	NA	[81]
GlyT1 PET radiotracers	DMCKZUT	Phase 1	NA	[82]
GSK1144814	DMK3S9J	Phase 1	NA	[83]
JNJ-17305600	DMMI4XR	Phase 1	NA	[84]
MK-2637	DMUHOJP	Phase 1	NA	[85]
NGD 94-1	DMM1Y8F	Phase 1	Small molecular drug	[86]
PF-05180999	DMXV116	Phase 1	NA	[87]
Pomaglumetad	DMTOLI5	Phase 1	NA	[42]
RG7203	DMYX4NP	Phase 1	NA	[33]
RG7342	DMIW5NG	Phase 1	NA	[88]
RO5545965	DMMSGGK	Phase 1	NA	[89]
SLV 354	DMAEH1L	Phase 1	NA	[90]
SSR-125047	DMSUFW6	Phase 1	Small molecular drug	[20]
SSR-181507	DMXQF1T	Phase 1	Small molecular drug	[20]
TAK-058	DMX9EA0	Phase 1	NA	[91]
TS-134	DMVG02Z	Phase 1	NA	[33]
YKP-1358	DMKHVNE	Phase 1	NA	[20]

This Disease is Treated as An Indication in 3 Patented Agent(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
PMID29334795-Compound-23	DM3VL64	Patented	Small molecular drug	[92]
PMID29338548-Compound-13	DMDJFUX	Patented	Small molecular drug	[93]
PMID29338548-Compound-21	DMRTBKC	Patented	Small molecular drug	[93]

This Disease is Treated as An Indication in 47 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Flupenthixol	DMY9P37	Withdrawn from market	Small molecular drug	[94]
Remoxipride	DMGQF3R	Withdrawn from market	Small molecular drug	[95]
Sertindole	DMMP65N	Withdrawn from market	Small molecular drug	[96]
(S)-amisulpride	DMEQ3IW	Discontinued in Phase 4	Small molecular drug	[20]
Bifeprunox	DMOQIMS	Discontinued in Phase 3	Small molecular drug	[20]
Osanetant	DMMT4PB	Discontinued in Phase 2b	Small molecular drug	[97]
ABT-089	DM8DT7U	Discontinued in Phase 2	Small molecular drug	[98]
AZD8529	DMEQ2N1	Discontinued in Phase 2	Small molecular drug	[99]
Ispronicline	DMKY2UE	Discontinued in Phase 2	Small molecular drug	[100]
PF-217830	DMBDPN2	Discontinued in Phase 2	Small molecular drug	[101]
SLV-310	DM71WGZ	Discontinued in Phase 2	Small molecular drug	[20]
TM30339	DMW7LQT	Discontinued in Phase 2	Small molecular drug	[102]
AM-831	DMO7920	Discontinued in Phase 1	Small molecular drug	[103]
ASP-2535	DM7USC7	Discontinued in Phase 1	NA	[104]
ASP-2905	DMBFFYS	Discontinued in Phase 1	NA	[105]
AVE-5997EF	DM5FDX2	Discontinued in Phase 1	Small molecular drug	[20]
AZD6280	DMFAZLU	Discontinued in Phase 1	Small molecular drug	[106]
CBD cannabis derivative	DM3G4JD	Discontinued in Phase 1	Small molecular drug	[20]
Farampator	DM76GRQ	Discontinued in Phase 1	Small molecular drug	[107]
GSK1018921	DM7ACJ4	Discontinued in Phase 1	NA	[108]
GSK729327	DMRTPY6	Discontinued in Phase 1	NA	[109]
NGD-94-4	DMZ9WLO	Discontinued in Phase 1	NA	[110]
PF-2400013	DMTN3BZ	Discontinued in Phase 1	NA	[111]
SLV-313	DMJFWB7	Discontinued in Phase 1	Small molecular drug	[20]
TS-032	DMOHEYU	Discontinued in Phase 1	NA	[112]
AC-260584	DMA93D8	Terminated	Small molecular drug	[120]
Belaperidone	DMM0ZIJ	Terminated	Small molecular drug	[20]
BP4.879a	DMN8FAG	Terminated	Small molecular drug	[20]
BTS-79018	DMAH3Z9	Terminated	Small molecular drug	[20]
CNS-1307	DM03LZB	Terminated	NA	[121]
CP-903397	DMEJBQY	Terminated	NA	[122]
E-2040	DMZWU8V	Terminated	NA	[123]
E-5842	DMV0QI1	Terminated	Small molecular drug	[20]
E-6276	DMTEY8W	Terminated	Small molecular drug	[20]
Fananserin	DME694O	Terminated	Small molecular drug	[124]
GMC-283	DMT1RH6	Terminated	Small molecular drug	[20]
MS-377	DMXERCA	Terminated	Small molecular drug	[20]
NE-100	DMP4J7T	Terminated	Small molecular drug	[125]
PNU-177864	DMRT69H	Terminated	NA	[20]
PNU-282987	DMGDC36	Terminated	Small molecular drug	[126]
RGH-1756	DM8RIA6	Terminated	Small molecular drug	[20]
Rimcazole	DMKDS1C	Terminated	Small molecular drug	[20]
SB-277011	DM3M16Q	Terminated	Small molecular drug	[127]
Sonepiprazole	DMFI0GW	Terminated	Small molecular drug	[128]
SR-31742A	DM7ZOLE	Terminated	Small molecular drug	[20]
Y-931	DMG024B	Terminated	Small molecular drug	[20]
ZD-3638	DM6M9GC	Terminated	Small molecular drug	[20]

This Disease is Treated as An Indication in 26 Preclinical Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
(S)-4-(Ethylsulfonyl)benzoylalanine	DMEJYV4	Preclinical	Small molecular drug	[113]
ADX-2 series	DM2WKDN	Preclinical	Small molecular drug	[20]
BFF-122	DM6BGJ9	Preclinical	Small molecular drug	[113]
BSF-78438	DMO15TX	Preclinical	NA	[20]
F-15063	DMUFP05	Preclinical	Small molecular drug	[114]
F-15441	DMH5KY4	Preclinical	NA	[114]
LE-300	DMGJL16	Preclinical	Small molecular drug	[20]
Org-23366	DMHQUM2	Preclinical	Small molecular drug	[20]
Org-24461	DMCMS7V	Preclinical	Small molecular drug	[20]
Organon	DMERWUC	Preclinical	Small molecular drug	[115]
Organon-2	DM46QXZ	Preclinical	NA	[20]
Organon-3	DM07EU4	Preclinical	NA	[20]
PD-157533	DMTG730	Preclinical	NA	[20]
PD-157695	DMDSR1X	Preclinical	Small molecular drug	[20]
PD-158771	DM682UV	Preclinical	Small molecular drug	[20]
PD-165167	DMD0GB4	Preclinical	Small molecular drug	[20]
PF-04859989	DM3U2S5	Preclinical	Small molecular drug	[113]
PGX-200097	DM1A2UI	Preclinical	NA	[116]
RMG-40083	DMJGQD2	Preclinical	NA	[20]
SB222200	DM6X0PZ	Preclinical	Small molecular drug	[117]
SPI-376	DMC1WAJ	Preclinical	Small molecular drug	[20]
SSR-103800	DM84EOW	Preclinical	NA	[118]
SSR-504734	DMQTR4I	Preclinical	Small molecular drug	[20]
TV-48438	DMWC9JC	Preclinical	Small molecule	[119]
U-99194A	DMW87JR	Preclinical	Small molecular drug	[20]
U-99363E	DMOIWVC	Preclinical	Small molecular drug	[20]

This Disease is Treated as An Indication in 12 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
A-690344	DMT6A7G	Investigative	Small molecular drug	[129]
Cannabinoids	DMZMJVP	Investigative	NA	[130]
CNS-1169	DMTEGNB	Investigative	NA	[131]
E-1455	DMHPFMV	Investigative	NA	[132]
MI-09018	DMR41DM	Investigative	NA	[130]
NRG-101	DMSJEP3	Investigative	NA	[130]
OMS-182410	DM6JGRW	Investigative	NA	[130]
PF-4859989	DMF19Q5	Investigative	NA	[130]
RO-4840700	DMC0V25	Investigative	NA	[133]
SCH-1518291	DMR3SFG	Investigative	Small molecular drug	[130]
TKP-1002	DMZU4O8	Investigative	NA	[132]
WS-50030	DM6A08D	Investigative	Small molecular drug	[134]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 1268 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
UIMC1	OT46QWL4	No Known	Unknown	[135]
USF3	OTORO3Q7	No Known	Unknown	[136]
USP48	OTNIEJ3W	No Known	Unknown	[137]
UTRN	OT7TZ637	No Known	Unknown	[138]
VPS13C	OT5GHC9K	No Known	Unknown	[139]
WASHC4	OTYIHCXJ	No Known	Unknown	[140]
ZDBF2	OTSPN4VZ	No Known	Unknown	[140]
ZNF229	OTV13PZY	No Known	Unknown	[141]
ZNF518B	OTAHMMBZ	No Known	Unknown	[136]
ZNF565	OT1S78L1	No Known	Unknown	[142]
ZP4	OTKV1HKP	No Known	Unknown	[136]
ZDHHC5	OTZMT6XV	Limited	Unknown	[143]
ANAPC5	OTGTJNNR	No Known	Unknown	[135]
ANKRD50	OTTLA4W2	No Known	Unknown	[582]
APOL2	OT303Q7B	No Known	Autosomal dominant	[136]
ARHGEF15	OTGHDJFP	No Known	Unknown	[139]
C6orf132	OTMH4S7O	No Known	Unknown	[136]
CBX8	OT4U5V1T	No Known	Unknown	[136]
CD163L1	OTZHN1XQ	No Known	Unknown	[139]
CHI3L1	OT2Z7VJH	No Known	Unknown	[136]
CLEC16A	OTLGV5SV	No Known	Unknown	[583]
CNTN1	OT7RNPEY	No Known	Unknown	[136]
CUZD1	OTDQJVZ8	No Known	Unknown	[136]
DCST1	OT2I5YXZ	No Known	Unknown	[139]
DPYSL2	OTWNQ74H	No Known	Unknown	[136]
ENTREP1	OT0YQR22	No Known	Unknown	[584]
EPYC	OTTRI5WO	No Known	Unknown	[136]
FABP4	OT3DKFOU	No Known	Unknown	[139]
FAXDC2	OTRRS828	No Known	Unknown	[585]
GNB5	OT3ZSAXH	No Known	Unknown	[136]
INSRR	OT3F75WA	No Known	Unknown	[586]
KIF17	OTHASX9G	No Known	Unknown	[587]
KIF24	OTJTA5V3	No Known	Unknown	[136]
KLHL25	OTPG0G97	No Known	Unknown	[588]
KRT20	OT4RB40L	No Known	Unknown	[139]
LHX6	OT47UQZ5	No Known	Unknown	[139]
LRRFIP1	OTN7XAUD	No Known	Unknown	[589]
MAMDC4	OTTL3DWT	No Known	Unknown	[139]
MAP2K7	OT1Q40TZ	No Known	Unknown	[144]
MDM1	OTI9JUWA	No Known	Unknown	[136]
MPG	OTAHW80B	No Known	Unknown	[136]
NDST2	OT21PY3J	No Known	Unknown	[140]
NOS2	OTKKIOJ1	No Known	Unknown	[139]
NR0B2	OT7UVICX	No Known	Unknown	[139]
NUP210	OT3BLQ9M	No Known	Unknown	[139]
PAQR8	OTGZ8W9F	No Known	Unknown	[139]
PDE8B	OT4217NK	No Known	Unknown	[590]
PLEKHA6	OTALCXKW	No Known	Unknown	[139]
PPP3CC	OT0AQD93	No Known	Unknown	[591]
PTPN3	OTSLZBVY	No Known	Unknown	[139]
QRICH1	OTPVAX04	No Known	Unknown	[140]
RELT	OT419II2	No Known	Unknown	[136]
RUNDC3B	OT8ZPQLC	No Known	Unknown	[139]
SELENBP1	OT3NZNTR	No Known	Unknown	[136]
SH2B3	OT4ALHBQ	No Known	Unknown	[137]
SHKBP1	OTJXWLEH	No Known	Unknown	[592]
SHOX2	OTLCZZJW	No Known	Unknown	[136]
SLC12A2	OT3ZJ3LH	No Known	Unknown	[535]
SLC18A2	OTUOMMM6	No Known	Unknown	[536]
SLC6A17	OTHJFW2G	No Known	Unknown	[136]
SNX31	OTMUGVSY	No Known	Unknown	[536]
SORCS1	OTP8PAKU	No Known	Unknown	[136]
STARD13	OTB4U1HY	No Known	Unknown	[139]
SULT1B1	OTH0RQYA	No Known	Unknown	[139]
SYNGR1	OT0MBUK5	No Known	Unknown	[593]
SYVN1	OTZ4ZJP5	No Known	Unknown	[136]
TAF9	OTCTH3C6	No Known	Unknown	[136]
TBXA2R	OT9CIHQ5	No Known	Unknown	[139]
TCP11L2	OTTIZO7B	No Known	Unknown	[139]
ABCA13	OTTHTUQN	Limited	Unknown	[594]
ABCA2	OTVSYK0X	Limited	Unknown	[136]
ADCK1	OTB7NSK3	Limited	Genetic Variation	[595]
ALMS1	OTW66JKS	Limited	Genetic Variation	[152]
ALYREF	OTOF2ADD	Limited	Biomarker	[596]
ANKRD23	OT0LX681	Limited	Genetic Variation	[152]
ANKS1B	OT26DGM9	Limited	Genetic Variation	[597]
AP2A2	OTD1UGUN	Limited	Unknown	[141]
ARFGEF1	OTPAU0L4	Limited	Unknown	[140]
ARHGAP18	OTYMJP6H	Limited	Genetic Variation	[598]
ARHGAP4	OTXV053R	Limited	Genetic Variation	[599]
ARHGEF26	OTX0U8PX	Limited	Genetic Variation	[152]
ARID3B	OTUP9MS4	Limited	Biomarker	[600]
ARVCF	OT78DKOU	Limited	Biomarker	[601]
ASAP1	OT4DLRYY	Limited	Genetic Variation	[152]
ATF7IP	OTU6ZA7F	Limited	Genetic Variation	[186]
BCL11B	OT8KKCVJ	Limited	Genetic Variation	[146]
BID	OTOSHSHU	Limited	Genetic Variation	[602]
BRCA1	OT5BN6VH	Limited	Biomarker	[149]
BTN3A2	OT3DIBU3	Limited	Biomarker	[165]
CADM3	OTSGOMWB	Limited	Genetic Variation	[186]
CAMK1D	OTU24HAU	Limited	Genetic Variation	[186]
CCHCR1	OT22C116	Limited	Genetic Variation	[158]
CCNH	OTKDU3SR	Limited	Biomarker	[456]
CCRL2	OT5PX0RX	Limited	Genetic Variation	[158]
CD8B	OTMZ1T7J	Limited	Biomarker	[456]
CENPM	OTYK9KOX	Limited	Genetic Variation	[152]
CHD5	OTS5EVHH	Limited	Unknown	[585]
CIB2	OT9ZJX1I	Limited	Biomarker	[294]
CLEC10A	OTD8HQT6	Limited	Biomarker	[603]
CNNM2	OTZHO8WU	Limited	Genetic Variation	[146]
CNNM3	OTJXP2SL	Limited	Genetic Variation	[152]
CNRIP1	OTXPWJ56	Limited	Genetic Variation	[604]
COL9A3	OTCUJOEK	Limited	Genetic Variation	[605]
CORT	OTX3GUHB	Limited	Altered Expression	[606]
CSPG4	OTW2D6DE	Limited	Autosomal dominant	[155]
CTNNA3	OT9Z0P1E	Limited	Genetic Variation	[186]
CTNNBL1	OT6KLHPA	Limited	Biomarker	[607]
CUX2	OTDJTQAJ	Limited	Biomarker	[608]
CXCL17	OTRCEVIZ	Limited	Biomarker	[609]
DAB1	OTPL9MA3	Limited	Biomarker	[610]
DGCR2	OTEGL17Z	Limited	Autosomal dominant	[155]
DLC1	OTP8LMCR	Limited	Genetic Variation	[277]
DNAH1	OTDZ26FJ	Limited	Genetic Variation	[152]
DNAH9	OTI2QIZQ	Limited	Autosomal dominant	[155]
DNAJA3	OT61924T	Limited	Genetic Variation	[152]
DNASE1L1	OT9ZOFN9	Limited	Altered Expression	[611]
DOP1A	OTBKLQH5	Limited	Genetic Variation	[152]
EDA	OTAKS5WS	Limited	Biomarker	[612]
EFNA5	OTOH4DRR	Limited	Genetic Variation	[186]
EFR3B	OTVKWU2L	Limited	Genetic Variation	[152]
ENDOU	OTB7OF7Y	Limited	Altered Expression	[606]
ERCC5	OTQAKFJM	Limited	Biomarker	[613]
ERCC8	OT0T4WKI	Limited	Genetic Variation	[152]
EXOSC6	OTAC10N6	Limited	Altered Expression	[606]
FAN1	OT1LM1HZ	Limited	Biomarker	[614]
FAT3	OT3C6H8W	Limited	Genetic Variation	[186]
FOXO3	OTHXQG4P	Limited	Genetic Variation	[146]
FXR1	OTEMQ1SR	Limited	Genetic Variation	[146]
GABBR2	OT67RIFY	Limited	Genetic Variation	[146]
GALNT2	OTZZ5386	Limited	Genetic Variation	[152]
GLIS3	OTBC960E	Limited	Genetic Variation	[152]
GPC6	OTNJBESF	Limited	Genetic Variation	[152]
GRP	OT8JDFNI	Limited	Altered Expression	[615]
HECW2	OTP2IN12	Limited	Genetic Variation	[152]
HLA-DOB	OTKADDUB	Limited	Biomarker	[616]
HLA-DRB5	OTUX5TWM	Limited	Biomarker	[617]
HNRNPD	OT5UO1FA	Limited	Biomarker	[456]
IL18R1	OT83XMPQ	Limited	Genetic Variation	[618]
ITIH3	OT4SLMLY	Limited	Genetic Variation	[146]
KCNK5	OT68V64E	Limited	Biomarker	[619]
KCNN3	OT11KYA8	Limited	Unknown	[169]
KLC1	OTSTTTW7	Limited	Biomarker	[620]
KLF12	OTVH4KD4	Limited	Genetic Variation	[152]
LHX2	OTK61NP8	Limited	Biomarker	[608]
LIPC	OTZY5SC9	Limited	Genetic Variation	[152]
LMX1B	OTM8145D	Limited	Altered Expression	[621]
LRP1	OTHTEH4G	Limited	Unknown	[142]
LRP1B	OT4YZG2N	Limited	Genetic Variation	[186]
LRP4	OTO4M459	Limited	Genetic Variation	[152]
LSAMP	OTYXVQX2	Limited	Biomarker	[622]
MAPK4	OTVWWUYS	Limited	Biomarker	[623]
MCPH1	OTYT3TT5	Limited	Genetic Variation	[624]
MEF2C	OTZGF1Y5	Limited	Genetic Variation	[146]
MICB	OTS2DVDW	Limited	Biomarker	[625]
MRTFA	OTCVXASM	Limited	Genetic Variation	[186]
MTHFD1L	OTV01EFP	Limited	Genetic Variation	[152]
MYT1L	OTV45MAS	Limited	Biomarker	[626]
NAB2	OTG4BDF3	Limited	Genetic Variation	[152]
NCS1	OT6JHAWM	Limited	Biomarker	[627]
NEGR1	OT57ECW9	Limited	Genetic Variation	[186]
NEU1	OTH9BY8Y	Limited	Genetic Variation	[152]
NEURL1	OT2C4P70	Limited	Genetic Variation	[152]
NEUROG1	OTMJZP9G	Limited	Biomarker	[628]
NFATC3	OTYOORME	Limited	Genetic Variation	[437]
NLGN4X	OTDJGBK8	Limited	Genetic Variation	[512]
NOSIP	OTQTNFPJ	Limited	Genetic Variation	[146]
NPAS2	OTMRT2TS	Limited	Genetic Variation	[629]
NR2E1	OTW47GKM	Limited	Biomarker	[630]
NRXN1	OTJN1JQA	Limited	Unknown	[631]
NUP37	OTPZH72U	Limited	Biomarker	[456]
NUP98	OTNT12G2	Limited	Altered Expression	[632]
PCDH19	OTSOW3MV	Limited	Genetic Variation	[633]
PDSS1	OTXGVHAB	Limited	Biomarker	[634]
PDXDC1	OTKH7U5Q	Limited	Genetic Variation	[186]
PIK3C2A	OTFBU4GD	Limited	Genetic Variation	[635]
PITPNM2	OTQXF4FF	Limited	Genetic Variation	[437]
PITX2	OTWMXAOY	Limited	Biomarker	[636]
PITX3	OTE2KT8P	Limited	Biomarker	[307]
PKP4	OTQHOF8L	Limited	Biomarker	[637]
POU3F2	OT30NFOC	Limited	Biomarker	[638]
PPM1K	OTNZ4N4E	Limited	Biomarker	[600]
PRKN	OTJBN41W	Limited	Genetic Variation	[208]
PRODH2	OTHO2TO0	Limited	Genetic Variation	[197]
PRORP	OTWIS44P	Limited	Genetic Variation	[152]
PRRC2A	OTBX6FM5	Limited	Biomarker	[639]
PTPRF	OTH5KF2D	Limited	Genetic Variation	[152]
RANBP9	OTM8COM5	Limited	Biomarker	[640]
RAP1A	OT5RH6TI	Limited	Genetic Variation	[186]
RASD2	OTETA815	Limited	Genetic Variation	[641]
REST	OTLL92LQ	Limited	Biomarker	[642]
RIT2	OTSNYG0D	Limited	Genetic Variation	[643]
RTN1	OTCX1SMK	Limited	Genetic Variation	[146]
S100A10	OTI71243	Limited	Altered Expression	[606]
SEPHS1	OTZ19I59	Limited	Biomarker	[634]
SFMBT1	OTKMZIBW	Limited	Genetic Variation	[152]
SHANK1	OTK8PV0S	Limited	Genetic Variation	[644]
SHISA9	OTZI2V0J	Limited	Genetic Variation	[152]
SLC4A8	OTKJ0X6Q	Limited	Unknown	[141]
SMARCA1	OT0Y6PTU	Limited	Unknown	[645]
SNAP29	OTT30ZON	Limited	Biomarker	[646]
SNAP91	OTE3EXWZ	Limited	Genetic Variation	[146]
SPAG9	OT45AHMB	Limited	Autosomal dominant	[155]
SPATS2L	OTFO07H8	Limited	Genetic Variation	[146]
SPG7	OT8OY9ST	Limited	Genetic Variation	[152]
SPHKAP	OT5RHUYJ	Limited	Genetic Variation	[146]
SRA1	OTYOGMTG	Limited	Genetic Variation	[647]
ST3GAL3	OTOORKUE	Limited	Genetic Variation	[186]
ST8SIA2	OTRBBBD8	Limited	Autosomal dominant	[155]
STT3A	OTDPS6AV	Limited	Genetic Variation	[648]
SUFU	OT0IRYG1	Limited	Genetic Variation	[152]
SYT11	OTLRTZEI	Limited	Biomarker	[649]
TAOK2	OTNUMOZ1	Limited	Genetic Variation	[146]
TBX4	OTW58FG4	Limited	Biomarker	[634]
TCF20	OT8LQAOV	Limited	Genetic Variation	[146]
TDRD6	OTW2UL4V	Limited	Autosomal dominant	[155]
TET1	OTZDHT1D	Limited	Altered Expression	[650]
TMEM108	OTE69DUG	Limited	Biomarker	[651]
TMTC1	OTZ7NW96	Limited	Genetic Variation	[146]
TRANK1	OT7DH5H4	Limited	Genetic Variation	[146]
TRAPPC3	OTJXCFZY	Limited	Genetic Variation	[152]
TRIO	OT71X1AK	Limited	Genetic Variation	[652]
TRPM3	OTE4CDOQ	Limited	Autosomal dominant	[155]
TRRAP	OT68OI2Y	Limited	Biomarker	[653]
TSNARE1	OTTJHX9A	Limited	Genetic Variation	[146]
TSPAN18	OTHSGPVB	Limited	Genetic Variation	[654]
TTLL6	OTHBM3DX	Limited	Genetic Variation	[655]
CAPN10	OTS9LJW4	Disputed	Genetic Variation	[656]
CDC42	OT5QBC5M	Disputed	Biomarker	[657]
GNB1L	OTXSUD8R	Disputed	Biomarker	[658]
KCTD21	OTQT85SN	Disputed	Biomarker	[197]
LRP2BP	OTVEH7V5	Disputed	Genetic Variation	[202]
MXRA5	OTXZBWCU	Disputed	Biomarker	[197]
NCAN	OT8OO6ZE	Disputed	Biomarker	[659]
NEUROD2	OTJMMX9K	Disputed	Biomarker	[660]
NTNG2	OTTY88DL	Disputed	Genetic Variation	[661]
PIK3C3	OTLUM9L7	Disputed	Genetic Variation	[662]
SEMA4B	OT1Y3YZD	Disputed	Genetic Variation	[202]
SUMF1	OTALXO2A	Disputed	Genetic Variation	[197]
ACTL7A	OT840164	moderate	Genetic Variation	[663]
ADNP2	OT7NQWJK	moderate	Biomarker	[270]
AGAP1	OTVX8835	moderate	Genetic Variation	[664]
AMBRA1	OTY0YGT9	moderate	Biomarker	[665]
ARHGEF10L	OTUAMHIZ	moderate	Genetic Variation	[663]
ATP6V1E2	OTNNHL6G	moderate	Genetic Variation	[663]
BCL9	OTRBIPR4	moderate	Genetic Variation	[666]
BLOC1S3	OTNRFFLW	moderate	Genetic Variation	[667]
C11orf21	OTJGXDHK	moderate	Genetic Variation	[663]
CABLES1	OTMN4XSX	moderate	Genetic Variation	[663]
CACNG5	OTN4PGI5	moderate	Biomarker	[668]
CACNG8	OTP6227G	moderate	Biomarker	[668]
CAMK2B	OTS9YK3E	moderate	Biomarker	[669]
CCDC102B	OTVDZVD0	moderate	Genetic Variation	[663]
CDC42SE2	OT8SG9I1	moderate	Genetic Variation	[670]
CDH15	OTJ1TO02	moderate	Biomarker	[209]
CHGA	OTXYX5JH	moderate	Genetic Variation	[671]
CHGB	OT7SAQT2	moderate	Genetic Variation	[672]
CHRNA3	OTCZQY1U	moderate	Genetic Variation	[146]
CKB	OTUCKOTT	moderate	Biomarker	[673]
CNTN5	OTWU5FLZ	moderate	Biomarker	[674]
CXCL16	OTD49T9R	moderate	Biomarker	[206]
DCC	OT2C1SHW	moderate	Genetic Variation	[146]
DOCK4	OTH3XY8B	moderate	Genetic Variation	[675]
DRP2	OTWR7WGU	moderate	Genetic Variation	[676]
ENO2	OTRODL0T	moderate	Biomarker	[677]
ESS2	OTZ08VCZ	moderate	Biomarker	[678]
FAM177A1	OTXTA14N	moderate	Genetic Variation	[204]
FAM178B	OT8HMHFD	moderate	Genetic Variation	[204]
GABRA6	OTX4UC3O	moderate	Genetic Variation	[679]
GABRB1	OT4L2SSB	moderate	Genetic Variation	[680]
GNB3	OTA6HYBA	moderate	Genetic Variation	[681]
GPM6A	OT8G13EG	moderate	Genetic Variation	[146]
GRIN3A	OTQS9GYY	moderate	Biomarker	[682]
HPS4	OTBTW01J	moderate	Biomarker	[667]
HTR3E	OTIWF1R5	moderate	Genetic Variation	[683]
IL6R	OTCQL07Z	moderate	Genetic Variation	[684]
IPO5	OTAK40ED	moderate	Biomarker	[685]
IPO8	OTBHGNKT	moderate	Genetic Variation	[663]
ITIH1	OTSXJGQF	moderate	Genetic Variation	[186]
KALRN	OT8WRCBH	moderate	Genetic Variation	[146]
KCNMB2	OTBXUQGK	moderate	Genetic Variation	[664]
KCNS3	OTHDD9F6	moderate	Altered Expression	[686]
KCTD7	OTRU3EOK	moderate	Genetic Variation	[687]
KSR2	OTSMUL59	moderate	Genetic Variation	[663]
LMAN2L	OTJ9FAWS	moderate	Biomarker	[688]
LMO7	OTDLY6TC	moderate	Genetic Variation	[663]
LTN1	OTIW2HTX	moderate	Genetic Variation	[663]
LYRM4	OTK6JCKL	moderate	Altered Expression	[689]
MBD2	OTUQPP0R	moderate	Biomarker	[690]
MDH1	OTJEO4E8	moderate	Altered Expression	[247]
MTHFD1	OTMKHVWC	moderate	Genetic Variation	[691]
NDUFS1	OTTIZDFR	moderate	Genetic Variation	[692]
NKAPL	OTIU393R	moderate	Genetic Variation	[693]
NLGN1	OTGHRRFQ	moderate	Genetic Variation	[616]
OPCML	OT93PQ6Y	moderate	Biomarker	[694]
PCDH12	OT2VANLI	moderate	Genetic Variation	[663]
PLCB4	OTPA0QHW	moderate	Genetic Variation	[663]
PRDX6	OTS8KC8A	moderate	Biomarker	[695]
PTPN5	OT2H1KDK	moderate	Biomarker	[696]
RAI1	OTKLQU00	moderate	Genetic Variation	[512]
RPN2	OTJ1SKOA	moderate	Genetic Variation	[663]
SETD1A	OTVVWRIC	moderate	Genetic Variation	[697]
SHANK2	OTSQTPFQ	moderate	Biomarker	[698]
SIRPB1	OTGHALWJ	moderate	Altered Expression	[699]
SMAD5	OTQNSVCQ	moderate	Altered Expression	[700]
SPG11	OTZ7LJX4	moderate	CausalMutation	[701]
SPTLC1	OTN0Z98K	moderate	Genetic Variation	[664]
SRSF1	OTF61HOV	moderate	Biomarker	[702]
STON2	OT01JHHE	moderate	Biomarker	[703]
STX2	OTO2IDDR	moderate	Genetic Variation	[663]
SYN1	OTMNPWC1	moderate	Biomarker	[704]
TENM4	OT91K3FC	moderate	Genetic Variation	[705]
TMPRSS5	OTERB7Z4	moderate	Genetic Variation	[663]
TSPAN8	OT1F68WQ	moderate	Biomarker	[706]
A1BG	OTFVUGNQ	Strong	Biomarker	[260]
A1CF	OTJBKFA1	Strong	Biomarker	[264]
A2M	OTFTX90K	Strong	Altered Expression	[196]
ABCF1	OT6Q079J	Strong	Genetic Variation	[707]
ACADS	OTGFANYQ	Strong	Genetic Variation	[146]
ACAN	OTUOCW8K	Strong	Altered Expression	[454]
ACOT6	OTDE5QKC	Strong	Biomarker	[415]
ACOT7	OT7C68YV	Strong	Genetic Variation	[248]
ACSM1	OT1TS9M9	Strong	Biomarker	[708]
ACTB	OT1MCP2F	Strong	Altered Expression	[709]
ACTBL2	OTD6B81U	Strong	Genetic Variation	[248]
ACTC1	OTJU04B1	Strong	Genetic Variation	[710]
ACTG2	OTRDWUO0	Strong	Genetic Variation	[248]
ACTR2	OT3C8U5T	Strong	Genetic Variation	[256]
ACTR3	OT05LJSH	Strong	Biomarker	[711]
ADAM11	OTPTVW5W	Strong	Altered Expression	[286]
ADAM12	OTZKOTDB	Strong	Genetic Variation	[712]
ADAMTS10	OTNJ9VSU	Strong	Biomarker	[713]
ADAMTS12	OTG7HEA2	Strong	Genetic Variation	[714]
ADAMTS16	OTTKUH99	Strong	Genetic Variation	[502]
ADAMTS2	OTTK22NO	Strong	Biomarker	[249]
ADAMTS3	OT2U6VF5	Strong	Biomarker	[415]
ADAMTSL3	OTMC2WFG	Strong	Genetic Variation	[146]
ADARB1	OTGKSZEV	Strong	Biomarker	[632]
ADCY7	OTAWMGP3	Strong	Biomarker	[415]
ADD2	OTRCPCD2	Strong	Altered Expression	[715]
ADGRF4	OT4PTCTF	Strong	Biomarker	[415]
ADGRV1	OTLVXHHP	Strong	Genetic Variation	[146]
ADNP	OTEGICWR	Strong	Biomarker	[716]
ADSS2	OTW26XXB	Strong	Genetic Variation	[717]
AFF3	OTR0705Z	Strong	Genetic Variation	[186]
AFM	OTPOR8IO	Strong	Genetic Variation	[718]
AGAP3	OT8C6PKL	Strong	Biomarker	[719]
AGBL4	OTOX2H61	Strong	Genetic Variation	[720]
AGO2	OT4JY32Q	Strong	Biomarker	[375]
AHI1	OT8K2YWY	Strong	Biomarker	[721]
AK1	OT614AR3	Strong	Altered Expression	[309]
AKAP6	OTN59BZS	Strong	Genetic Variation	[146]
AKAP9	OT7Z2YRP	Strong	Genetic Variation	[722]
ALDH1L1	OT15HOJX	Strong	Biomarker	[516]
ALDH3A1	OTAYZZE6	Strong	Biomarker	[723]
ALDH7A1	OTV57BZD	Strong	Biomarker	[724]
ALDOC	OTEC13I5	Strong	Altered Expression	[454]
ALG1	OTVXPA9E	Strong	Biomarker	[725]
ALG9	OT5V9PIR	Strong	Genetic Variation	[726]
ALS2CL	OT8RY7TZ	Strong	Biomarker	[142]
AMBP	OTLU8GU8	Strong	Biomarker	[727]
AMELX	OTIN26MM	Strong	Biomarker	[728]
AMIGO1	OT2EPDFC	Strong	Biomarker	[400]
AMOTL1	OT40G45S	Strong	Genetic Variation	[480]
AMY1A	OT6G4B8O	Strong	Biomarker	[729]
ANGPTL2	OTB6JG41	Strong	Genetic Variation	[256]
ANKK1	OT0OM1O0	Strong	Posttranslational Modification	[730]
ANKRD12	OTK16BL9	Strong	Biomarker	[731]
ANLN	OTXJY54C	Strong	Biomarker	[481]
ANO4	OT8E2PMA	Strong	Genetic Variation	[208]
ANOS1	OTZJT4KN	Strong	Genetic Variation	[732]
ANXA3	OTDD8OI7	Strong	Biomarker	[733]
ANXA6	OT9KIQ0Y	Strong	Genetic Variation	[462]
AP2B1	OTL6LZJ4	Strong	Genetic Variation	[186]
APBA1	OTUH9JPD	Strong	Genetic Variation	[186]
APBA2	OTXD8ID1	Strong	Biomarker	[734]
APC	OTKV0TIK	Strong	Biomarker	[735]
APEX2	OTJ22LIT	Strong	Altered Expression	[309]
APOA5	OTEVKLVA	Strong	Biomarker	[736]
ARHGAP1	OT0H2ZBZ	Strong	Biomarker	[737]
ARHGAP11B	OT6752M0	Strong	Genetic Variation	[738]
ARHGAP15	OT9CKHDC	Strong	Genetic Variation	[186]
ARHGAP32	OTBWBGUB	Strong	Biomarker	[737]
ARHGAP33	OTIU622H	Strong	Altered Expression	[495]
ARHGEF11	OTDOMEH6	Strong	Biomarker	[739]
ARHGEF6	OTN1ABGL	Strong	Biomarker	[419]
ARID2	OTIRJXWM	Strong	Biomarker	[740]
ARL3	OT3OGOMX	Strong	Genetic Variation	[741]
ARL6IP5	OTYZ6BEQ	Strong	Biomarker	[742]
ARNT	OTMSIEZY	Strong	Genetic Variation	[743]
ARNT2	OTAQD3YV	Strong	Biomarker	[232]
ARX	OTBGYH25	Strong	Biomarker	[744]
ASAH1	OT1DNGXL	Strong	Biomarker	[745]
ASB16	OT81CGRQ	Strong	Genetic Variation	[746]
ASCL1	OTI4X44G	Strong	Biomarker	[397]
ASH2L	OT3HG324	Strong	Biomarker	[405]
ASPM	OTKXQMNA	Strong	Biomarker	[264]
ASTN1	OT23FQIB	Strong	Genetic Variation	[747]
ATCAY	OTSIAM08	Strong	Altered Expression	[309]
ATP13A4	OTJYVW1I	Strong	Genetic Variation	[748]
ATP13A5	OTOXPRSC	Strong	Altered Expression	[748]
ATP2B2	OT1NPZ9T	Strong	Genetic Variation	[265]
ATP2B4	OTMWFDAC	Strong	Altered Expression	[454]
ATP5F1A	OT3FZDLX	Strong	Biomarker	[749]
ATP5F1C	OTV5GZK5	Strong	Biomarker	[750]
ATP5PD	OTAJDLE2	Strong	Altered Expression	[247]
ATP6V0D1	OT9GU2NW	Strong	Altered Expression	[309]
ATXN7	OTL3YF1H	Strong	Genetic Variation	[437]
AUTS2	OTAEXHSC	Strong	Genetic Variation	[751]
B3GAT1	OTXFP98E	Strong	Biomarker	[752]
B3GAT2	OTNSM9XP	Strong	Biomarker	[752]
B3GNT2	OTE69HV8	Strong	Biomarker	[753]
B9D1	OTWTXO75	Strong	Genetic Variation	[208]
BAIAP2	OT1KKMYZ	Strong	Biomarker	[754]
BBS4	OT0D3JC0	Strong	Biomarker	[755]
BBX	OTNQ3QUC	Strong	Genetic Variation	[186]
BCAN	OTPVY3ZR	Strong	Biomarker	[752]
BCAP31	OTKSACR4	Strong	Genetic Variation	[368]
BCAR3	OTPJ17M8	Strong	Genetic Variation	[186]
BCAS1	OTQKJR81	Strong	Biomarker	[756]
BEST1	OTWHE1ZC	Strong	Biomarker	[757]
BFAR	OTTBG0V7	Strong	Biomarker	[758]
BHLHE40	OTITX14U	Strong	Biomarker	[759]
BLOC1S1	OT123376	Strong	Biomarker	[760]
BLOC1S6	OT96NE03	Strong	Biomarker	[417]
BMPR1B	OTGFN0OD	Strong	Genetic Variation	[761]
BNIP3L	OTJKOMXE	Strong	Genetic Variation	[146]
BRAP	OTB7BAFQ	Strong	Genetic Variation	[762]
BRINP1	OTEUVSCP	Strong	Altered Expression	[763]
BSN	OTZ72VIB	Strong	Altered Expression	[309]
BTBD9	OTWQ6GA3	Strong	Biomarker	[764]
BTC	OTW4B2O0	Strong	Altered Expression	[712]
BTN2A1	OTUYPMZJ	Strong	Genetic Variation	[265]
BTN2A2	OTUOAJZA	Strong	Genetic Variation	[265]
BTN3A1	OTGZADIX	Strong	Genetic Variation	[265]
BTNL2	OTTTEMZA	Strong	Genetic Variation	[617]
C10orf90	OT6DNZC4	Strong	Genetic Variation	[277]
C1orf167	OTUEJ1MR	Strong	Genetic Variation	[741]
C2	OTHMF4YM	Strong	Genetic Variation	[265]
C3orf38	OTK4O2C1	Strong	Genetic Variation	[208]
C4A	OTXMOYXU	Strong	Genetic Variation	[765]
CABP1	OTLSSRGG	Strong	Genetic Variation	[146]
CACHD1	OTW13G4O	Strong	Genetic Variation	[277]
CACNG4	OTE70DMK	Strong	Genetic Variation	[668]
CACNG6	OT2PC1E1	Strong	Biomarker	[668]
CADM2	OT45PVKC	Strong	Genetic Variation	[186]
CADPS2	OTV1FW0M	Strong	Biomarker	[766]
CALB1	OTM7IXDG	Strong	Biomarker	[767]
CALB2	OTSNMCG9	Strong	Biomarker	[767]
CALHM1	OTUZPEYQ	Strong	Biomarker	[768]
CALN1	OTN2XE4T	Strong	Biomarker	[399]
CAMK2A	OTJGX19T	Strong	Altered Expression	[769]
CAMKMT	OTLJBRUW	Strong	Altered Expression	[770]
CARF	OTWE0T6Q	Strong	Genetic Variation	[544]
CARMIL1	OT1A5IX5	Strong	Genetic Variation	[146]
CBLIF	OTNE20WU	Strong	Biomarker	[415]
CCDC122	OTYJQAVG	Strong	Genetic Variation	[208]
CCDC137	OTV7FGKI	Strong	Biomarker	[142]
CCDC170	OTNQOJ6S	Strong	Genetic Variation	[544]
CCDC192	OTNIBPPY	Strong	Genetic Variation	[146]
CCDC25	OTNC58MD	Strong	Altered Expression	[771]
CCDC39	OTXRCVUD	Strong	Genetic Variation	[772]
CCDC60	OT9GGLTH	Strong	Genetic Variation	[773]
CCDC68	OT4KF6TL	Strong	Biomarker	[774]
CCDC86	OT5YQ0R0	Strong	Biomarker	[774]
CCDC88C	OTIU02BS	Strong	Genetic Variation	[775]
CCN6	OTRFHQ2Z	Strong	Biomarker	[375]
CCND2	OTDULQF9	Strong	Biomarker	[398]
CCT3	OTL6EOS1	Strong	Altered Expression	[309]
CCT6A	OTCYWL5F	Strong	Biomarker	[776]
CD2AP	OTC76KQM	Strong	Genetic Variation	[777]
CD79A	OTOJC8DV	Strong	Biomarker	[778]
CDC42EP3	OTUZ3U9Z	Strong	Biomarker	[481]
CDC42EP4	OTCPHZGJ	Strong	Biomarker	[481]
CDCA5	OTZLCQ5U	Strong	Biomarker	[292]
CDH13	OTD2CYM5	Strong	Genetic Variation	[779]
CDH20	OTJQVC1V	Strong	Genetic Variation	[277]
CDK16	OTUBXIIT	Strong	Biomarker	[780]
CDK2AP2	OTR99SJ8	Strong	Genetic Variation	[368]
CDNF	OT1TP2T8	Strong	Genetic Variation	[781]
CEACAM21	OTHVCMIP	Strong	Biomarker	[782]
CELF2	OTLJJ4VT	Strong	Biomarker	[415]
CEP41	OTKZTBOX	Strong	Genetic Variation	[783]
CETN1	OTGQ8JOZ	Strong	Biomarker	[784]
CFAP65	OTGB5HVT	Strong	Biomarker	[415]
CFC1	OT5DHGI8	Strong	Biomarker	[785]
CGNL1	OTRE9DGT	Strong	Genetic Variation	[786]
CHD4	OTBDEHDP	Strong	Biomarker	[142]
CHD8	OTS7A6AF	Strong	Genetic Variation	[787]
CHL1	OT6E6E8P	Strong	Biomarker	[788]
CHP1	OTHTXN1A	Strong	Altered Expression	[309]
CHPT1	OT4FJ0K3	Strong	Genetic Variation	[789]
CHST10	OTEDU5YC	Strong	Biomarker	[752]
CHST11	OTNJJ5Q1	Strong	Genetic Variation	[277]
CHST9	OT1DEZRM	Strong	Genetic Variation	[790]
CHURC1	OTCVNVQN	Strong	Biomarker	[691]
CKLF	OTHLPHA0	Strong	Genetic Variation	[277]
CLDN1	OT27KV99	Strong	Biomarker	[616]
CLDN12	OTO55YZI	Strong	Biomarker	[791]
CLDN5	OTUX60YO	Strong	Biomarker	[792]
CLEC4D	OTT7X1UC	Strong	Biomarker	[793]
CLSTN3	OTPUFK4C	Strong	Genetic Variation	[146]
CLTB	OTPW9VRE	Strong	Altered Expression	[454]
CLVS1	OTQH008A	Strong	Genetic Variation	[794]
CLVS2	OTMIUTUF	Strong	Biomarker	[795]
CNBP	OTTGM9NK	Strong	Biomarker	[796]
CNIH3	OTNLZ2QS	Strong	Biomarker	[797]
CNOT1	OTTEU05F	Strong	Genetic Variation	[265]
CNPPD1	OT8G88R2	Strong	Biomarker	[537]
CNTN4	OTULXVE0	Strong	Genetic Variation	[146]
CNTNAP2	OT48T2ZP	Strong	Genetic Variation	[798]
CNTNAP3	OTIN65PT	Strong	Altered Expression	[799]
CNTNAP5	OTF0AAJD	Strong	Genetic Variation	[534]
COA8	OTOM9C4A	Strong	Genetic Variation	[146]
COL3A1	OTT1EMLM	Strong	Biomarker	[415]
COMMD10	OT1ANQLQ	Strong	Genetic Variation	[544]
COMTD1	OTLQJTBI	Strong	Biomarker	[800]
COPE	OTBKHBT7	Strong	Biomarker	[801]
COQ10B	OTNITN8H	Strong	Genetic Variation	[437]
CORO7	OTG7MEAJ	Strong	Genetic Variation	[146]
COX5A	OTP0961M	Strong	Biomarker	[802]
COX8A	OTU0NR39	Strong	Biomarker	[802]
CP	OTM8JE4Y	Strong	Biomarker	[803]
CPEB1	OTLCXC6H	Strong	Genetic Variation	[146]
CPLX2	OTU5QWFH	Strong	Genetic Variation	[804]
CRIP1	OT0EICG3	Strong	Biomarker	[805]
CRIP2	OTVVJSYX	Strong	Biomarker	[805]
CRLS1	OT7XNL0K	Strong	Biomarker	[475]
CRYBB2	OTL0Z8E6	Strong	Genetic Variation	[806]
CRYGD	OTW29JC4	Strong	Genetic Variation	[807]
CRYM	OTRGSR6B	Strong	Altered Expression	[309]
CSMD2	OT541Z3W	Strong	Genetic Variation	[808]
CSNK2B	OT2WW7R1	Strong	Biomarker	[809]
CSPG5	OTXFEBWR	Strong	Biomarker	[810]
CTCF	OT8ZB70U	Strong	Genetic Variation	[811]
CTIF	OT7DU7WN	Strong	Genetic Variation	[277]
CTNNA2	OTJ8G92T	Strong	Genetic Variation	[812]
CTNND2	OTYKE30Y	Strong	Biomarker	[813]
CTRL	OTB6NA5O	Strong	Altered Expression	[814]
CTXN3	OT534FDX	Strong	Genetic Variation	[815]
CUX1	OTU1LCNJ	Strong	Biomarker	[816]
CWC22	OT22MEO6	Strong	Genetic Variation	[146]
CYB561D1	OTNFHIC3	Strong	Genetic Variation	[186]
CYFIP1	OTOBEH24	Strong	Biomarker	[817]
CYFIP2	OTCAY35T	Strong	Altered Expression	[149]
CYP2D7	OTYJTL3S	Strong	Genetic Variation	[186]
CYTH4	OTOR82ID	Strong	Genetic Variation	[818]
DAXX	OTX6O7PL	Strong	Altered Expression	[371]
DAZAP1	OTWLY0UE	Strong	Biomarker	[819]
DBN1	OTZVKG8A	Strong	Biomarker	[395]
DCAF1	OT3ZDVOE	Strong	Genetic Variation	[186]
DCDC2	OTSUFH1H	Strong	Biomarker	[820]
DDN	OTM52ZF5	Strong	Genetic Variation	[186]
DDTL	OTG1LU87	Strong	Genetic Variation	[821]
DEGS2	OTXC27FL	Strong	Genetic Variation	[822]
DENND4A	OT8FFZ29	Strong	Genetic Variation	[186]
DENND5B	OTNDJJUR	Strong	Genetic Variation	[186]
DENND6B	OTZ006UD	Strong	Genetic Variation	[186]
DESI1	OTFNIW98	Strong	Biomarker	[823]
DGCR6	OTBOXM33	Strong	Genetic Variation	[824]
DGCR8	OT62LXE4	Strong	Biomarker	[825]
DGKI	OTDZ602D	Strong	Genetic Variation	[146]
DHDDS	OTVLYBUS	Strong	Genetic Variation	[789]
DHX9	OT5AAOQI	Strong	Biomarker	[826]
DIAPH2	OTBEYFEZ	Strong	Biomarker	[172]
DIXDC1	OT87DXEG	Strong	Biomarker	[827]
DKK4	OTWCCVF6	Strong	Biomarker	[828]
DLGAP3	OT0GR2F6	Strong	Biomarker	[829]
DLX1	OT7BH057	Strong	Biomarker	[830]
DMTF1	OTDKO9OO	Strong	Genetic Variation	[146]
DNAJB4	OTUD01BK	Strong	Genetic Variation	[186]
DNAJC5	OTCZDXAL	Strong	Genetic Variation	[831]
DNAJC6	OT1P6ZIE	Strong	Altered Expression	[309]
DNALI1	OTTB3L8N	Strong	Genetic Variation	[368]
DNASE1L3	OTEUIMC2	Strong	Biomarker	[832]
DOCK1	OTCFV3ON	Strong	Genetic Variation	[833]
DPYS	OTLTUIVL	Strong	Genetic Variation	[834]
DR1	OTR081M4	Strong	Biomarker	[835]
DST	OTHZBM4X	Strong	Genetic Variation	[836]
DTNB	OTX1HKM7	Strong	Biomarker	[320]
DUSP2	OTH54FMR	Strong	Biomarker	[205]
DYM	OTQ670WI	Strong	Biomarker	[609]
EBPL	OT59J1GY	Strong	Biomarker	[332]
EDEM2	OTQXYD65	Strong	Biomarker	[415]
EEPD1	OTTOGO05	Strong	Genetic Variation	[146]
EFCAB11	OTXDJ9R8	Strong	Biomarker	[795]
EFHD2	OTM9VMN3	Strong	Altered Expression	[309]
EFNB2	OT0DCUOM	Strong	Genetic Variation	[837]
EGR4	OT4R3ECK	Strong	Biomarker	[838]
EHD1	OTDMEKLV	Strong	Genetic Variation	[839]
EIF2D	OTE109AY	Strong	Altered Expression	[840]
EIF2S1	OTM0GDTP	Strong	Biomarker	[841]
EIF2S2	OTXF0B09	Strong	Biomarker	[841]
EIF2S3	OTARRES9	Strong	Biomarker	[841]
EIF3F	OTU20K6L	Strong	Genetic Variation	[208]
EIF4A2	OT08H03R	Strong	Altered Expression	[454]
EIF4ENIF1	OTZWDB2X	Strong	Genetic Variation	[842]
EIF5	OT79PQUN	Strong	Biomarker	[142]
ELAVL2	OT6EJ8MQ	Strong	Altered Expression	[843]
ELAVL4	OT3YH6J6	Strong	Genetic Variation	[146]
ELP4	OTP5GZ9V	Strong	Biomarker	[844]
EML5	OT0EFCPB	Strong	Biomarker	[845]
EMX1	OT7NG5MJ	Strong	Genetic Variation	[146]
EN1	OT2DKIDK	Strong	Genetic Variation	[846]
ENDOV	OTX2GXXX	Strong	Genetic Variation	[847]
EPB41L1	OT4CL5DC	Strong	Altered Expression	[309]
EPB41L3	OTS6CHG2	Strong	Altered Expression	[309]
EPC2	OTTG0W9R	Strong	Genetic Variation	[146]
EPM2A	OTJU4IAG	Strong	Biomarker	[180]
EPN2	OTH5BHUN	Strong	Genetic Variation	[186]
ERLIN1	OTUOOODY	Strong	Genetic Variation	[186]
ERMN	OTS3PBOH	Strong	Altered Expression	[454]
ERVW-1	OTWV8DXJ	Strong	Biomarker	[848]
ESAM	OTF518AI	Strong	Biomarker	[415]
ESD	OTUSIBPS	Strong	Genetic Variation	[849]
ESYT2	OTWCXTX3	Strong	Genetic Variation	[850]
ETF1	OTH8C5U5	Strong	Genetic Variation	[146]
ETFA	OTXX61VZ	Strong	Genetic Variation	[729]
EXOC4	OT5EWXAN	Strong	Genetic Variation	[186]
EXT1	OTRPALJK	Strong	Biomarker	[851]
EYS	OT0NBPL5	Strong	Genetic Variation	[146]
FABP7	OTRE2H4G	Strong	Biomarker	[852]
FAM184A	OTAI8E9G	Strong	Genetic Variation	[146]
FAM20C	OTW5YZ7X	Strong	Biomarker	[853]
FAM3D	OTM3GWFP	Strong	Biomarker	[415]
FAM53C	OTC2S7J3	Strong	Genetic Variation	[146]
FARP1	OTL1EBTM	Strong	Genetic Variation	[186]
FARSA	OT3U1P20	Strong	Altered Expression	[309]
FASTKD5	OTBNBGVI	Strong	Biomarker	[415]
FBP1	OTQBANEP	Strong	Genetic Variation	[570]
FBXO28	OTKTMVC4	Strong	Biomarker	[854]
FBXO45	OTD4D2OP	Strong	Genetic Variation	[855]
FCN2	OTTHJBKZ	Strong	Biomarker	[292]
FER1L6	OTII95GE	Strong	Genetic Variation	[544]
FGA	OTMIHY80	Strong	Genetic Variation	[856]
FGF9	OT2SKDGM	Strong	Biomarker	[857]
FH	OTEQWU6Q	Strong	Biomarker	[793]
FHL5	OT6C00Z1	Strong	Genetic Variation	[248]
FLOT1	OT0JPPJZ	Strong	Genetic Variation	[146]
FOXG1	OTAW57J4	Strong	Altered Expression	[858]
FOXN3	OTOJYJZP	Strong	Genetic Variation	[277]
FRMPD4	OT60SNXQ	Strong	Genetic Variation	[859]
FSTL1	OT6KEZUD	Strong	Genetic Variation	[398]
FUBP1	OT77SC9N	Strong	Altered Expression	[309]
FUCA2	OTY5NVMJ	Strong	Biomarker	[563]
FUT8	OTJJCVG1	Strong	Altered Expression	[563]
FXYD1	OTNKT6GP	Strong	Biomarker	[860]
FZD1	OTZATHVS	Strong	Biomarker	[861]
FZD4	OTGLZIE0	Strong	Biomarker	[364]
FZD5	OTXFFY56	Strong	Biomarker	[861]
GABARAP	OTAQUX6E	Strong	Altered Expression	[680]
GABRA4	OT5I7OI2	Strong	Biomarker	[352]
GABRB3	OT80C3D4	Strong	Altered Expression	[862]
GABRG1	OT1NGUYY	Strong	Genetic Variation	[863]
GALNT10	OTZ6FDOL	Strong	Genetic Variation	[146]
GAS7	OT0M5TNY	Strong	Biomarker	[864]
GATAD2A	OTFM8D3O	Strong	Biomarker	[865]
GBP1	OTUM7RPJ	Strong	Altered Expression	[866]
GC	OTWS63BY	Strong	Biomarker	[260]
GCHFR	OTEOT8GI	Strong	Biomarker	[292]
GFRA1	OT3WBVYB	Strong	Genetic Variation	[355]
GID4	OT0TOD0M	Strong	Genetic Variation	[146]
GIGYF2	OTFNVEJ4	Strong	Genetic Variation	[186]
GIPC2	OT68YFO1	Strong	Genetic Variation	[186]
GIT1	OTHO92S5	Strong	Genetic Variation	[867]
GLT8D1	OTG14TPO	Strong	Biomarker	[809]
GLUD1	OTXKOCUH	Strong	Biomarker	[868]
GLUD2	OTF3GGYY	Strong	Biomarker	[869]
GLYCTK	OTVTBNSM	Strong	Altered Expression	[870]
GMFB	OTR1JN1D	Strong	Biomarker	[871]
GNA13	OTVDL515	Strong	Biomarker	[872]
GNAL	OTESDTEU	Strong	Altered Expression	[873]
GNAS	OTMH8BKJ	Strong	Biomarker	[874]
GNB1	OTLL7L74	Strong	Altered Expression	[247]
GNL3	OTILGYO4	Strong	Genetic Variation	[179]
GNMT	OT0O2OQO	Strong	Biomarker	[875]
GNPAT	OTF6LWPO	Strong	Biomarker	[876]
GOLGA6A	OTHU9MRX	Strong	Biomarker	[330]
GOLGA8A	OTSNE9EQ	Strong	Biomarker	[877]
GOLPH3L	OTT2K3LQ	Strong	Altered Expression	[878]
GOSR1	OTX8TMVU	Strong	Genetic Variation	[368]
GOT2	OT6XBWN0	Strong	Altered Expression	[879]
GPC1	OTQKRSSV	Strong	Biomarker	[880]
GPHN	OTAKK1SV	Strong	Genetic Variation	[881]
GPR151	OT7EACU6	Strong	Biomarker	[364]
GPR153	OT81CA1Z	Strong	Biomarker	[415]
GPR42	OTEB0ROY	Strong	Biomarker	[246]
GPR50	OT0EJBM4	Strong	Genetic Variation	[882]
GPR52	OTPR99C7	Strong	Biomarker	[883]
GPR78	OT8TKE6F	Strong	Biomarker	[884]
GPRC5C	OT45AJT3	Strong	Altered Expression	[363]
GPRIN2	OT4A0O1S	Strong	Biomarker	[614]
GPS1	OT97FRYE	Strong	Biomarker	[742]
GRAMD1B	OTCG1GX2	Strong	Genetic Variation	[146]
GRB10	OTCKXGRC	Strong	Genetic Variation	[885]
GRHL3	OT1V4ZEH	Strong	Biomarker	[886]
GRIN3B	OT7T1OJP	Strong	Genetic Variation	[887]
GRTP1	OT8HORRZ	Strong	Genetic Variation	[544]
GSDME	OT1ZWY32	Strong	Genetic Variation	[437]
GSPT1	OT18H1B0	Strong	Altered Expression	[309]
GSTK1	OTDNGWAF	Strong	Biomarker	[540]
GSTM2	OTG4WT05	Strong	Genetic Variation	[888]
GSTT2	OTANW3TJ	Strong	Biomarker	[889]
GSTT2B	OTCMRDLE	Strong	Genetic Variation	[889]
GTDC1	OT8OBXKK	Strong	Genetic Variation	[775]
GTF3A	OTVROUVQ	Strong	Genetic Variation	[890]
GUK1	OTLI0HRU	Strong	Genetic Variation	[891]
GYPC	OTOEDR7O	Strong	Genetic Variation	[892]
H1-4	OTQ450A3	Strong	Biomarker	[893]
H1-5	OTAN7RD9	Strong	Genetic Variation	[680]
H2AC6	OTF3YK7V	Strong	Genetic Variation	[277]
H2AX	OT18UX57	Strong	Biomarker	[894]
H2AZ1	OT3KJJNQ	Strong	Genetic Variation	[895]
H2BC15	OTU39CFZ	Strong	Genetic Variation	[265]
H3-3B	OT9XHQ3C	Strong	Genetic Variation	[896]
H4C1	OTB71W46	Strong	Altered Expression	[897]
HABP2	OTAUIPW0	Strong	Genetic Variation	[898]
HAPLN2	OT0G3KEQ	Strong	Altered Expression	[899]
HAPLN4	OTZQOG9A	Strong	Biomarker	[752]
HAT1	OT307KEN	Strong	Genetic Variation	[186]
HCFC1	OT0UCK62	Strong	Biomarker	[900]
HCP5	OTV0YRI8	Strong	Genetic Variation	[265]
HEG1	OT3CUXA7	Strong	Biomarker	[901]
HIP1R	OTIPKEJC	Strong	Genetic Variation	[146]
HIVEP2	OTVOMCW4	Strong	Biomarker	[902]
HLA-DMB	OT17HGXJ	Strong	Genetic Variation	[265]
HLA-DQA2	OT1DH0N9	Strong	Genetic Variation	[265]
HLA-DRA	OT7KZMP2	Strong	Biomarker	[903]
HLA-DRB3	OT5PM9N7	Strong	Genetic Variation	[265]
HNRNPA0	OTCP792K	Strong	Altered Expression	[309]
HNRNPA3	OT4O4NFS	Strong	Biomarker	[273]
HNRNPC	OT47AK4C	Strong	Altered Expression	[904]
HNRNPDL	OTB3BFCV	Strong	Altered Expression	[904]
HNRNPK	OTNPRM8U	Strong	Altered Expression	[309]
HNRNPU	OTLQN1E2	Strong	Altered Expression	[309]
HOMER1	OTWFD3SI	Strong	Biomarker	[905]
HOMER2	OT4JGKJF	Strong	Biomarker	[906]
HOOK1	OTTTKV7V	Strong	Genetic Variation	[907]
HP1BP3	OTTJ5LX2	Strong	Altered Expression	[309]
HPS1	OTKS5I7T	Strong	Genetic Variation	[667]
HS3ST5	OTOB6Z3F	Strong	Genetic Variation	[506]
HS6ST1	OTABV7D2	Strong	Genetic Variation	[783]
HSPA12A	OTFOCDD6	Strong	Altered Expression	[908]
HTR3D	OTP6L08T	Strong	Biomarker	[683]
HYKK	OTBK1QPN	Strong	Genetic Variation	[146]
IARS1	OT9WXH5N	Strong	Biomarker	[909]
ICAM3	OTTZ5A5D	Strong	Genetic Variation	[616]
IFITM3	OT2QP8D3	Strong	Biomarker	[910]
IFT74	OTZBFEDD	Strong	Genetic Variation	[911]
IGF2BP2	OT4ZSEEE	Strong	Biomarker	[912]
IGFALS	OTTWCZYM	Strong	Biomarker	[913]
IGFBP4	OT2HZRBD	Strong	Biomarker	[914]
IGSF11	OTQEG2X1	Strong	Genetic Variation	[186]
IGSF9B	OTNOMYYQ	Strong	Genetic Variation	[146]
IL2RG	OTRZ3OMY	Strong	Altered Expression	[915]
IL3	OT0CQ35N	Strong	Biomarker	[916]
IL9R	OTILCLXA	Strong	Genetic Variation	[917]
IMMP2L	OT9WGAFD	Strong	Genetic Variation	[146]
IMMT	OTBDSLE7	Strong	Biomarker	[587]
INA	OT1D33T4	Strong	Altered Expression	[247]
INPP5A	OT9CMGMS	Strong	Biomarker	[415]
INSIG2	OTX4VY51	Strong	Genetic Variation	[918]
IP6K3	OTKUIVQZ	Strong	Genetic Variation	[186]
IPO9	OT1DGLQE	Strong	Biomarker	[919]
IQCB1	OTYQ28V9	Strong	Altered Expression	[920]
IQCJ	OTOC5U9H	Strong	Biomarker	[921]
IQGAP2	OTX2UA7P	Strong	Genetic Variation	[208]
ISL1	OTVNVKAX	Strong	Biomarker	[922]
ISM1	OTZTK2TV	Strong	Biomarker	[923]
ISX	OTULQRWA	Strong	Genetic Variation	[924]
ITGA2B	OT4Y17PY	Strong	Genetic Variation	[571]
ITGB4	OT28UK84	Strong	Genetic Variation	[925]
ITGB5	OT21MF51	Strong	Altered Expression	[926]
ITIH4	OT460OO1	Strong	Genetic Variation	[927]
ITSN2	OT8S0OO8	Strong	Biomarker	[928]
JAG1	OT3LGT6K	Strong	Altered Expression	[280]
JAKMIP3	OT4EDANR	Strong	Genetic Variation	[783]
JARID2	OT14UM8H	Strong	Biomarker	[929]
KAT5	OTL7257A	Strong	Genetic Variation	[930]
KAT8	OT5LPQTR	Strong	Biomarker	[795]
KATNAL2	OTL33OIT	Strong	Genetic Variation	[186]
KATNB1	OT7CLZKS	Strong	Altered Expression	[339]
KCNH6	OTQ52G7V	Strong	Biomarker	[931]
KCNIP1	OTGLGK1R	Strong	Genetic Variation	[208]
KCTD12	OTPYKT4Z	Strong	Biomarker	[932]
KCTD13	OTSKZ1KM	Strong	Genetic Variation	[933]
KDM2B	OTDMCVW7	Strong	Biomarker	[142]
KDM3B	OTZU5J5S	Strong	Genetic Variation	[265]
KIAA0319	OTN42Y77	Strong	Biomarker	[934]
KIAA0513	OT7AVTFB	Strong	Altered Expression	[935]
KIDINS220	OTLBH2MA	Strong	Biomarker	[936]
KIF13A	OTSSZGBQ	Strong	Genetic Variation	[937]
KIF21A	OT511XD9	Strong	Altered Expression	[309]
KIF2A	OT2WQ6QD	Strong	Genetic Variation	[938]
KIF3B	OT0HJREB	Strong	Biomarker	[939]
KLF5	OT1ABI9N	Strong	Biomarker	[940]
KLF6	OTQY9S7F	Strong	Biomarker	[205]
KLHL23	OT2UVSD2	Strong	Genetic Variation	[544]
KMT2C	OTC59BCO	Strong	Biomarker	[941]
KPNA1	OTEMVAJ6	Strong	Biomarker	[142]
KPNA3	OTLI3TM2	Strong	Biomarker	[942]
KREMEN1	OTGJFSAC	Strong	Biomarker	[943]
KRIT1	OT58AP1I	Strong	Altered Expression	[770]
KTN1	OTQAV541	Strong	Biomarker	[944]
KYAT3	OTO4U2QK	Strong	Altered Expression	[309]
LAMA1	OTQZMP86	Strong	Biomarker	[142]
LAMA2	OTFROQWE	Strong	Biomarker	[141]
LAMP3	OTN0XL3W	Strong	Genetic Variation	[277]
LAMTOR2	OTHEDISB	Strong	Genetic Variation	[368]
LAT	OTZC1XZ1	Strong	Biomarker	[945]
LCN1	OT8BWXTV	Strong	Genetic Variation	[946]
LEMD2	OT0YLT7L	Strong	Genetic Variation	[146]
LETM2	OTCYGL4F	Strong	Genetic Variation	[146]
LGR6	OTPZ1PWR	Strong	Biomarker	[364]
LIG4	OT40DNXU	Strong	Biomarker	[947]
LIN28B	OTVWP0FN	Strong	Genetic Variation	[146]
LMLN	OTQF0JPY	Strong	Biomarker	[175]
LMNB2	OTXRDUOS	Strong	Altered Expression	[309]
LMOD2	OTFXHQFL	Strong	Biomarker	[948]
LPP	OT6TU8SE	Strong	Genetic Variation	[949]
LRFN2	OTI2QPM2	Strong	Genetic Variation	[950]
LRRC4	OT7XJ70N	Strong	Biomarker	[951]
LRRC57	OTOXZQ4K	Strong	Altered Expression	[952]
LRRN2	OTGP2DCY	Strong	Genetic Variation	[186]
LRRN3	OT7X0AA7	Strong	Genetic Variation	[146]
LRRTM1	OTKI3IU9	Strong	Genetic Variation	[953]
LRRTM4	OTYJ4348	Strong	Genetic Variation	[146]
LYPD4	OTYNO8BS	Strong	Biomarker	[143]
LYST	OTIUB1B3	Strong	Biomarker	[475]
MACF1	OTVIHD77	Strong	Genetic Variation	[954]
MAGI1	OTMV4ASV	Strong	Genetic Variation	[955]
MAIP1	OTR6I798	Strong	Genetic Variation	[265]
MAML2	OT1TSVAR	Strong	Genetic Variation	[186]
MAML3	OTZFV53Z	Strong	Genetic Variation	[186]
MAN1C1	OT44TM7D	Strong	Biomarker	[956]
MAP1A	OTHO8K43	Strong	Altered Expression	[309]
MAP1B	OTVXW089	Strong	Biomarker	[957]
MAP6	OTPUI00F	Strong	Biomarker	[958]
MAP7	OTVSSJ33	Strong	Biomarker	[959]
MAPK8IP3	OT0X8ACY	Strong	Biomarker	[960]
MARCHF1	OTI2EYO6	Strong	Genetic Variation	[961]
MARCHF10	OTAYGHDM	Strong	Altered Expression	[962]
MARCHF6	OTBTA03N	Strong	Biomarker	[963]
MARCHF9	OTWF84QT	Strong	Biomarker	[964]
MARK1	OTP7KL47	Strong	Biomarker	[965]
MAU2	OTALDF8Q	Strong	Genetic Variation	[146]
MBD5	OTFHT4MO	Strong	Genetic Variation	[966]
MBNL1	OTOV7J85	Strong	Biomarker	[967]
MCAT	OTH07FIW	Strong	Biomarker	[968]
MCC	OTQVI1EM	Strong	Genetic Variation	[969]
MCTP2	OTFMZ8I2	Strong	Biomarker	[970]
MDGA1	OTVXEF85	Strong	Biomarker	[971]
ME2	OTO4LL76	Strong	Biomarker	[972]
MECR	OTJQ5XKQ	Strong	Genetic Variation	[924]
MED26	OTT08OAS	Strong	Genetic Variation	[186]
MEF2A	OTV2SF6E	Strong	Biomarker	[973]
MEGF10	OTILSPJ6	Strong	Genetic Variation	[534]
MFAP1	OTZN4FT3	Strong	Altered Expression	[974]
MINDY2	OTQYW1J3	Strong	Biomarker	[975]
MLLT11	OTG5RVHC	Strong	Genetic Variation	[976]
MLLT3	OTXH4DDG	Strong	Biomarker	[977]
MNAT1	OTXLOYCB	Strong	Biomarker	[292]
MOB4	OTOQRMAS	Strong	Genetic Variation	[265]
MOXD1	OTUMCWRN	Strong	Genetic Variation	[978]
MPHOSPH9	OTNUNDQN	Strong	Genetic Variation	[146]
MPP2	OTPH8CZY	Strong	Biomarker	[979]
MPP4	OT7YG0AY	Strong	Genetic Variation	[507]
MPZL1	OTJSUUHR	Strong	Genetic Variation	[980]
MRGPRX3	OTRKCCDS	Strong	Biomarker	[364]
MRGPRX4	OTOBHZVA	Strong	Biomarker	[364]
MROH6	OTB3ENN6	Strong	Genetic Variation	[437]
MRPL33	OTA3YDH0	Strong	Genetic Variation	[146]
MRTFB	OT9OXGS9	Strong	Genetic Variation	[981]
MSANTD1	OT4NKG1S	Strong	Genetic Variation	[186]
MSH5	OTDARQT3	Strong	Genetic Variation	[265]
MSS51	OTDWY1RO	Strong	Biomarker	[982]
MT1B	OTUA4FFH	Strong	Biomarker	[435]
MTERF4	OT50CTOJ	Strong	Genetic Variation	[675]
MUC21	OTQ8GP5L	Strong	Biomarker	[720]
MUCL3	OTGAD3I0	Strong	Genetic Variation	[146]
MYH11	OTVNVWY3	Strong	Genetic Variation	[186]
MYL12B	OTXMLQOT	Strong	Altered Expression	[309]
MYO16	OTMS3D8W	Strong	Genetic Variation	[983]
MYO18B	OTGYY4NK	Strong	Genetic Variation	[772]
MYO1D	OTP2RGPN	Strong	Altered Expression	[309]
MYO5B	OTCKL3W3	Strong	Biomarker	[984]
NANOG	OTUEY1FM	Strong	Altered Expression	[985]
NANOS1	OT3UNZZY	Strong	Biomarker	[986]
NAT8L	OTA96AVN	Strong	Biomarker	[987]
NAV1	OT667KTL	Strong	Biomarker	[988]
NCAPG2	OTZYENKO	Strong	Genetic Variation	[850]
NCOA6	OTOMIGTV	Strong	Genetic Variation	[989]
NCSTN	OT5QBTA4	Strong	Genetic Variation	[990]
ND1	OTCLGIXV	Strong	Altered Expression	[991]
ND4	OT4RQVAA	Strong	Biomarker	[992]
ND5	OT45LW1K	Strong	Genetic Variation	[993]
NDOR1	OTKEA582	Strong	Altered Expression	[994]
NDP	OTGDJ4US	Strong	Biomarker	[995]
NDRG4	OTJBOTD8	Strong	Genetic Variation	[512]
NDUFB5	OTQAA1B8	Strong	Altered Expression	[454]
NDUFS6	OT9IOONQ	Strong	Altered Expression	[454]
NDUFV1	OTEVK4WW	Strong	Altered Expression	[996]
NDUFV2	OTSZF7D6	Strong	Biomarker	[997]
NEFH	OTMSCW5I	Strong	Altered Expression	[998]
NEFM	OT8VCBNF	Strong	Biomarker	[999]
NEK4	OTOB8366	Strong	Genetic Variation	[179]
NETO1	OTXP9A63	Strong	Genetic Variation	[1000]
NEUROD1	OTZQ7QJ2	Strong	Biomarker	[1001]
NEUROG2	OTAEMIGT	Strong	Biomarker	[1002]
NFASC	OTBDUXZT	Strong	Biomarker	[712]
NFATC2	OTK5T6HZ	Strong	Genetic Variation	[507]
NFIB	OTX94PD0	Strong	Genetic Variation	[186]
NGEF	OT9QUXJ3	Strong	Genetic Variation	[265]
NHS	OTKE8QAT	Strong	Genetic Variation	[1003]
NIPA1	OT9ODC8X	Strong	Biomarker	[1004]
NLGN2	OTHDYL3H	Strong	Altered Expression	[1005]
NLGN3	OTKDEC1Q	Strong	Genetic Variation	[1006]
NMBR	OTBJEGPN	Strong	Biomarker	[180]
NOL4	OTWI587R	Strong	Genetic Variation	[146]
NONO	OTN36Q6U	Strong	Altered Expression	[309]
NOTCH2NLA	OTD5QPCI	Strong	Genetic Variation	[1007]
NPAS1	OTZKO6ZN	Strong	Biomarker	[1008]
NPAS4	OTA3HH6W	Strong	Altered Expression	[1009]
NPC1	OTRIPICX	Strong	Genetic Variation	[186]
NPL	OTA7P0TO	Strong	Biomarker	[1010]
NPRL2	OTOB10MO	Strong	Biomarker	[415]
NPS	OTEG25A2	Strong	Genetic Variation	[1011]
NPTN	OTAQKSAU	Strong	Biomarker	[1012]
NPTX1	OTKVHCV0	Strong	Biomarker	[847]
NRCAM	OT80HHQ2	Strong	Biomarker	[616]
NRG2	OTMDE844	Strong	Altered Expression	[1013]
NRIP1	OTIZOJQV	Strong	Biomarker	[142]
NRSN1	OT1KKXC8	Strong	Biomarker	[1014]
NRXN2	OTB04QSU	Strong	Biomarker	[631]
NRXN3	OTJ0I7HJ	Strong	Genetic Variation	[1015]
NSD3	OT3677ZG	Strong	Genetic Variation	[512]
NSFL1C	OTIKQF3U	Strong	Altered Expression	[309]
NSG1	OTRIMA50	Strong	Genetic Variation	[524]
NSMCE2	OTJXLDC9	Strong	Genetic Variation	[208]
NSUN6	OTPBRUH6	Strong	Genetic Variation	[146]
NT5DC2	OTPDRGGN	Strong	Biomarker	[1016]
NTM	OTHF0UQU	Strong	Genetic Variation	[186]
NTNG1	OTF48IID	Strong	Genetic Variation	[1017]
NUCB2	OTHO6JWN	Strong	Biomarker	[1018]
NUCKS1	OTL4VJC5	Strong	Altered Expression	[309]
NUFIP2	OTZBZ224	Strong	Biomarker	[1019]
NUMBL	OTWMTMMH	Strong	Genetic Variation	[397]
NVL	OTWTGVTI	Strong	Genetic Variation	[1020]
NXF1	OTEFHXG6	Strong	Genetic Variation	[1021]
OCLN	OTSUTVWL	Strong	Biomarker	[283]
OPN1MW	OTPJ7LX4	Strong	Altered Expression	[1022]
OPN5	OTCYGHDA	Strong	Biomarker	[1023]
OR10A4	OTYYB8SY	Strong	Biomarker	[283]
OR12D3	OTQ9XNBB	Strong	Genetic Variation	[146]
OR2AG1	OTEITRP4	Strong	Biomarker	[1024]
OR5V1	OTSYXOD6	Strong	Genetic Variation	[146]
OSBPL10	OT0TFMBE	Strong	Genetic Variation	[146]
OSCP1	OTZ4IFGJ	Strong	Genetic Variation	[208]
OTUD7A	OT3GCY98	Strong	Genetic Variation	[544]
OXT	OT48M72Z	Strong	Altered Expression	[1025]
P2RX2	OT0LF34A	Strong	Genetic Variation	[448]
P2RX5	OTLBR20R	Strong	Genetic Variation	[448]
P2RX6	OT1FNTXA	Strong	Genetic Variation	[448]
P4HB	OTTYNYPF	Strong	Genetic Variation	[1026]
PADI1	OT13WAQX	Strong	Genetic Variation	[1026]
PAFAH1B1	OT9T2TCJ	Strong	Biomarker	[170]
PAG1	OTFOJUIQ	Strong	Genetic Variation	[1027]
PAK3	OT80M3BV	Strong	Genetic Variation	[867]
PAK6	OTAHPZTT	Strong	Genetic Variation	[437]
PANK2	OTFBW889	Strong	Biomarker	[1028]
PANX3	OTKRQZ1T	Strong	Genetic Variation	[1029]
PARP9	OT7K4494	Strong	Genetic Variation	[1030]
PAX6	OTOC9876	Strong	Biomarker	[844]
PBX2	OTEBYCAW	Strong	Genetic Variation	[265]
PCDH17	OTRK0M05	Strong	Genetic Variation	[186]
PCDH7	OTP091X8	Strong	Genetic Variation	[534]
PCDH8	OTDDOQM2	Strong	Genetic Variation	[1031]
PCDHA1	OT65E2NU	Strong	Genetic Variation	[1032]
PCED1B	OT19CDAB	Strong	Genetic Variation	[277]
PCLAF	OTMVIOUU	Strong	Biomarker	[1033]
PCLO	OTXJZZ98	Strong	Biomarker	[1034]
PCMT1	OTGYVSGU	Strong	Altered Expression	[247]
PCNX1	OTFP8XHC	Strong	Genetic Variation	[146]
PDIA2	OTC2WMXS	Strong	Genetic Variation	[1026]
PDIA6	OT8YBR17	Strong	Genetic Variation	[186]
PDIK1L	OTISF4KG	Strong	Biomarker	[1035]
PENK	OT8P3HMP	Strong	Genetic Variation	[1036]
PFKM	OT1QY9JM	Strong	Altered Expression	[309]
PGK1	OT6V1ICH	Strong	Altered Expression	[247]
PGP	OT6QQ7OR	Strong	Genetic Variation	[1037]
PHACTR3	OTUN0OAY	Strong	Genetic Variation	[174]
PHF5A	OTS94JFM	Strong	Altered Expression	[1038]
PICALM	OTQVRPMQ	Strong	Genetic Variation	[1039]
PIP4K2C	OTHRWR93	Strong	Biomarker	[1040]
PITPNM1	OTIUYAG5	Strong	Biomarker	[415]
PIWIL1	OT7CRGZ3	Strong	Genetic Variation	[1041]
PIWIL4	OTDA9MY0	Strong	Genetic Variation	[1041]
PKDCC	OTVXJR26	Strong	Genetic Variation	[850]
PKHD1	OTAH8SMF	Strong	Biomarker	[1042]
PLA1A	OT2IXYNX	Strong	Genetic Variation	[1043]
PLA2G10	OTRZ2L5A	Strong	Biomarker	[1044]
PLA2G12A	OTHHCQ17	Strong	Genetic Variation	[1045]
PLA2G15	OT6VJTPA	Strong	Genetic Variation	[512]
PLA2G5	OTQRSKCZ	Strong	Genetic Variation	[930]
PLA2G6	OT5FL0WU	Strong	Genetic Variation	[1046]
PLCH2	OTYERO80	Strong	Genetic Variation	[437]
PLCL1	OTJL2C79	Strong	Genetic Variation	[146]
PLCL2	OTK5FDF6	Strong	Genetic Variation	[186]
PLEC	OTU4XDEG	Strong	Altered Expression	[309]
PLEKHF1	OT9OL16U	Strong	Biomarker	[1047]
PLLP	OTFGCB9U	Strong	Biomarker	[1048]
PLXNA2	OTNNBJMQ	Strong	Genetic Variation	[1049]
PLXNB1	OTCA7JIT	Strong	Biomarker	[568]
PLXNB3	OTXRKPOO	Strong	Biomarker	[1050]
PMCH	OT3D9SA4	Strong	Biomarker	[231]
PMP2	OTKYV2NE	Strong	Biomarker	[1051]
PMP22	OTXWYWCZ	Strong	Biomarker	[1052]
POFUT1	OTOBJZIT	Strong	Biomarker	[563]
POFUT2	OT1MNJFZ	Strong	Altered Expression	[563]
POLD4	OTG578YH	Strong	Biomarker	[424]
POLR2A	OTHJQ1DZ	Strong	Biomarker	[811]
POM121L2	OTQI36MZ	Strong	Genetic Variation	[146]
POTEF	OTV3WXYE	Strong	Altered Expression	[1053]
POTEM	OT7L2HGH	Strong	Genetic Variation	[248]
POU3F1	OTYARA94	Strong	Biomarker	[489]
PPARGC1A	OTHCDQ22	Strong	Genetic Variation	[461]
PPP1R13B	OTC88VQO	Strong	Genetic Variation	[265]
PPP1R16B	OTZJFX5C	Strong	Genetic Variation	[186]
PPP1R9A	OTJL2TOC	Strong	Biomarker	[1054]
PPP1R9B	OTDCTHTT	Strong	Altered Expression	[309]
PPP3CB	OTEGNEHW	Strong	Altered Expression	[1055]
PPP3R1	OTGQNFJQ	Strong	Biomarker	[1056]
PRDM14	OTWZKY4L	Strong	Genetic Variation	[146]
PRKAA1	OT7TNF0L	Strong	Genetic Variation	[775]
PRPF40B	OTBPUXVD	Strong	Genetic Variation	[186]
PRRG2	OTDB5E7V	Strong	Genetic Variation	[146]
PRSS3	OTN3S5YB	Strong	Biomarker	[1057]
PSD	OTUZIXUZ	Strong	Biomarker	[1058]
PSD3	OTTN9B9O	Strong	Genetic Variation	[146]
PSMG1	OTZ5I6UM	Strong	Biomarker	[205]
PSORS1C1	OT9HK436	Strong	Genetic Variation	[146]
PSORS1C2	OTK43GE4	Strong	Genetic Variation	[720]
PTGES3	OTPPQWI0	Strong	Altered Expression	[348]
PTPN21	OTQBZWSE	Strong	Genetic Variation	[845]
PTPN4	OT6SXU5Y	Strong	Biomarker	[1059]
PTPRG	OT9N2WOF	Strong	Altered Expression	[1060]
PTPRN2	OTL6SH28	Strong	Genetic Variation	[186]
PURA	OT975ELW	Strong	Altered Expression	[309]
PVR	OT3N91T7	Strong	Genetic Variation	[1061]
PYCARD	OT67RON3	Strong	Biomarker	[1062]
R3HDM2	OTMJ3S6J	Strong	Genetic Variation	[512]
R3HDML	OTWEYRPN	Strong	Biomarker	[1063]
RAB11FIP5	OTNA33DE	Strong	Genetic Variation	[186]
RAB3GAP1	OT4DQ8F2	Strong	Biomarker	[871]
RABGEF1	OTWC3Z3R	Strong	Genetic Variation	[1049]
RALGPS1	OTEQN0MA	Strong	Genetic Variation	[146]
RANGAP1	OTZGD3LJ	Strong	Biomarker	[1064]
RAPGEF2	OTZWX2AA	Strong	Biomarker	[1065]
RAPGEF6	OTR1QQA3	Strong	Biomarker	[1065]
RASGRF1	OTNWJ7EN	Strong	Altered Expression	[1066]
RASL12	OTNAK9X4	Strong	Genetic Variation	[1067]
RASSF1	OTEZIPB7	Strong	Genetic Variation	[146]
RB1CC1	OTZK8PFX	Strong	Genetic Variation	[1068]
RBFOX1	OTFPKEL7	Strong	Biomarker	[1069]
RBKS	OTDG01Y9	Strong	Genetic Variation	[146]
RBM12	OTQYZ3LQ	Strong	Genetic Variation	[1070]
RBM23	OTDNGLHY	Strong	Genetic Variation	[186]
RBM6	OTI99KAZ	Strong	Genetic Variation	[186]
RBP1	OTRP1MFC	Strong	Biomarker	[773]
RCBTB1	OTAYELI8	Strong	Biomarker	[330]
RELA	OTUJP9CN	Strong	Biomarker	[1071]
REM1	OTUXL0HC	Strong	Genetic Variation	[1072]
RERE	OT3G4GBZ	Strong	Genetic Variation	[146]
RETREG2	OT5CJTMK	Strong	Biomarker	[537]
RFESD	OTLYAJIB	Strong	Genetic Variation	[675]
RFLNA	OT6GS3XQ	Strong	Genetic Variation	[146]
RFT1	OTW82NET	Strong	Genetic Variation	[265]
RFX1	OTZUDMPR	Strong	Biomarker	[1073]
RGS5	OTUY0Q2I	Strong	Genetic Variation	[1074]
RGS9	OTRA1LOC	Strong	Genetic Variation	[1075]
RIMS2	OTQASWDH	Strong	Altered Expression	[1076]
RLBP1	OTCY4D6B	Strong	Altered Expression	[309]
RNF40	OTC8SDA3	Strong	Biomarker	[1077]
RNH1	OT6EC79B	Strong	Altered Expression	[454]
ROPN1L	OTRWZJ68	Strong	Biomarker	[264]
RPA1	OT76POLP	Strong	Biomarker	[1078]
RPL13	OTFKNTD6	Strong	Altered Expression	[454]
RPL3	OTX6VXLB	Strong	Biomarker	[491]
RPL37	OTB6SDZ1	Strong	Genetic Variation	[775]
RPP14	OT4OYFSK	Strong	Genetic Variation	[368]
RPS10	OTE3VSAH	Strong	Altered Expression	[454]
RRN3	OTKGOZ49	Strong	Genetic Variation	[186]
RTKN2	OTV2AXQM	Strong	Genetic Variation	[152]
S100A11	OTI57KDN	Strong	Altered Expression	[1079]
SAMD4A	OT4MKCC8	Strong	Genetic Variation	[208]
SAP30BP	OT970EYO	Strong	Biomarker	[415]
SATB2	OT2W80XC	Strong	Genetic Variation	[1080]
SBNO1	OTNX3RL0	Strong	Biomarker	[142]
SBNO2	OT1C6J3K	Strong	Biomarker	[1081]
SCAF1	OT16TM3N	Strong	Genetic Variation	[512]
SCPEP1	OT43LYEZ	Strong	Genetic Variation	[1082]
SDF2L1	OTE7JIO2	Strong	Biomarker	[1083]
SDF4	OTQ7WFYW	Strong	Biomarker	[142]
SEC24C	OTMTJBQ1	Strong	Biomarker	[1081]
SEH1L	OTHW13AE	Strong	Genetic Variation	[186]
SELENOH	OTZ0QU22	Strong	Genetic Variation	[146]
SELENOP	OT02B8IR	Strong	Biomarker	[568]
SEMA3D	OTD5TJV1	Strong	Biomarker	[1084]
SEMA6A	OTDQ7QAW	Strong	Genetic Variation	[1085]
SEMA6D	OTU0UAZS	Strong	Genetic Variation	[186]
SEPTIN11	OTX2O0ZX	Strong	Biomarker	[1086]
SEPTIN2	OT3G33TM	Strong	Biomarker	[481]
SEPTIN4	OTD16B30	Strong	Altered Expression	[309]
SEPTIN5	OT6JTJBO	Strong	Biomarker	[1087]
SEPTIN7	OTJI08YX	Strong	Biomarker	[292]
SERPINA3	OT9BP2S0	Strong	Genetic Variation	[248]
SERPINA4	OTBK0GG7	Strong	Genetic Variation	[732]
SERPINA5	OTTZXPGD	Strong	Biomarker	[1088]
SERPINF2	OTZGAF8B	Strong	Biomarker	[482]
SERPINI1	OTUJHIJW	Strong	Biomarker	[1089]
SET	OTGYYQJO	Strong	Biomarker	[1090]
SETDB1	OTWVUA1B	Strong	Genetic Variation	[1091]
SF3B6	OTPRKS6S	Strong	Genetic Variation	[368]
SFI1	OTI1P52G	Strong	Altered Expression	[1092]
SFSWAP	OT7H3ETA	Strong	Biomarker	[928]
SFTA2	OTVRIUIV	Strong	Genetic Variation	[146]
SFXN5	OTISLOMU	Strong	Genetic Variation	[146]
SGCD	OTRBL3NQ	Strong	Genetic Variation	[208]
SH3GL2	OTOE443G	Strong	Biomarker	[794]
SH3PXD2A	OTYRQJIH	Strong	Biomarker	[1093]
SHMT1	OTIINA3J	Strong	Biomarker	[1094]
SIPA1L2	OT8NJE5D	Strong	Genetic Variation	[146]
SKAP2	OTSF44KP	Strong	Biomarker	[1095]
SKIL	OTNBXH32	Strong	Altered Expression	[1096]
SKP1	OT5BPAZ4	Strong	Biomarker	[1097]
SLC26A8	OTNCW8RJ	Strong	Biomarker	[415]
SLC35G1	OTKZUA8O	Strong	Biomarker	[823]
SLC7A6OS	OT09YHAQ	Strong	Genetic Variation	[146]
SLIT3	OTU8MKEU	Strong	Genetic Variation	[1098]
SLITRK1	OT1QQ7FR	Strong	Biomarker	[1099]
SMG1	OTTS3SXE	Strong	Genetic Variation	[277]
SMG6	OTRCEJQL	Strong	Genetic Variation	[512]
SMPD3	OTHQBETH	Strong	Genetic Variation	[186]
SMS	OT8JYKNH	Strong	Biomarker	[1100]
SNCB	OTELSEK6	Strong	Biomarker	[1101]
SNED1	OTBQVXY5	Strong	Genetic Variation	[675]
SNIP1	OTL3RA91	Strong	Genetic Variation	[1102]
SNORC	OTY3IJK5	Strong	Genetic Variation	[146]
SNRPN	OTQB1ID1	Strong	Biomarker	[1103]
SNTG1	OT6GBQHI	Strong	Genetic Variation	[480]
SNX19	OTGNS3HG	Strong	Genetic Variation	[1104]
SNX29	OTYMXH13	Strong	Genetic Variation	[186]
SOCS2	OTBPNKJQ	Strong	Biomarker	[1105]
SORBS1	OTWH8762	Strong	Altered Expression	[309]
SORCS3	OT4VOMBC	Strong	Genetic Variation	[186]
SORL1	OTQ8FFNS	Strong	Biomarker	[1106]
SOS1	OTTCWXC3	Strong	Altered Expression	[1066]
SP4	OTWB30IZ	Strong	Altered Expression	[201]
SPATA6L	OTCQ01F6	Strong	Genetic Variation	[534]
SPECC1	OTPEML48	Strong	Genetic Variation	[146]
SPRED2	OTUX685J	Strong	Genetic Variation	[186]
SPRY4	OT2VK9N0	Strong	Altered Expression	[1107]
SPTBN2	OTDMJ75N	Strong	Biomarker	[742]
SRCIN1	OTQZNQQ5	Strong	Genetic Variation	[1108]
SRF	OTW18FQN	Strong	Genetic Variation	[1109]
SRM	OT4N5MDP	Strong	Biomarker	[1110]
SRPRA	OT5NMYTY	Strong	Biomarker	[1111]
SRRT	OTMYPSWV	Strong	Biomarker	[1081]
SRSF10	OTY6IJ11	Strong	Altered Expression	[1112]
SRSF6	OTGLOSYE	Strong	Altered Expression	[309]
SRSF7	OTRS4W4S	Strong	Altered Expression	[309]
ST3GAL1	OTFCO8QX	Strong	Biomarker	[1113]
ST6GALNAC1	OT3JQD99	Strong	Biomarker	[1114]
STAG1	OT564IX4	Strong	Genetic Variation	[146]
STATH	OTQHBHM9	Strong	Biomarker	[1115]
STAU1	OTTR5311	Strong	Genetic Variation	[186]
STH	OTK8ULTH	Strong	Genetic Variation	[1116]
STK19	OTYM6437	Strong	Genetic Variation	[146]
STK24	OTGUHOIL	Strong	Genetic Variation	[186]
STMN2	OT0FUHLH	Strong	Altered Expression	[1053]
STRN	OTLOZL5I	Strong	Altered Expression	[309]
STUB1	OTSUYI9A	Strong	Altered Expression	[309]
STX7	OTHW3GEI	Strong	Genetic Variation	[978]
STXBP1	OTRYA8C3	Strong	Biomarker	[1117]
STXBP5L	OTNXAUKD	Strong	Genetic Variation	[812]
SUCO	OT3I9VO9	Strong	Biomarker	[1118]
SUGP1	OT7W0EB8	Strong	Biomarker	[1119]
SYNDIG1	OT8P9T93	Strong	Biomarker	[1063]
SYNE1	OTSBSLUH	Strong	Altered Expression	[1120]
SYNGAP1	OT41HVYQ	Strong	Biomarker	[1121]
SYNPO	OTICDJAB	Strong	Genetic Variation	[1122]
TAC1	OTM842YW	Strong	Biomarker	[1123]
TAF15	OTNE038N	Strong	Genetic Variation	[186]
TAGLN3	OTJBP3VJ	Strong	Altered Expression	[1124]
TAPBP	OTL81AVZ	Strong	Biomarker	[505]
TAS2R38	OTX5MM36	Strong	Genetic Variation	[1125]
TBC1D1	OTI9V7B0	Strong	Genetic Variation	[1126]
TBC1D22A	OTP3JJLW	Strong	Genetic Variation	[975]
TBC1D2B	OT1GVN5H	Strong	Genetic Variation	[277]
TBC1D5	OTNHLLAX	Strong	Genetic Variation	[146]
TBCB	OTHZGAC4	Strong	Altered Expression	[309]
TBCD	OTS4JKNQ	Strong	Genetic Variation	[1127]
TBP	OT6C0S52	Strong	Altered Expression	[766]
TBPL1	OT4I143E	Strong	Biomarker	[519]
TBR1	OT14JQT8	Strong	Biomarker	[218]
TCEAL1	OTAPG2L5	Strong	Genetic Variation	[524]
TCTA	OT0AH12O	Strong	Genetic Variation	[1128]
TEAD1	OTK6971C	Strong	Genetic Variation	[186]
TEKT5	OTZ5OUHY	Strong	Biomarker	[415]
TENM2	OTPLUYEF	Strong	Genetic Variation	[534]
TENM3	OTWY13GR	Strong	Genetic Variation	[146]
TERF2IP	OT3M5P3G	Strong	Genetic Variation	[1049]
TET2	OTKKT03T	Strong	Genetic Variation	[186]
TEX36	OT1EBCJX	Strong	Genetic Variation	[277]
TGFBRAP1	OT80QNR5	Strong	Genetic Variation	[186]
THOC7	OTGZ74DG	Strong	Genetic Variation	[146]
TMC2	OTIUM099	Strong	Biomarker	[278]
TMED10	OTUXSHH7	Strong	Biomarker	[880]
TMED2	OTBLO7RW	Strong	Biomarker	[1014]
TMED5	OT70W1J8	Strong	Genetic Variation	[368]
TMEM132D	OTV6I4Z0	Strong	Genetic Variation	[277]
TMEM176A	OTOZDWXX	Strong	Biomarker	[147]
TMEM245	OTR7KEXW	Strong	Biomarker	[1129]
TMPRSS13	OTMAOAP3	Strong	Biomarker	[175]
TMSB10	OTLVZ13T	Strong	Biomarker	[1053]
TMX2	OTM9O21K	Strong	Genetic Variation	[512]
TOP3B	OTNFEUOO	Strong	Biomarker	[1130]
TOX	OTE8BL5Z	Strong	Biomarker	[840]
TPI1	OT14KP4B	Strong	Biomarker	[673]
TPPP	OTCFMSUF	Strong	Biomarker	[1014]
TPPP3	OTU8VUIG	Strong	Altered Expression	[309]
TRAK1	OTMQVYNP	Strong	Biomarker	[415]
TRIM10	OTEO4UCZ	Strong	Genetic Variation	[265]
TRIM26	OTS0DJIP	Strong	Genetic Variation	[146]
TRIM3	OT704FQ0	Strong	Altered Expression	[309]
TRIM31	OT7VW6RP	Strong	Genetic Variation	[265]
TRIM32	OTJOV0PG	Strong	Genetic Variation	[1131]
TRIM5	OTMZH7EJ	Strong	Biomarker	[614]
TRIP13	OTFM3TI9	Strong	Biomarker	[1034]
TRIP4	OTA8OASA	Strong	Biomarker	[491]
TRMT2A	OTQSAJGF	Strong	Genetic Variation	[1132]
TSBP1	OT5GE8IO	Strong	Genetic Variation	[265]
TSTD1	OT5DMKFX	Strong	Altered Expression	[339]
TTC12	OTDB24YV	Strong	Genetic Variation	[146]
TTC33	OTVN2VGH	Strong	Genetic Variation	[775]
TTC9C	OTMOWK6Z	Strong	Altered Expression	[309]
TTLL11	OTWXLE1J	Strong	Genetic Variation	[186]
ACP1	OTJ9CKLU	Definitive	Genetic Variation	[1133]
AGA	OTNWT1WB	Definitive	Biomarker	[1134]
BPIFA2	OTLFSDZD	Definitive	Altered Expression	[1135]
BTN1A1	OTSQWC36	Definitive	Biomarker	[1136]
CALM2	OTNYA92F	Definitive	Altered Expression	[770]
CNTN6	OTXVGVOR	Definitive	Genetic Variation	[1137]
COX1	OTG3O9BN	Definitive	Biomarker	[466]
DLD	OT378CU9	Definitive	Biomarker	[580]
ETNPPL	OTSXO9P6	Definitive	Biomarker	[1138]
GCSH	OTNC1OKA	Definitive	Biomarker	[580]
LMX1A	OTEEYD5L	Definitive	Biomarker	[1139]
NOVA1	OT6A9KHY	Definitive	Biomarker	[189]
PSPH	OTV1PVAX	Definitive	Altered Expression	[1135]
PSPN	OT54LLZJ	Definitive	Altered Expression	[1135]
RIDA	OTW4098I	Definitive	Altered Expression	[1135]
RSRC1	OTFCJ4S0	Definitive	Biomarker	[1140]
SARNP	OTE0OVK5	Definitive	Genetic Variation	[1141]
SRGAP3	OT9ZS72C	Definitive	Biomarker	[1142]
STXBP3	OTTTYMAQ	Definitive	Altered Expression	[1135]
TBX1	OTQLBPRA	Definitive	Biomarker	[1143]
THOC1	OTVABJ4Z	Definitive	Genetic Variation	[1141]
TPSG1	OTDESHKT	Definitive	Biomarker	[1144]

This Disease Is Related to 503 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
CNTN1	TTPR8FK	No Known	Unknown	[136]
DPYSL2	TTZCW3T	No Known	Unknown	[136]
FABP4	TTHWMFZ	No Known	Unknown	[139]
MAP2K7	TT6QY3J	No Known	Unknown	[144]
NR0B2	TT25A9Q	No Known	Unknown	[139]
SH2B3	TT36N7Z	No Known	Unknown	[137]
SYVN1	TT8XKYM	No Known	Unknown	[136]
TBXA2R	TT2O84V	No Known	Unknown	[139]
AGER	TTMO9HF	Limited	Altered Expression	[145]
AKT3	TTO6SGY	Limited	Genetic Variation	[146]
AMACR	TTLN1AP	Limited	Genetic Variation	[147]
ATF4	TTQCKWT	Limited	Genetic Variation	[148]
ATM	TTKBM7V	Limited	Altered Expression	[149]
CACNA1I	TTQZFTH	Limited	Genetic Variation	[146]
CD163	TTTZ9DE	Limited	Biomarker	[150]
CHEK1	TTTU902	Limited	Biomarker	[149]
CHRM2	TTYEG6Q	Limited	Genetic Variation	[151]
CHRNA2	TTF4E0J	Limited	Genetic Variation	[152]
CLCN3	TT8XNZ7	Limited	Genetic Variation	[146]
CRH	TTA7YIZ	Limited	Biomarker	[153]
CRY2	TTAO58M	Limited	Genetic Variation	[154]
CSPG4	TT7MYXI	Limited	Autosomal dominant	[155]
CUL3	TTPCU0Q	Limited	Genetic Variation	[156]
DGKZ	TTSBBXL	Limited	Genetic Variation	[157]
EIF2AK1	TTRUJBV	Limited	Genetic Variation	[158]
EPHX2	TT7WVHI	Limited	Biomarker	[159]
FOXP1	TT0MUCI	Limited	Genetic Variation	[146]
FURIN	TTH9WF6	Limited	Genetic Variation	[146]
GABRD	TTGXH6N	Limited	Biomarker	[160]
GABRQ	TTXDUR9	Limited	Genetic Variation	[161]
GCH1	TTLSWP6	Limited	Altered Expression	[162]
GNG7	TTCMBKF	Limited	Genetic Variation	[152]
GRIN2D	TT5POTG	Limited	Biomarker	[163]
GUSB	TTHS7CM	Limited	Altered Expression	[164]
HLA-DQA1	TTU2I3J	Limited	Biomarker	[165]
IL15RA	TTGN89I	Limited	Genetic Variation	[166]
IL2RA	TT10Y9E	Limited	Altered Expression	[167]
IMPA2	TTXWL6D	Limited	Genetic Variation	[168]
INHBA	TTVB30D	Limited	Genetic Variation	[152]
KCNN3	TT9JH25	Limited	Unknown	[169]
KIF5A	TTCJPAH	Limited	Biomarker	[170]
LASP1	TTZJA87	Limited	Genetic Variation	[171]
LIF	TTGZ5WN	Limited	Biomarker	[172]
LRP1	TT9JAGO	Limited	Unknown	[142]
MAD1L1	TTNE9U7	Limited	Genetic Variation	[173]
MARK2	TTAJ45Y	Limited	Genetic Variation	[152]
MMP16	TTNP4CU	Limited	Genetic Variation	[146]
MSI2	TTTXQF6	Limited	Genetic Variation	[174]
MSMB	TTYH1ZK	Limited	Biomarker	[175]
NAALAD2	TTUWQLT	Limited	Biomarker	[176]
NR4A3	TTJQB49	Limited	Genetic Variation	[177]
NTRK3	TTXABCW	Limited	Genetic Variation	[152]
OPRD1	TT27RFC	Limited	Genetic Variation	[152]
P2RX7	TT473XN	Limited	Biomarker	[178]
PBRM1	TTH8ZRL	Limited	Genetic Variation	[179]
PDE7B	TTWIEY9	Limited	Biomarker	[180]
PDGFB	TTQA6SX	Limited	Biomarker	[181]
PDGFRB	TTI7421	Limited	Biomarker	[182]
PEPD	TTLZXI0	Limited	Genetic Variation	[152]
PLG	TTP86E2	Limited	Genetic Variation	[183]
PRKCA	TTFJ8Q1	Limited	Biomarker	[184]
PRKCD	TT7A1BO	Limited	Biomarker	[185]
RARG	TT1Q3IE	Limited	Genetic Variation	[186]
SF3B1	TTL2WUI	Limited	Genetic Variation	[186]
SLC7A5	TTPH2JB	Limited	Biomarker	[187]
SNCA	TT08OSU	Limited	Biomarker	[188]
TARDBP	TT9RZ03	Limited	Biomarker	[189]
TCF7L2	TT80QAL	Limited	Biomarker	[190]
TMEM97	TT9NXW4	Limited	Biomarker	[191]
TPT1	TT3PTB6	Limited	Genetic Variation	[192]
TRPM3	TTO3TD8	Limited	Autosomal dominant	[155]
TRPM6	TTV76RD	Limited	Genetic Variation	[152]
TYR	TTULVH8	Limited	Biomarker	[176]
ZEB2	TTT2WK4	Limited	Genetic Variation	[186]
CSF2	TTNYZG2	Disputed	Biomarker	[193]
GAP43	TTSGLN5	Disputed	Biomarker	[194]
GSK3A	TTQWAU1	Disputed	Genetic Variation	[195]
HP	TTLC8E1	Disputed	Altered Expression	[196]
KDM5B	TTCLI75	Disputed	Genetic Variation	[197]
LTA	TTP73TM	Disputed	Genetic Variation	[198]
MET	TTNDSF4	Disputed	Biomarker	[199]
PDE4A	TTZ97H5	Disputed	Biomarker	[200]
SP1	TTZEP6S	Disputed	Biomarker	[201]
TOP1	TTGTQHC	Disputed	Genetic Variation	[202]
UBE3A	TTUZX6V	Disputed	Biomarker	[203]
ADCY1	TTV1ZSQ	moderate	Genetic Variation	[204]
ADCYAP1R1	TT5OREU	moderate	Biomarker	[205]
ALCAM	TT2AFT6	moderate	Biomarker	[206]
APOH	TT2OUI9	moderate	Biomarker	[207]
ATP2A2	TTE6THL	moderate	Genetic Variation	[146]
BCL11A	TTR61MW	moderate	Genetic Variation	[186]
CACNA1B	TT4FDG6	moderate	Genetic Variation	[208]
CDH11	TTRGWZC	moderate	Altered Expression	[209]
CSF2RA	TT6MP2Z	moderate	Biomarker	[210]
CSNK1E	TTA8PLI	moderate	Biomarker	[211]
CTLA4	TTI2S1D	moderate	Biomarker	[212]
CYP3A4	TTWP7HQ	moderate	Altered Expression	[213]
CYP3A5	TTHS0OK	moderate	Biomarker	[214]
DDR1	TTI1FPZ	moderate	Genetic Variation	[215]
DICER1	TTTEOPU	moderate	Biomarker	[216]
DNM1	TTE3JW9	moderate	Genetic Variation	[217]
FGFR1	TTRLW2X	moderate	Biomarker	[218]
FOLH1	TT9G4N0	moderate	Biomarker	[219]
GRIA3	TT82EZV	moderate	Biomarker	[220]
GSN	TTUH7OM	moderate	Biomarker	[221]
HCRTR1	TT60Q8D	moderate	Genetic Variation	[222]
HDAC9	TT8M4E1	moderate	Biomarker	[223]
HSPA9	TTMTPG3	moderate	Biomarker	[224]
IGF2	TTE8WGO	moderate	Posttranslational Modification	[225]
LBP	TTVQJLY	moderate	Altered Expression	[226]
LILRB1	TTC0QRJ	moderate	Biomarker	[227]
LPL	TTOF3WZ	moderate	Biomarker	[228]
MAPK1	TT4TQBX	moderate	Genetic Variation	[229]
MAPK3	TT1MG9E	moderate	Altered Expression	[230]
MCHR1	TTX4RTB	moderate	Altered Expression	[231]
NGFR	TTEDJN4	moderate	Biomarker	[232]
NRN1	TTS05MJ	moderate	Biomarker	[233]
NTSR1	TTTUMEP	moderate	Genetic Variation	[234]
PAK2	TT279WO	moderate	Biomarker	[235]
PDE4D	TTSKMI8	moderate	Genetic Variation	[236]
PPT1	TTSQC14	moderate	Altered Expression	[237]
SLC6A5	TTI0138	moderate	Biomarker	[238]
SREBF2	TTRQ4AP	moderate	Biomarker	[239]
THRA	TTTSEPU	moderate	Genetic Variation	[240]
TNFRSF1A	TTG043C	moderate	Biomarker	[241]
TNIK	TTPB1W3	moderate	Biomarker	[189]
AADAT	TTT3IXG	Strong	Biomarker	[242]
ABCA1	TTJW1GN	Strong	Genetic Variation	[243]
ABCG1	TTMWDGU	Strong	Genetic Variation	[244]
ACHE	TT1RS9F	Strong	Biomarker	[245]
ACKR3	TTRQJTC	Strong	Biomarker	[246]
ACO2	TTMTF2P	Strong	Altered Expression	[247]
ACTG1	TTGAZF9	Strong	Genetic Variation	[248]
ADAM10	TTVXEGU	Strong	Genetic Variation	[146]
ADAMTS4	TTYG6BU	Strong	Biomarker	[249]
ADK	TTL732K	Strong	Genetic Variation	[250]
ADM	TTV14YH	Strong	Biomarker	[251]
ADORA1	TTK25J1	Strong	Genetic Variation	[252]
ADRA1D	TT34BHT	Strong	Genetic Variation	[253]
ADRA2B	TTWM4TY	Strong	Biomarker	[246]
ADRA2C	TT2NUT5	Strong	Biomarker	[254]
AGRP	TT4DE1O	Strong	Biomarker	[255]
AICDA	TTKRTP6	Strong	Genetic Variation	[256]
ALAS1	TTG1FXO	Strong	Biomarker	[257]
ALK	TTPMQSO	Strong	Genetic Variation	[258]
AOC1	TTM3B5R	Strong	Altered Expression	[259]
APOA4	TTNC3WS	Strong	Biomarker	[260]
APP	TTE4KHA	Strong	Altered Expression	[261]
AQP3	TTLDNMQ	Strong	Biomarker	[262]
ARF1	TT70KXY	Strong	Altered Expression	[263]
ASPA	TT6TLZP	Strong	Biomarker	[264]
ATAT1	TTWUHQ1	Strong	Genetic Variation	[265]
ATP6V1A	TTL2PXZ	Strong	Altered Expression	[247]
ATXN2	TTPQJ7P	Strong	Genetic Variation	[266]
AVP	TTJ8EWH	Strong	Biomarker	[267]
BACE2	TT69DB8	Strong	Genetic Variation	[186]
BAGE	TTS5GLJ	Strong	Biomarker	[268]
BBOX1	TT9FOLC	Strong	Biomarker	[269]
BECN1	TT5M7LN	Strong	Altered Expression	[270]
BMP1	TT0L58T	Strong	Biomarker	[271]
BMP6	TT07RIB	Strong	Genetic Variation	[272]
BRD3	TTHE657	Strong	Genetic Variation	[186]
BRS3	TTKYEPM	Strong	Biomarker	[246]
BTG1	TTL7N2W	Strong	Biomarker	[273]
C1QB	TT8A9DM	Strong	Biomarker	[274]
C5	TTKANGO	Strong	Altered Expression	[275]
CACNA1F	TTJ0SO4	Strong	Genetic Variation	[276]
CACNA1S	TT94HRF	Strong	Genetic Variation	[277]
CACNA2D3	TTN7T29	Strong	Biomarker	[278]
CAMKK2	TTV298Y	Strong	Biomarker	[279]
CASP3	TTPF2QI	Strong	Altered Expression	[280]
CASP4	TT6KIOT	Strong	Biomarker	[142]
CAV1	TTXUBN2	Strong	Biomarker	[281]
CBS	TTVZJ7G	Strong	Genetic Variation	[282]
CCL11	TTCF05Y	Strong	Biomarker	[283]
CCL17	TTMPHAE	Strong	Biomarker	[284]
CCL2	TTNAY0P	Strong	Biomarker	[285]
CCL22	TTBTWI1	Strong	Altered Expression	[286]
CCNA2	TTAMQ62	Strong	Biomarker	[287]
CCND1	TTFCJ7S	Strong	Biomarker	[288]
CCR5	TTJIH8Q	Strong	Genetic Variation	[289]
CD160	TTOFEAS	Strong	Biomarker	[290]
CD4	TTN2JFW	Strong	Biomarker	[291]
CD9	TTZEIBV	Strong	Biomarker	[221]
CDC25C	TTESBNC	Strong	Genetic Variation	[146]
CDK5	TTL4Q97	Strong	Biomarker	[292]
CDK5R1	TTBYM6V	Strong	Biomarker	[292]
CDK9	TT1LVF2	Strong	Biomarker	[293]
CDKN1C	TTBSUAR	Strong	Biomarker	[294]
CFB	TTA0P7K	Strong	Biomarker	[295]
CFP	TTLA0VS	Strong	Biomarker	[296]
CGA	TTFC29G	Strong	Genetic Variation	[297]
CHAT	TTKYFSB	Strong	Biomarker	[298]
CHRM4	TTQ3JTF	Strong	Genetic Variation	[299]
CHRM5	TTH18TF	Strong	Biomarker	[300]
CHRNA1	TT54JVQ	Strong	Genetic Variation	[301]
CLU	TTRL76H	Strong	Genetic Variation	[302]
CNTN2	TT2Z1WB	Strong	Genetic Variation	[146]
CPS1	TT42M75	Strong	Biomarker	[303]
CRHBP	TT3PKZE	Strong	Genetic Variation	[304]
CRHR2	TTIY658	Strong	Biomarker	[305]
CRY1	TT5MLZR	Strong	Biomarker	[306]
CRYBB1	TTDS503	Strong	Altered Expression	[307]
CSF2RB	TTPYS82	Strong	Biomarker	[308]
CSNK2A1	TTER6YH	Strong	Altered Expression	[309]
CSPG4	TT7MYXI	Strong	Genetic Variation	[310]
CTSK	TTDZN01	Strong	Biomarker	[311]
CXCR6	TT2BVUA	Strong	Biomarker	[246]
CYP21A2	TTP4GLG	Strong	Genetic Variation	[146]
CYP2B6	TTMH124	Strong	Biomarker	[312]
CYP2C19	TTZ58XG	Strong	Genetic Variation	[313]
CYP2C9	TTR40YJ	Strong	Biomarker	[313]
DAAM2	TTN0Z6H	Strong	Biomarker	[314]
DAGLA	TTRQ6UD	Strong	Altered Expression	[315]
DEK	TT1NMGV	Strong	Altered Expression	[316]
DKK3	TTY2ZV6	Strong	Biomarker	[317]
DLK1	TTF4AVB	Strong	Biomarker	[318]
DLL1	TT9CFQD	Strong	Genetic Variation	[319]
DMD	TTWLFXU	Strong	Biomarker	[320]
DNAJB1	TTPXAWS	Strong	Altered Expression	[321]
DNASE1	TTYWGOJ	Strong	Biomarker	[322]
DNMT1	TT6S2FE	Strong	Biomarker	[323]
DNMT3A	TTJUALD	Strong	Genetic Variation	[324]
DNMT3B	TT6VZ78	Strong	Genetic Variation	[325]
DNMT3L	TT3FDAV	Strong	Biomarker	[326]
DPYD	TTZPS91	Strong	Genetic Variation	[146]
DPYSL2	TTZCW3T	Strong	Biomarker	[327]
DRD5	TTS2PH3	Strong	Biomarker	[328]
EBP	TT4VQZX	Strong	Genetic Variation	[329]
EDNRA	TTKRD0G	Strong	Biomarker	[246]
EHMT1	TTOFXD7	Strong	Biomarker	[330]
EHMT2	TTS6RZT	Strong	Genetic Variation	[265]
EIF2AK4	TT9U4EP	Strong	Genetic Variation	[331]
ELK3	TT5OJMV	Strong	Biomarker	[332]
EP300	TTGH73N	Strong	Posttranslational Modification	[333]
EPHA5	TTV9KOD	Strong	Genetic Variation	[186]
EPHB4	TTI4ZX2	Strong	Genetic Variation	[334]
ESR1	TTZAYWL	Strong	Biomarker	[335]
ESRRA	TTPNQAC	Strong	Altered Expression	[336]
EZH1	TTNJA0C	Strong	Biomarker	[337]
F10	TTCIHJA	Strong	Biomarker	[338]
F11R	TT3C8EG	Strong	Altered Expression	[339]
F2	TT6L509	Strong	Genetic Variation	[265]
F2R	TTL935N	Strong	Biomarker	[340]
FABP4	TTHWMFZ	Strong	Altered Expression	[341]
FADS2	TTT2VDU	Strong	Altered Expression	[342]
FAS	TT7LTUJ	Strong	Biomarker	[343]
FES	TTLBY21	Strong	Genetic Variation	[146]
FGF10	TTNPEFX	Strong	Biomarker	[344]
FGF14	TTKJX1V	Strong	Genetic Variation	[345]
FGF2	TTGKIED	Strong	Altered Expression	[346]
FGF21	TTQ916P	Strong	Biomarker	[347]
FKBP4	TTHY0FT	Strong	Altered Expression	[348]
FKBP5	TT0J5KQ	Strong	Altered Expression	[348]
FZD7	TTUQMO5	Strong	Altered Expression	[349]
GABRA5	TTNZPQ1	Strong	Genetic Variation	[350]
GABRR1	TT6XFEU	Strong	Biomarker	[351]
GABRR3	TT4N6D8	Strong	Genetic Variation	[352]
GALC	TT5IZRB	Strong	Altered Expression	[353]
GAPDH	TTUGSWA	Strong	Altered Expression	[309]
GART	TTEXB9Z	Strong	Biomarker	[354]
GFRA3	TT63XRS	Strong	Genetic Variation	[355]
GHR	TTHJWYD	Strong	Biomarker	[356]
GIPR	TTYMKBE	Strong	Genetic Variation	[357]
GJA8	TTJ7ATH	Strong	Biomarker	[358]
GLP1R	TTVIMDE	Strong	Biomarker	[330]
GNAQ	TTL1SRG	Strong	Biomarker	[359]
GPR17	TTMPART	Strong	Biomarker	[360]
GPR85	TTNRQJ3	Strong	Biomarker	[361]
GPR88	TTMRQY1	Strong	Altered Expression	[362]
GPRC5D	TTHRAPJ	Strong	Altered Expression	[363]
GPRC6A	TTI1PRE	Strong	Biomarker	[364]
GRIK5	TTO6LI7	Strong	Biomarker	[160]
GRM1	TTVBPDM	Strong	Biomarker	[365]
GRM5	TTHS256	Strong	Biomarker	[366]
GSTA1	TT4P8DE	Strong	Genetic Variation	[367]
GSTO1	TTWO3SH	Strong	Genetic Variation	[368]
HCAR2	TTWNV8U	Strong	Biomarker	[369]
HCN1	TTNB6UQ	Strong	Genetic Variation	[146]
HCRT	TTU5HJP	Strong	Biomarker	[370]
HDAC1	TT6R7JZ	Strong	Altered Expression	[371]
HDAC11	TT8K17W	Strong	Altered Expression	[372]
HDAC4	TTTQGH8	Strong	Biomarker	[265]
HHAT	TT1VNCG	Strong	Biomarker	[373]
HK2	TTK02H8	Strong	Genetic Variation	[277]
HMGA1	TTBA219	Strong	Biomarker	[374]
HPD	TT8DSFC	Strong	Biomarker	[375]
HPGDS	TTCYE56	Strong	Genetic Variation	[376]
HRH1	TTTIBOJ	Strong	Genetic Variation	[377]
HRH3	TT9JNIC	Strong	Genetic Variation	[378]
HRH4	TTXJ178	Strong	Biomarker	[379]
HSD11B2	TT9H85R	Strong	Genetic Variation	[380]
HSPA8	TTMQL3K	Strong	Altered Expression	[247]
HTR5A	TTRUFDT	Strong	Biomarker	[381]
HTT	TTIWZ0O	Strong	Genetic Variation	[382]
ICAM1	TTA1L39	Strong	Altered Expression	[383]
IDE	TT2EDHU	Strong	Biomarker	[384]
IFNGR2	TT13TL0	Strong	Genetic Variation	[385]
IFNL3	TTRF4Q2	Strong	Biomarker	[386]
IL12A	TTRTK6Y	Strong	Biomarker	[292]
IL12B	TTGW72V	Strong	Genetic Variation	[387]
IL17F	TT2B6PS	Strong	Altered Expression	[388]
IL19	TT87RWS	Strong	Biomarker	[389]
IL1R2	TT51DEV	Strong	Biomarker	[390]
IL2RB	TT9721Y	Strong	Biomarker	[391]
IL3RA	TTENHJ0	Strong	Biomarker	[392]
IRF3	TTYR7OH	Strong	Genetic Variation	[393]
ITGA8	TT1FW8B	Strong	Biomarker	[394]
ITGAM	TTB69FJ	Strong	Biomarker	[395]
ITGB3	TTJA1ZO	Strong	Biomarker	[396]
JAG2	TTOJY1B	Strong	Biomarker	[397]
JUN	TTS7IR5	Strong	Biomarker	[398]
KAT2B	TTVK7SB	Strong	Biomarker	[399]
KCNB1	TT5OEKU	Strong	Biomarker	[400]
KCNH2	TTQ6VDM	Strong	Genetic Variation	[401]
KCNJ3	TTGM19J	Strong	Genetic Variation	[402]
KCNN2	TT2T5M0	Strong	Genetic Variation	[186]
KCNQ2	TTPXI3S	Strong	Genetic Variation	[403]
KCNQ3	TTIVDM3	Strong	Genetic Variation	[404]
KCNQ5	TTWVL5Q	Strong	Genetic Variation	[404]
KDM1A	TTNR0UQ	Strong	Biomarker	[405]
KDM4C	TTV8CRH	Strong	Genetic Variation	[146]
KDM5C	TT94UCF	Strong	Biomarker	[405]
KDR	TTUTJGQ	Strong	Biomarker	[406]
KIR3DL2	TTQH3N0	Strong	Altered Expression	[309]
KMT2A	TT1GNDM	Strong	Altered Expression	[407]
L1CAM	TTC9D3K	Strong	Altered Expression	[309]
LANCL2	TTMK3EX	Strong	Altered Expression	[309]
LCK	TT860QF	Strong	Biomarker	[408]
LCT	TTA0OSE	Strong	Biomarker	[409]
LIFR	TTID542	Strong	Biomarker	[410]
LINGO1	TTZYQ80	Strong	Genetic Variation	[186]
LNPEP	TTY2KP7	Strong	Biomarker	[411]
LPAR1	TTQ6S1K	Strong	Biomarker	[412]
LPAR2	TTB7Y8I	Strong	Biomarker	[246]
LPAR3	TTE2YJR	Strong	Biomarker	[364]
LRP1	TTF2V7I	Strong	Genetic Variation	[413]
LSM1	TT2KHSC	Strong	Genetic Variation	[174]
LYVE1	TTG8DNU	Strong	Altered Expression	[414]
MAGEC1	TT9M6NA	Strong	Biomarker	[415]
MAN2A1	TT34DCN	Strong	Genetic Variation	[146]
MAP2K7	TT6QY3J	Strong	Biomarker	[144]
MAP3K8	TTGECUM	Strong	Genetic Variation	[416]
MAP4	TT0VFPN	Strong	Genetic Variation	[186]
MAPK14	TTQBR95	Strong	Biomarker	[417]
MAPK8	TT0K6EO	Strong	Biomarker	[418]
MARCKS	TTHRM39	Strong	Biomarker	[419]
MAS1	TTOISYB	Strong	Biomarker	[420]
MBOAT4	TTSYOWR	Strong	Biomarker	[421]
MC2R	TTPWFDX	Strong	Biomarker	[305]
MC4R	TTD0CIQ	Strong	Genetic Variation	[422]
MC5R	TT6QAJ3	Strong	Biomarker	[423]
MCHR2	TTS17MG	Strong	Biomarker	[423]
MCM7	TT1RM3F	Strong	Biomarker	[424]
MDK	TTV8UE7	Strong	Genetic Variation	[146]
MECP2	TTTAU9R	Strong	Genetic Variation	[425]
METAP2	TTZL0OI	Strong	Biomarker	[426]
MGAT1	TTYJRN5	Strong	Genetic Variation	[427]
MIA	TT5HNVS	Strong	Genetic Variation	[428]
MMP3	TTUZ2L5	Strong	Biomarker	[429]
MMP9	TT6X50U	Strong	Genetic Variation	[430]
MRGPRX1	TTIX6PK	Strong	Biomarker	[364]
MSRB1	TT1QUZV	Strong	Biomarker	[431]
MTNR1A	TT0WAIE	Strong	Biomarker	[432]
MTOR	TTCJG29	Strong	Biomarker	[433]
MTR	TTUTO39	Strong	Biomarker	[434]
MTTP	TTUS1RD	Strong	Biomarker	[435]
NDUFAF2	TTCHGVF	Strong	Genetic Variation	[186]
NEDD4	TT1QU6G	Strong	Genetic Variation	[436]
NEK1	TTO5QT2	Strong	Genetic Variation	[437]
NGF	TTDN3LF	Strong	Biomarker	[438]
NISCH	TT789FN	Strong	Biomarker	[439]
NPY	TT64REZ	Strong	Biomarker	[440]
NPY2R	TTJ6WK9	Strong	Altered Expression	[441]
NTF4	TTIM2WO	Strong	Altered Expression	[442]
NTRK1	TTTDVOJ	Strong	Biomarker	[443]
OPA1	TTTU49Q	Strong	Biomarker	[444]
OPRL1	TTNT7K8	Strong	Biomarker	[445]
OXER1	TT7WBSV	Strong	Biomarker	[364]
OXSR1	TT7ZY03	Strong	Biomarker	[446]
OXTR	TTSCIUP	Strong	Altered Expression	[447]
P2RX1	TTJW7B3	Strong	Genetic Variation	[448]
P2RX3	TT2THBD	Strong	Genetic Variation	[448]
P2RX4	TT1NLOA	Strong	Genetic Variation	[448]
P2RY1	TTA93TL	Strong	Genetic Variation	[448]
P2RY2	TTOZHQC	Strong	Genetic Variation	[448]
PCCB	TT5LURU	Strong	Genetic Variation	[449]
PDE10A	TTJW4LU	Strong	Biomarker	[450]
PDE2A	TTJGW1Z	Strong	Biomarker	[451]
PDE9A	TTZOEBC	Strong	Biomarker	[452]
PDZK1	TTDTBLM	Strong	Biomarker	[453]
PEBP1	TT1BGU8	Strong	Altered Expression	[454]
PGC	TT7K6AD	Strong	Genetic Variation	[455]
PHB	TT6U071	Strong	Altered Expression	[454]
PIK3CB	TT9H4P3	Strong	Biomarker	[456]
PLA2G2A	TTO8QRU	Strong	Altered Expression	[457]
PLAT	TTXAGYU	Strong	Biomarker	[458]
PLCB1	TTLPGU7	Strong	Biomarker	[459]
PLCG1	TT6T4JI	Strong	Biomarker	[460]
PML	TTLH9NY	Strong	Biomarker	[415]
PPARGC1B	TTKSQ3W	Strong	Genetic Variation	[461]
PPP2CA	TTHTKNY	Strong	Altered Expression	[462]
PPP3CA	TTA4LDE	Strong	Altered Expression	[454]
PRCP	TTTJZ4M	Strong	Biomarker	[271]
PREP	TTNGKET	Strong	Biomarker	[463]
PRKAR2B	TTW4Y2M	Strong	Biomarker	[464]
PRKCG	TTRFOXJ	Strong	Altered Expression	[309]
PRKD1	TTSLUMT	Strong	Genetic Variation	[146]
PRKG1	TT7IZSA	Strong	Genetic Variation	[146]
PSMB6	TT8EPLT	Strong	Genetic Variation	[319]
PSMB9	TTOUSTQ	Strong	Genetic Variation	[265]
PSMD10	TT2H4LN	Strong	Genetic Variation	[368]
PTGER3	TTPNGDE	Strong	Biomarker	[465]
PTGIS	TTLXKZR	Strong	Genetic Variation	[146]
PTGS1	TT8NGED	Strong	Biomarker	[466]
PTK7	TTXH2ZN	Strong	Biomarker	[467]
PTPN1	TTELIN2	Strong	Genetic Variation	[468]
PTPN6	TT369M5	Strong	Altered Expression	[469]
PYY	TTVFJLX	Strong	Biomarker	[255]
QPCT	TTJ7YTV	Strong	Genetic Variation	[248]
RAPGEF4	TTOS63B	Strong	Genetic Variation	[186]
RBPJ	TT72D4Z	Strong	Biomarker	[470]
RENBP	TTZCG0Q	Strong	Genetic Variation	[471]
RGS12	TTP9AV7	Strong	Biomarker	[415]
RGS6	TTJ96M8	Strong	Genetic Variation	[146]
RHD	TTLCKI8	Strong	Genetic Variation	[472]
RIPK2	TTCQ2E5	Strong	Genetic Variation	[473]
RORA	TT1TYN7	Strong	Genetic Variation	[474]
RORC	TTGV6LY	Strong	Biomarker	[388]
RPS6KA3	TTUM2ZR	Strong	Biomarker	[475]
RXRB	TTKLV96	Strong	Biomarker	[476]
S100A9	TT0TMQG	Strong	Genetic Variation	[368]
S100B	TTQ0V86	Strong	Altered Expression	[477]
S1PR1	TT9JZCK	Strong	Biomarker	[478]
SCN2A	TTLJTUF	Strong	Genetic Variation	[479]
SCN4A	TT84DRB	Strong	Genetic Variation	[480]
SEPTIN6	TTAGE7U	Strong	Biomarker	[481]
SERPINC1	TT4QPUL	Strong	Biomarker	[482]
SERPING1	TTVQ6R9	Strong	Biomarker	[483]
SGCG	TTSMT9W	Strong	Biomarker	[484]
SIRPA	TTBRJS9	Strong	Altered Expression	[309]
SLC12A6	TT8DFHE	Strong	Genetic Variation	[485]
SLC1A2	TT2F078	Strong	Biomarker	[486]
SLC1A3	TT8WRDA	Strong	Altered Expression	[487]
SLC1A6	TT6KMPN	Strong	Genetic Variation	[488]
SLC22A16	TTITAVR	Strong	Biomarker	[489]
SLC25A4	TTU5A6Q	Strong	Altered Expression	[490]
SLC38A2	TTUSC27	Strong	Biomarker	[491]
SLC38A3	TTMAVJQ	Strong	Genetic Variation	[146]
SLC6A1	TTPRKM0	Strong	Altered Expression	[492]
SLC6A11	TT8RXO5	Strong	Biomarker	[493]
SLC6A12	TTQBMPI	Strong	Biomarker	[494]
SORT1	TTRX9AV	Strong	Altered Expression	[495]
SOX5	TTXHSZK	Strong	Genetic Variation	[152]
SPDEF	TT2ZUPY	Strong	Biomarker	[496]
SPN	TTOZAX0	Strong	Biomarker	[497]
SRD5A2	TTT02K8	Strong	Biomarker	[498]
SREBF1	TTER0UB	Strong	Biomarker	[239]
SRPK2	TTCZEJ9	Strong	Genetic Variation	[146]
SST	TTWF7UG	Strong	Biomarker	[499]
SSTR4	TTAE1BR	Strong	Biomarker	[246]
SSTR5	TT2BC4G	Strong	Biomarker	[500]
STAB1	TTJFEOC	Strong	Biomarker	[501]
STAR	TTEI40H	Strong	Biomarker	[502]
SV2A	TTT3P91	Strong	Genetic Variation	[503]
TAAR1	TTIU98M	Strong	Biomarker	[504]
TAP1	TT7JZI8	Strong	Genetic Variation	[505]
TBXAS1	TTKNWZ4	Strong	Genetic Variation	[506]
TEP1	TTQGAVX	Strong	Genetic Variation	[507]
THBS1	TTKI0H1	Strong	Biomarker	[508]
THRB	TTGER3L	Strong	Genetic Variation	[509]
TKT	TT04R7I	Strong	Altered Expression	[247]
TLR3	TTD24Y0	Strong	Altered Expression	[510]
TLR4	TTISGCA	Strong	Biomarker	[510]
TLR5	TTCXP8J	Strong	Altered Expression	[511]
TMEM219	TTY078U	Strong	Genetic Variation	[512]
TNFRSF17	TTZ3P4W	Strong	Altered Expression	[513]
TNFSF13	TTOI1RM	Strong	Biomarker	[343]
TPH1	TTZSJHV	Strong	Biomarker	[514]
TPP2	TTQ7R2V	Strong	Altered Expression	[515]
TREM1	TTHZQP0	Strong	Biomarker	[408]
TREM2	TTQRMSJ	Strong	Altered Expression	[516]
TRIM27	TTTO3QN	Strong	Genetic Variation	[146]
TRPM1	TTTDAI9	Strong	Biomarker	[517]
TXNRD3	TTDYFVB	Strong	Genetic Variation	[518]
TYRP1	TTFRV98	Strong	Biomarker	[519]
UCHL1	TTX9IFP	Strong	Biomarker	[520]
UCP1	TTI12YJ	Strong	Biomarker	[521]
ULK1	TT4D7MJ	Strong	Biomarker	[522]
UTS2	TTERU0T	Strong	Biomarker	[523]
UTS2R	TTW5UDX	Strong	Genetic Variation	[524]
VIP	TTGTWLF	Strong	Biomarker	[525]
VSIR	TT51SK8	Strong	Biomarker	[526]
WAS	TTE8T73	Strong	Biomarker	[527]
WNK3	TTI7FDX	Strong	Biomarker	[446]
WNT7A	TT8NARC	Strong	Genetic Variation	[528]
ARSA	TTYQANR	Definitive	Altered Expression	[529]
CIT	TT3BKTU	Definitive	Biomarker	[530]
HMOX1	TTI6V2A	Definitive	Altered Expression	[531]
HTR3B	TTR6K75	Definitive	Biomarker	[532]
LCN2	TTKTLAI	Definitive	Altered Expression	[533]
SLC1A1	TTG2A6F	Definitive	Genetic Variation	[534]
TDO2	TTXNCBV	Definitive	Biomarker	[423]

This Disease Is Related to 28 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
SLC12A2	DTHKL3Q	No Known	Unknown	[535]
SLC18A2	DTT7VPB	No Known	Unknown	[536]
SLC6A17	DT1VX0F	No Known	Unknown	[136]
ABCA2	DTJ4NEG	Limited	Unknown	[136]
SLC17A3	DTFOJL7	Limited	Genetic Variation	[152]
SLC23A3	DTG15J6	Limited	Biomarker	[537]
SLC27A5	DT0TQS3	Limited	Genetic Variation	[538]
SLC30A3	DTKMECW	Limited	Genetic Variation	[539]
SLC45A1	DTMSNOU	Limited	Genetic Variation	[152]
SLC4A10	DT7RYVF	Limited	Genetic Variation	[186]
SLC4A8	DTW40Z7	Limited	Unknown	[141]
SLCO6A1	DTIFXNS	Limited	Biomarker	[540]
SLC17A6	DT5LHCR	Disputed	Biomarker	[541]
CACNB2	DTBZWL4	moderate	Genetic Variation	[146]
SLC25A27	DT0HW5C	moderate	Biomarker	[542]
SLC39A8	DTLPQGT	moderate	Genetic Variation	[543]
ABCA5	DT195NK	Strong	Genetic Variation	[544]
ABCB9	DT68UV2	Strong	Altered Expression	[545]
CACNB4	DTV8E46	Strong	Biomarker	[546]
SLC14A2	DT8QC7K	Strong	Genetic Variation	[524]
SLC17A1	DT8ARWJ	Strong	Genetic Variation	[547]
SLC17A4	DTHE530	Strong	Genetic Variation	[146]
SLC18A1	DTM953D	Strong	Biomarker	[548]
SLC25A14	DTHSNUW	Strong	Biomarker	[521]
SLC26A7	DTOTME4	Strong	Biomarker	[415]
SLC2A3	DT9SQ3L	Strong	Genetic Variation	[549]
SLC7A6	DTTBSQG	Strong	Genetic Variation	[146]
SLC9B1	DTR462N	Strong	Genetic Variation	[146]

This Disease Is Related to 44 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
NOS2	DE3C1JY	No Known	Unknown	[139]
SULT1B1	DED5UR3	No Known	Unknown	[139]
HK1	DEDMAGE	Limited	Biomarker	[550]
ALDH1A1	DE2JP1Y	moderate	Biomarker	[551]
ALDH1A2	DEKN1H4	moderate	Biomarker	[552]
MSRA	DEU2ZBY	moderate	Genetic Variation	[146]
NNMT	DECVGJ3	moderate	Genetic Variation	[553]
ACP3	DEDW5H6	Strong	Altered Expression	[554]
ADH5	DEIOH6A	Strong	Altered Expression	[309]
AKR1A1	DED2FW3	Strong	Biomarker	[555]
ALDH3B1	DE2ZWSM	Strong	Biomarker	[556]
CES2	DETHCPD	Strong	Genetic Variation	[557]
CHDH	DEAHED0	Strong	Genetic Variation	[558]
CHST3	DEQIZP2	Strong	Biomarker	[559]
CRMP1	DE0EUXB	Strong	Biomarker	[560]
CYP4F3	DEFCMPI	Strong	Genetic Variation	[561]
DDO	DE8PQ7T	Strong	Altered Expression	[562]
DIO3	DET89OV	Strong	Biomarker	[318]
FUT11	DERG61P	Strong	Biomarker	[563]
HINT1	DEWJATF	Strong	Biomarker	[564]
HSD17B10	DEGSPC9	Strong	Altered Expression	[565]
KYAT1	DES9MCU	Strong	Biomarker	[566]
LARS2	DEP7BTH	Strong	Genetic Variation	[567]
MMEL1	DEYCUQ2	Strong	Biomarker	[568]
MTRR	DE6NIY9	Strong	Genetic Variation	[569]
NDUFS3	DE741FI	Strong	Altered Expression	[454]
NT5C2	DE1DOKJ	Strong	Genetic Variation	[146]
PCK1	DEPLH5Z	Strong	Genetic Variation	[570]
PCYT1A	DEQYXD4	Strong	Genetic Variation	[571]
PGPEP1	DEVDR46	Strong	Biomarker	[271]
PLPP1	DE6WXTH	Strong	Genetic Variation	[277]
PNPO	DE3Z1RA	Strong	Biomarker	[572]
PSAT1	DEBS17P	Strong	Biomarker	[573]
SCLY	DEH4TD6	Strong	Biomarker	[574]
SPR	DEJVDAT	Strong	Biomarker	[575]
SULT1E1	DESTKG6	Strong	Genetic Variation	[416]
SULT2A1	DE0P6LK	Strong	Biomarker	[576]
TGM5	DEW8QEH	Strong	Genetic Variation	[577]
THOP1	DE95LJC	Strong	Genetic Variation	[578]
UBASH3B	DE10BJ5	Strong	Genetic Variation	[462]
UGT1A3	DEF2WXN	Strong	Biomarker	[415]
UGT1A8	DE2GB8N	Strong	Genetic Variation	[579]
GLDC	DEIN8FB	Definitive	Genetic Variation	[580]
HSD17B12	DE915QP	Definitive	Biomarker	[581]

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 963).
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 34).
• [3] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 22).
• [4] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [5] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7140).
• [6] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 83).
• [7] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 38).
• [8] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7070).
• [9] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 85).
• [10] 2004 approvals: the demise of the blockbuster. Nat Rev Drug Discov. 2005 Feb;4(2):93-4.
• [11] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 86).
• [12] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 87).
• [13] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1369).
• [14] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
• [15] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7461).
• [16] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7227).
• [17] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 207).
• [18] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 983).
• [19] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 47).
• [20] The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22.
• [21] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7258).
• [22] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 209).
• [23] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 90).
• [24] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7557).
• [25] ClinicalTrials.gov (NCT01800045) Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP). U.S. National Institutes of Health.
• [26] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 016727.
• [27] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 96).
• [28] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 960).
• [29] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 100).
• [30] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 212).
• [31] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7559).
• [32] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2376).
• [33] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [34] ClinicalTrials.gov (NCT04846868) Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1). U.S. National Institutes of Health.
• [35] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7670).
• [36] Pharmaceutical Research Companies Are Developing More Than 300 Medicines to Treat Mental Illnesses. Pharmaceutical Research and Manufacturers of America report.2010.
• [37] ClinicalTrials.gov (NCT02004392) Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025. U.S. National Institutes of Health.
• [38] ClinicalTrials.gov (NCT05211947) An Open Label, Single Arm, Extension Trial to Examine Long-term Safety of Iclepertin Once Daily in Patients With Schizophrenia Who Have Completed Previous Iclepertin Phase III Trials (CONNEX-X). U.S.National Institutes of Health.
• [39] ClinicalTrials.gov (NCT02469155) A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment.
• [40] ClinicalTrials.gov (NCT04820309) An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5). U.S. National Institutes of Health.
• [41] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8689).
• [42] ClinicalTrials.gov (NCT01487083) A Long-Term Study in Schizophrenia. U.S. National Institutes of Health.
• [43] ClinicalTrials.gov (NCT03397134) Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of Schizophrenia. U.S. National Institutes of Health.
• [44] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7546).
• [45] ClinicalTrials.gov (NCT04109950) A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia. U.S. National Institutes of Health.
• [46] ClinicalTrials.gov (NCT01295372) Safety and Efficacy of Zicronapine in Patients With Schizophrenia. U.S. National Institutes of Health.
• [47] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4165).
• [48] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [49] ClinicalTrials.gov (NCT01655680) A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia. U.S. National Institutes of Health.
• [50] ClinicalTrials.gov (NCT01568216) 20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms. U.S. National Institutes of Health.
• [51] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5775).
• [52] ClinicalTrials.gov (NCT04158687) A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia. U.S. National Institutes of Health.
• [53] ClinicalTrials.gov (NCT04461119) Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia. U.S. National Institutes of Health.
• [54] ClinicalTrials.gov (NCT00728195) An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia. U.S. National Institutes of Health.
• [55] ClinicalTrials.gov (NCT03929497) Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms. U.S. National Institutes of Health.
• [56] ClinicalTrials.gov (NCT00827918) A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004). U.S. National Institutes of Health.
• [57] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 333).
• [58] ClinicalTrials.gov (NCT00637793) Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome. U.S. National Institutes of Health.
• [59] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 46).
• [60] ClinicalTrials.gov (NCT01939548) An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia. U.S. National Institutes of Health.
• [61] Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.
• [62] ClinicalTrials.gov (NCT00977522) A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia. U.S. National Institutes of Health.
• [63] ClinicalTrials.gov (NCT00063297) Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia. U.S. National Institutes of Health.
• [64] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035778)
• [65] ClinicalTrials.gov (NCT01490086) RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder. U.S. National Institutes of Health.
• [66] ClinicalTrials.gov (NCT00259870) SB-773812 Administered In Adults With Schizophrenia. U.S. National Institutes of Health.
• [67] SGS742: the first GABA(B) receptor antagonist in clinical trials. Biochem Pharmacol. 2004 Oct 15;68(8):1479-87.
• [68] ClinicalTrials.gov (NCT02477020) A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia.
• [69] ClinicalTrials.gov (NCT00300963) Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients in GlaxoSmithKline.
• [70] Clinical pipeline report, company report or official report of Fabre-Kramer Pharmaceuticals.
• [71] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800036537)
• [72] Clinical pipeline report, company report or official report of Forum pharmaceuticals.
• [73] Pharmacologic properties of (-)-3PPP (preclamol) in man. J Neural Transm Gen Sect. 1992;88(3):165-75.
• [74] Small Molecule Therapeutics for Schizophrenia, Sylvain Celanire. Page(30).
• [75] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4618).
• [76] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035904)
• [77] ClinicalTrials.gov (NCT01027234) This Study Will Assess the Safety and Tolerability of AZD8418 After Single Increasing Oral Doses. U.S. National Institutes of Health.
• [78] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028844)
• [79] ClinicalTrials.gov (NCT03669250) CVN058 Effect on Mismatch Negativity in Schizophrenics. U.S. National Institutes of Health.
• [80] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029447)
• [81] ClinicalTrials.gov (NCT02037074) Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics. U.S. National Institutes of Health.
• [82] Characterization of the novel GlyT1 PET tracer [18F]MK-6577 in humans. Synapse. 2015 Jan;69(1):33-40.
• [83] ClinicalTrials.gov (NCT01090440) Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects (MNK112891) in GlaxoSmithKline.
• [84] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026554)
• [85] ClinicalTrials.gov (NCT00934466) Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008). U.S. National Institutes of Health.
• [86] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 979).
• [87] ClinicalTrials.gov (NCT01530529) A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999. U.S. National Institutes of Health.
• [88] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800040973)
• [89] ClinicalTrials.gov (NCT01923025) A PET Study With RO5545965 in Healthy Male Volunteers. U.S. National Institutes of Health.
• [90] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032265)
• [91] ClinicalTrials.gov (NCT02389881) Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants. U.S. National Institutes of Health.
• [92] Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017).Expert Opin Ther Pat. 2018 Mar;28(3):175-196.
• [93] Glycine transporter-1 inhibitors: a patent review (2011-2016).Expert Opin Ther Pat. 2018 Mar;28(3):197-210.
• [94] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 968).
• [95] Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist. CNS Drug Rev. 2001 Fall;7(3):265-82.
• [96] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 98).
• [97] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2110).
• [98] Emerging drugs for attention-deficit/hyperactivity disorder. Expert Opin Emerg Drugs. 2007 Sep;12(3):423-34.
• [99] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7678).
• [100] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011083)
• [101] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025560)
• [102] ClinicalTrials.gov (NCT00746824) A Study to Determine the Effects of TM30339 on Weight Loss in Obese Individuals.. U.S. National Institutes of Health.
• [103] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016551)
• [104] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028968)
• [105] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028969)
• [106] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027607)
• [107] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012259)
• [108] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027678)
• [109] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025967)
• [110] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008657)
• [111] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025562)
• [112] ClinicalTrials.gov (NCT00876304) Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia. U.S. National Institutes of Health.
• [113] Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019 May;18(5):379-401.
• [114] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026348)
• [115] Receptor binding of allylestrenol, a progestagen of the 19-nortestosterone series without androgenic properties. J Steroid Biochem. 1985 Aug;23(2):165-8.
• [116] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024498)
• [117] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2131).
• [118] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4778).
• [119] Clinical pipeline report, company report or official report of Teva Pharmaceutical
• [120] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 334).
• [121] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003010)
• [122] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025558)
• [123] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009126)
• [124] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5434).
• [125] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6679).
• [126] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3988).
• [127] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 143).
• [128] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 980).
• [129] Synthesis and SAR of highly potent and selective dopamine D(3)-receptor antagonists: 1H-pyrimidin-2-one derivatives. Bioorg Med Chem Lett. 2006 Feb;16(3):490-4.
• [130] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
• [131] Antitussives and substance abuse. Subst Abuse Rehabil. 2013 Nov 6;4:75-82.
• [132] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 217).
• [133] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 935).
• [134] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 215).
• [135] Rare damaging variants in DNA repair and cell cycle pathways are associated with hippocampal and cognitive dysfunction: a combined genetic imaging study in first-episode treatment-naive patients with schizophrenia. Transl Psychiatry. 2017 Feb 14;7(2):e1028. doi: 10.1038/tp.2016.291.
• [136] The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.
• [137] Increased co-expression of genes harboring the damaging de novo mutations in Chinese schizophrenic patients during prenatal development. Sci Rep. 2015 Dec 15;5:18209. doi: 10.1038/srep18209.
• [138] A rare microduplication in a familial case of annular pancreas and duodenal stenosis. J Pediatr Surg. 2012 Nov;47(11):2039-43. doi: 10.1016/j.jpedsurg.2012.06.028.
• [139] De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014 Feb 13;506(7487):179-84. doi: 10.1038/nature12929. Epub 2014 Jan 22.
• [140] Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia. Nat Neurosci. 2016 Nov;19(11):1433-1441. doi: 10.1038/nn.4402. Epub 2016 Oct 3.
• [141] De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet. 2012 Dec;44(12):1365-9. doi: 10.1038/ng.2446. Epub 2012 Oct 3.
• [142] Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet. 2011 Jul 10;43(9):860-3. doi: 10.1038/ng.886.
• [143] Integrating genome-wide association study and expression quantitative trait locus study identifies multiple genes and gene sets associated with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:50-54. doi: 10.1016/j.pnpbp.2017.10.003. Epub 2017 Oct 9.
• [144] Map2k7 Haploinsufficiency Induces Brain Imaging Endophenotypes and Behavioral Phenotypes Relevant to Schizophrenia. Schizophr Bull. 2020 Jan 4;46(1):211-223. doi: 10.1093/schbul/sbz044.
• [145] A Longitudinal Study of Alterations of S100B, sRAGE and Fas Ligand in Association to Olanzapine Medication in a Sample of First Episode Patients with Schizophrenia.CNS Neurol Disord Drug Targets. 2018;17(5):383-388. doi: 10.2174/1871527317666180605120244.
• [146] Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.Schizophr Bull. 2019 Jun 18;45(4):824-834. doi: 10.1093/schbul/sby140.
• [147] Exome sequences of multiplex, multigenerational families reveal schizophrenia risk loci with potential implications for neurocognitive performance.Am J Med Genet B Neuropsychiatr Genet. 2017 Dec;174(8):817-827. doi: 10.1002/ajmg.b.32597. Epub 2017 Sep 13.
• [148] Host-parasite interaction associated with major mental illness.Mol Psychiatry. 2020 Jan;25(1):194-205. doi: 10.1038/s41380-018-0217-z. Epub 2018 Aug 20.
• [149] Cell cycle checkpoint abnormalities during dementia: A plausible association with the loss of protection against oxidative stress in Alzheimer's disease [corrected].PLoS One. 2013 Jul 5;8(7):e68361. doi: 10.1371/journal.pone.0068361. Print 2013.
• [150] Increased macrophages andchanged brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation.Mol Psychiatry. 2020 Apr;25(4):761-775. doi: 10.1038/s41380-018-0235-x. Epub 2018 Sep 13.
• [151] Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors.World J Biol Psychiatry. 2020 Jan;21(1):72-77. doi: 10.1080/15622975.2018.1548780. Epub 2019 Jan 9.
• [152] Genome-wide association study of schizophrenia in Ashkenazi Jews.Am J Med Genet B Neuropsychiatr Genet. 2015 Dec;168(8):649-59. doi: 10.1002/ajmg.b.32349. Epub 2015 Jul 21.
• [153] The hypothalamus and neuropsychiatric disorders: psychiatry meets microscopy.Cell Tissue Res. 2019 Jan;375(1):243-258. doi: 10.1007/s00441-018-2849-3. Epub 2018 May 16.
• [154] Depression-associated ARNTL and PER2 genetic variants in psychotic disorders.Chronobiol Int. 2015 May;32(4):579-84. doi: 10.3109/07420528.2015.1012588. Epub 2015 Mar 23.
• [155] Classification of Genes: Standardized Clinical Validity Assessment of Gene-Disease Associations Aids Diagnostic Exome Analysis and Reclassifications. Hum Mutat. 2017 May;38(5):600-608. doi: 10.1002/humu.23183. Epub 2017 Feb 13.
• [156] CUL3 Deficiency Causes Social Deficits and Anxiety-like Behaviors by Impairing Excitation-Inhibition Balance through the Promotion of Cap-Dependent Translation.Neuron. 2020 Feb 5;105(3):475-490.e6. doi: 10.1016/j.neuron.2019.10.035. Epub 2019 Nov 25.
• [157] Expression analysis and genotyping of DGKZ: a GWAS-derived risk gene for schizophrenia.Mol Biol Rep. 2019 Aug;46(4):4105-4111. doi: 10.1007/s11033-019-04860-1. Epub 2019 May 13.
• [158] Prediction of Violence, Suicide Behaviors and Suicide Ideation in a Sample of Institutionalized Offenders With Schizophrenia and Other Psychosis.Front Psychol. 2018 Aug 7;9:1385. doi: 10.3389/fpsyg.2018.01385. eCollection 2018.
• [159] Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation.Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7083-7088. doi: 10.1073/pnas.1819234116. Epub 2019 Mar 19.
• [160] Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia pati... Am J Psychiatry. 2008 Dec;165(12):1594-603.
• [161] Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia.Schizophr Res. 2018 Jan;191:51-60. doi: 10.1016/j.schres.2017.06.023. Epub 2017 Jun 28.
• [162] Regulation of cortical and peripheral GCH1 expression and biopterin levels in schizophrenia-spectrum disorders.Psychiatry Res. 2018 Apr;262:229-236. doi: 10.1016/j.psychres.2018.02.020. Epub 2018 Feb 8.
• [163] Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes.Sci Rep. 2019 May 20;9(1):7572. doi: 10.1038/s41598-019-43957-2.
• [164] Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain.Synapse. 2007 May;61(5):303-9. doi: 10.1002/syn.20368.
• [165] Integrating genome-wide association study and methylation functional annotation data identified candidate genes and pathways for schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109736. doi: 10.1016/j.pnpbp.2019.109736. Epub 2019 Aug 16.
• [166] Schizophrenia Patient Shows a Rare Interleukin 15 Receptor alpha Variant Disrupting Signal Transduction.Curr Mol Med. 2019;19(8):560-569. doi: 10.2174/1566524019666190617172054.
• [167] Anti-TSNARE1 IgG plasma levels differ by sex in patients with schizophrenia in a Chinese population.FEBS Open Bio. 2019 Oct;9(10):1705-1712. doi: 10.1002/2211-5463.12704. Epub 2019 Sep 4.
• [168] A promoter polymorphism rs2075824 within IMPA2 gene affecting the transcription activity: possible relationship with schizophrenia.J Cell Mol Med. 2017 Apr;21(4):658-664. doi: 10.1111/jcmm.13009. Epub 2016 Oct 17.
• [169] Mutation screening of the KCNN3 gene reveals a rare frameshift mutation. Mol Psychiatry. 2001 May;6(3):259-60. doi: 10.1038/sj.mp.4000128.
• [170] Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia.Hum Mol Genet. 2008 Oct 15;17(20):3212-22. doi: 10.1093/hmg/ddn217. Epub 2008 Jul 24.
• [171] Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia.Sci Rep. 2019 Dec 11;9(1):18840. doi: 10.1038/s41598-019-55414-1.
• [172] Clinical Characteristics of Diagnosis for Internet Gaming Disorder: Comparison of DSM-5 IGD and ICD-11 GD Diagnosis.J Clin Med. 2019 Jun 28;8(7):945. doi: 10.3390/jcm8070945.
• [173] Association of MAD1L1 polymorphism (rs871925) with prenatal famine exposure and schizophrenia in a Chinese population: A case-control study.IUBMB Life. 2020 Feb;72(2):259-265. doi: 10.1002/iub.2160. Epub 2019 Sep 9.
• [174] Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia.Nat Genet. 2017 Nov;49(11):1576-1583. doi: 10.1038/ng.3973. Epub 2017 Oct 9.
• [175] Comparative linkage meta-analysis reveals regionally-distinct, disparate genetic architectures: application to bipolar disorder and schizophrenia.PLoS One. 2011 Apr 29;6(4):e19073. doi: 10.1371/journal.pone.0019073.
• [176] Identification of genes from a schizophrenia-linked translocation breakpoint region.Genomics. 2001 Apr 1;73(1):123-6. doi: 10.1006/geno.2001.6516.
• [177] Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder.Genes Brain Behav. 2010 Nov;9(8):910-7. doi: 10.1111/j.1601-183X.2010.00631.x.
• [178] Association of purinergic receptor P2RX7 gene polymorphisms with depression symptoms.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:207-216. doi: 10.1016/j.pnpbp.2019.01.006. Epub 2019 Jan 19.
• [179] The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine.Mol Psychiatry. 2020 Jan;25(1):48-66. doi: 10.1038/s41380-019-0592-0. Epub 2019 Nov 13.
• [180] PDE7B, NMBR and EPM2A Variants and Schizophrenia: A Case-Control and Pharmacogenetics Study.Neuropsychobiology. 2016;73(3):160-8. doi: 10.1159/000445295. Epub 2016 Apr 20.
• [181] Neurobiology and consequences of social isolation stress in animal model-A comprehensive review.Biomed Pharmacother. 2018 Sep;105:1205-1222. doi: 10.1016/j.biopha.2018.05.086. Epub 2018 Jun 22.
• [182] Weak association of the platelet-derived growth factor beta (PDGFB) and PDGF receptor beta (PDGFRB) genes with schizophrenia and schizoaffective disorder.World J Biol Psychiatry. 2011 Mar;12(2):127-33. doi: 10.3109/15622975.2010.520333. Epub 2010 Oct 18.
• [183] A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.J Clin Pharm Ther. 2017 Feb;42(1):103-107. doi: 10.1111/jcpt.12470. Epub 2016 Oct 30.
• [184] Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia.Genes Brain Behav. 2011 Jun;10(4):410-7. doi: 10.1111/j.1601-183X.2011.00679.x. Epub 2011 Feb 10.
• [185] Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study.JAMA Psychiatry. 2018 Jan 1;75(1):36-46. doi: 10.1001/jamapsychiatry.2017.3554.
• [186] Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.Am J Hum Genet. 2019 Aug 1;105(2):334-350. doi: 10.1016/j.ajhg.2019.06.012.
• [187] Genetic and Functional Study of L-Type Amino Acid Transporter 1 in Schizophrenia.Neuropsychobiology. 2016;74(2):96-103. doi: 10.1159/000455234. Epub 2017 Feb 11.
• [188] Evaluation of -synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophrenia.Neuropsychiatr Dis Treat. 2019 Jul 19;15:2073-2085. doi: 10.2147/NDT.S205550. eCollection 2019.
• [189] TDP-43 and NOVA-1 RNA-binding proteins as competitive splicing regulators of the schizophrenia-associated TNIK gene.Biochim Biophys Acta Gene Regul Mech. 2019 Sep;1862(9):194413. doi: 10.1016/j.bbagrm.2019.194413. Epub 2019 Aug 2.
• [190] Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.Am J Med Genet B Neuropsychiatr Genet. 2019 Apr;180(3):186-203. doi: 10.1002/ajmg.b.32712. Epub 2019 Feb 6.
• [191] Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury.ACS Chem Neurosci. 2019 Mar 20;10(3):1595-1602. doi: 10.1021/acschemneuro.8b00543. Epub 2018 Dec 3.
• [192] Schizophrenia hippocampus has elevated expression of chondrex glycoprotein gene.Synapse. 2003 Oct;50(1):29-34. doi: 10.1002/syn.10228.
• [193] Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?.Schizophr Res. 2020 Dec;226:95-110. doi: 10.1016/j.schres.2019.03.009. Epub 2019 Mar 29.
• [194] Genetic and functional analysis of the gene encoding GAP-43 in schizophrenia.Schizophr Res. 2012 Feb;134(2-3):239-45. doi: 10.1016/j.schres.2011.11.016. Epub 2011 Dec 3.
• [195] A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects.Neuron. 2014 Dec 17;84(6):1302-16. doi: 10.1016/j.neuron.2014.11.007. Epub 2014 Nov 26.
• [196] The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia.Mol Neurobiol. 2020 Feb;57(2):778-797. doi: 10.1007/s12035-019-01737-z. Epub 2019 Aug 31.
• [197] Whole exome sequencing reveals inherited and de novo variants in autism spectrum disorder: a trio study from Saudi families.Sci Rep. 2017 Jul 18;7(1):5679. doi: 10.1038/s41598-017-06033-1.
• [198] Tumor necrosis factor- and - genetic polymorphisms as a risk factor in Saudi patients with schizophrenia.Neuropsychiatr Dis Treat. 2017 Apr 12;13:1081-1088. doi: 10.2147/NDT.S131144. eCollection 2017.
• [199] Prenatal one-carbon metabolism dysregulation programs schizophrenia-like deficits.Mol Psychiatry. 2018 Feb;23(2):282-294. doi: 10.1038/mp.2017.164. Epub 2017 Aug 15.
• [200] An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients.Psychopharmacology (Berl). 2021 May;238(5):1279-1289. doi: 10.1007/s00213-018-5134-y. Epub 2018 Dec 8.
• [201] Specificity proteins 1 and 4 in peripheral blood mononuclear cells in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.Eur Arch Psychiatry Clin Neurosci. 2019 Dec;269(8):941-948. doi: 10.1007/s00406-018-0938-7. Epub 2018 Aug 30.
• [202] Differential DNA methylation at birth associated with mental disorder in individuals with 22q11.2 deletion syndrome.Transl Psychiatry. 2017 Aug 29;7(8):e1221. doi: 10.1038/tp.2017.181.
• [203] Genetic variation of UBE3A is associated with schizotypy in a population of typical individuals.Psychiatry Res. 2019 May;275:94-99. doi: 10.1016/j.psychres.2019.03.019. Epub 2019 Mar 14.
• [204] Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.JAMA Psychiatry. 2018 Jan 1;75(1):65-74. doi: 10.1001/jamapsychiatry.2017.3433.
• [205] PACAP Protects Adult Neural Stem Cells from the Neurotoxic Effect of Ketamine Associated with Decreased Apoptosis, ER Stress and mTOR Pathway Activation.PLoS One. 2017 Jan 26;12(1):e0170496. doi: 10.1371/journal.pone.0170496. eCollection 2017.
• [206] Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors.Psychol Med. 2019 Jul;49(10):1749-1757. doi: 10.1017/S0033291718004142. Epub 2019 Jan 28.
• [207] Metallomics-based platforms for comparing the human blood serum profiles between bipolar disorder and schizophrenia patients.Rapid Commun Mass Spectrom. 2020 Sep;34 Suppl 3:e8698. doi: 10.1002/rcm.8698. Epub 2020 Feb 18.
• [208] Genome-wide association study of paliperidone efficacy.Pharmacogenet Genomics. 2017 Jan;27(1):7-18. doi: 10.1097/FPC.0000000000000250.
• [209] Cadherins and neuropsychiatric disorders.Brain Res. 2012 Aug 27;1470:130-44. doi: 10.1016/j.brainres.2012.06.020. Epub 2012 Jul 2.
• [210] SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution.Hum Mol Genet. 2010 Jul 15;19(14):2841-57. doi: 10.1093/hmg/ddq184. Epub 2010 May 10.
• [211] Association between a casein kinase 1 gene polymorphism and schizophrenia in a Chinese Han population.J Mol Neurosci. 2012 Jul;47(3):470-4. doi: 10.1007/s12031-012-9729-1. Epub 2012 Feb 25.
• [212] CTLA4 and CD28 Gene Polymorphisms with Respect to Affective Symptom Domain in Schizophrenia.Neuropsychobiology. 2015;71(3):158-67. doi: 10.1159/000379751. Epub 2015 May 13.
• [213] Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.Int J Neuropsychopharmacol. 2016 Dec 30;19(12):pyw083. doi: 10.1093/ijnp/pyw083. Print 2016 Dec.
• [214] Xenobiotic metabolizing and transporter genes: gene-gene interactions in schizophrenia and related disorders.Pharmacogenomics. 2010 Dec;11(12):1725-31. doi: 10.2217/pgs.10.158.
• [215] Discoidin domain receptor 1 gene variants are associated with decreased white matter fractional anisotropy and decreased processing speed in schizophrenia.J Psychiatr Res. 2019 Mar;110:74-82. doi: 10.1016/j.jpsychires.2018.12.021. Epub 2018 Dec 24.
• [216] Evaluation of six SNPs of MicroRNA machinery genes and risk of schizophrenia.J Mol Neurosci. 2013 Mar;49(3):594-9. doi: 10.1007/s12031-012-9887-1. Epub 2012 Sep 27.
• [217] Convergent roles of de novo mutations and common variants in schizophrenia in tissue-specific and spatiotemporal co-expression network.Transl Psychiatry. 2018 May 24;8(1):105. doi: 10.1038/s41398-018-0154-2.
• [218] Cerebral organoids reveal early cortical maldevelopment in schizophrenia-computational anatomy and genomics, role of FGFR1.Transl Psychiatry. 2017 Nov 17;7(11):6. doi: 10.1038/s41398-017-0054-x.
• [219] Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophrenia.Schizophr Res. 2009 Jun;111(1-3):131-7. doi: 10.1016/j.schres.2009.03.038. Epub 2009 Apr 28.
• [220] Evaluation of hypermethylation and expression pattern of GMR2, GMR5, GMR8, and GRIA3 in patients with schizophrenia.Gene. 2013 Feb 15;515(1):163-6. doi: 10.1016/j.gene.2012.10.075. Epub 2012 Nov 10.
• [221] Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia.Schizophr Res. 2007 Feb;90(1-3):15-27. doi: 10.1016/j.schres.2006.11.017. Epub 2007 Jan 12.
• [222] The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia-hyponatremia in schizophrenia.Neuromolecular Med. 2007;9(4):292-7. doi: 10.1007/s12017-007-8001-2. Epub 2007 Aug 1.
• [223] Family-based association study of common variants, rare mutation study and epistatic interaction detection in HDAC genes in schizophrenia.Schizophr Res. 2014 Dec;160(1-3):97-103. doi: 10.1016/j.schres.2014.09.029. Epub 2014 Oct 18.
• [224] Human blood analysis reveals differences in gene expression of catecholamine-regulated protein 40 (CRP40) in schizophrenia.Schizophr Res. 2013 Jan;143(1):203-6. doi: 10.1016/j.schres.2012.10.034. Epub 2012 Nov 24.
• [225] No association between genetic or epigenetic variation in insulin growth factors and antipsychotic-induced metabolic disturbances in a cross-sectional sample.Pharmacogenomics. 2014 May;15(7):951-62. doi: 10.2217/pgs.14.46.
• [226] Monocyte activation detected prior to a diagnosis of schizophrenia in the US Military New Onset Psychosis Project (MNOPP).Schizophr Res. 2018 Jul;197:465-469. doi: 10.1016/j.schres.2017.12.016. Epub 2018 Jan 6.
• [227] A preliminary analysis of microRNA as potential clinical biomarker for schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2015 Apr;168B(3):170-8. doi: 10.1002/ajmg.b.32292. Epub 2015 Feb 5.
• [228] Association between schizophrenia and single nucleotide polymorphisms in lipoprotein lipase gene in a Han Chinese population.Psychiatr Genet. 2011 Dec;21(6):307-14. doi: 10.1097/YPG.0b013e32834acc85.
• [229] Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.J Mol Neurosci. 2018 Jan;64(1):62-74. doi: 10.1007/s12031-017-1002-1. Epub 2017 Nov 21.
• [230] Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT(2A) receptor agonism.Eur Neuropsychopharmacol. 2017 Apr;27(4):383-398. doi: 10.1016/j.euroneuro.2017.02.005. Epub 2017 Mar 7.
• [231] Melanin Concentrating Hormone Signaling Deficits in Schizophrenia: Association With Memory and Social Impairments and Abnormal Sensorimotor Gating.Int J Neuropsychopharmacol. 2020 Mar 10;23(1):53-65. doi: 10.1093/ijnp/pyz051.
• [232] Heat shock alters the expression of schizophrenia and autism candidate genes in an induced pluripotent stem cell model of the human telencephalon.PLoS One. 2014 Apr 15;9(4):e94968. doi: 10.1371/journal.pone.0094968. eCollection 2014.
• [233] Evidence of an epistatic effect between Dysbindin-1 and Neuritin-1 genes on the risk for schizophrenia spectrum disorders.Eur Psychiatry. 2017 Feb;40:60-64. doi: 10.1016/j.eurpsy.2016.07.006. Epub 2016 Nov 14.
• [234] Association between neurotensin receptor 1 (NTR1) gene polymorphisms and schizophrenia in a Han Chinese population.J Mol Neurosci. 2013 Jun;50(2):345-52. doi: 10.1007/s12031-013-9988-5. Epub 2013 Mar 13.
• [235] Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(7):844-9. doi: 10.1002/ajmg.b.31231. Epub 2011 Aug 17.
• [236] Variants in regulatory elements of PDE4D associate with major mental illness in the Finnish population.Mol Psychiatry. 2021 Mar;26(3):816-824. doi: 10.1038/s41380-019-0429-x. Epub 2019 May 28.
• [237] Enzymatic activity of palmitoyl-protein thioesterase-1 in serum from schizophrenia significantly associates with schizophrenia diagnosis scales.J Cell Mol Med. 2019 Sep;23(9):6512-6518. doi: 10.1111/jcmm.14496. Epub 2019 Jul 3.
• [238] A MusD retrotransposon insertion in the mouse Slc6a5 gene causes alterations in neuromuscular junction maturation and behavioral phenotypes.PLoS One. 2012;7(1):e30217. doi: 10.1371/journal.pone.0030217. Epub 2012 Jan 17.
• [239] Genetic variation in 117 myelination-related genes in schizophrenia: Replication of association to lipid biosynthesis genes.Sci Rep. 2018 May 2;8(1):6915. doi: 10.1038/s41598-018-25280-4.
• [240] Scanning of estrogen receptor alpha (ERalpha) and thyroid hormone receptor alpha (TRalpha) genes in patients with psychiatric diseases: four missense mutations identified in ERalpha gene.Am J Med Genet. 2001 May 8;105(4):369-74. doi: 10.1002/ajmg.1364.
• [241] Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia.Front Psychiatry. 2018 Mar 13;9:82. doi: 10.3389/fpsyt.2018.00082. eCollection 2018.
• [242] Selective and competitive inhibition of kynurenine aminotransferase 2 by glycyrrhizic acid and its analogues.Sci Rep. 2019 Jul 15;9(1):10243. doi: 10.1038/s41598-019-46666-y.
• [243] A polymorphism of the ABCA1 gene confers susceptibility to schizophrenia and related brain changes.Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1877-83. doi: 10.1016/j.pnpbp.2011.07.012. Epub 2011 Aug 3.
• [244] A Case-Control Study of ABCB1, ABCB6, and ABCG1 Polymorphisms and Schizophrenia in a Han Chinese Population.Neuropsychobiology. 2019;78(3):113-117. doi: 10.1159/000496295. Epub 2019 Jun 12.
• [245] Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia.J Psychopharmacol. 2018 Nov;32(11):1155-1166. doi: 10.1177/0269881118805496. Epub 2018 Oct 16.
• [246] Risk gene-set and pathways in 22q11.2 deletion-related schizophrenia: a genealogical molecular approach.Transl Psychiatry. 2019 Jan 17;9(1):15. doi: 10.1038/s41398-018-0354-9.
• [247] Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia.J Psychiatr Res. 2009 Jul;43(11):978-86. doi: 10.1016/j.jpsychires.2008.11.006. Epub 2008 Dec 24.
• [248] Association of CCL11 promoter polymorphisms with schizophrenia in a Korean population.Gene. 2018 May 20;656:80-85. doi: 10.1016/j.gene.2018.02.053. Epub 2018 Feb 22.
• [249] A disintegrin and metalloproteinase with thrombospondin motifs 2 cleaves and inactivates Reelin in the postnatal cerebral cortex and hippocampus, but not in the cerebellum.Mol Cell Neurosci. 2019 Oct;100:103401. doi: 10.1016/j.mcn.2019.103401. Epub 2019 Sep 3.
• [250] Copy Number Variant in the Region of Adenosine Kinase (ADK) and Its Possible Contribution to Schizophrenia Susceptibility.Int J Neuropsychopharmacol. 2018 May 1;21(5):405-409. doi: 10.1093/ijnp/pyx103.
• [251] Extracellular elevation of adrenomedullin, a gene associated with schizophrenia, suppresses heat shock protein 1A/1B mRNA.Neuroreport. 2016 Dec 14;27(18):1312-1316. doi: 10.1097/WNR.0000000000000699.
• [252] Association analysis of adenosine A1 receptor gene (ADORA1) polymorphisms with schizophrenia in a Japanese population.Psychiatr Genet. 2009 Dec;19(6):328-35. doi: 10.1097/YPG.0b013e3283328e26.
• [253] Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/schizoaffective disorder in a Spanish isolate population.Biol Psychiatry. 2005 Sep 15;58(6):435-9. doi: 10.1016/j.biopsych.2005.04.051.
• [254] An in-frame deletion in the alpha(2C) adrenergic receptor is common in African--Americans.Mol Psychiatry. 2001 Mar;6(2):168-72. doi: 10.1038/sj.mp.4000817.
• [255] Effect of clozapine dose and concentration on fasting concentration of appetite regulating peptides.Psychiatry Res. 2018 Feb;260:473-477. doi: 10.1016/j.psychres.2017.12.018. Epub 2017 Dec 10.
• [256] Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.Am J Psychiatry. 2017 Feb 1;174(2):163-171. doi: 10.1176/appi.ajp.2016.16020204. Epub 2016 Aug 13.
• [257] Impaired heme metabolism in schizophrenia-derived cell lines and in a rat model of the disorder: Possible involvement of mitochondrial complex I.Eur Neuropsychopharmacol. 2019 May;29(5):577-589. doi: 10.1016/j.euroneuro.2019.03.011. Epub 2019 Apr 1.
• [258] Possible association between nonsynonymous polymorphisms of the anaplastic lymphoma kinase (ALK) gene and schizophrenia in a Japanese population.J Neural Transm (Vienna). 2006 Oct;113(10):1569-73. doi: 10.1007/s00702-006-0436-3. Epub 2006 Apr 11.
• [259] mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics.J Neurosci Res. 2005 Mar 15;79(6):868-78. doi: 10.1002/jnr.20423.
• [260] Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophrenia. Proteomics Clin Appl. 2015 Oct;9(9-10):907-16. doi: 10.1002/prca.201400148. Epub 2015 May 15.
• [261] Epigenetic dysregulation of host gene expression in Toxoplasma infection with specific reference to dopamine and amyloid pathways.Infect Genet Evol. 2018 Nov;65:159-162. doi: 10.1016/j.meegid.2018.07.034. Epub 2018 Jul 26.
• [262] Dysregulation of schizophrenia-related aquaporin 3 through disruption of paranode influences neuronal viability.J Neurochem. 2018 Nov;147(3):395-408. doi: 10.1111/jnc.14553. Epub 2018 Aug 29.
• [263] The SNAP25 Interactome in Ventromedial Caudate in Schizophrenia Includes the Mitochondrial Protein ARF1.Neuroscience. 2019 Nov 10;420:97-111. doi: 10.1016/j.neuroscience.2018.12.045. Epub 2019 Jan 2.
• [264] C3 Polymorphism Influences Circulating Levels of C3, ASP and Lipids in Schizophrenic Patients.Neurochem Res. 2015 May;40(5):906-14. doi: 10.1007/s11064-015-1543-z. Epub 2015 Feb 27.
• [265] Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.Mol Autism. 2017 May 22;8:21. doi: 10.1186/s13229-017-0137-9. eCollection 2017.
• [266] Association analysis of a functional variant in ATXN2 with schizophrenia.Neurosci Lett. 2014 Mar 6;562:24-7. doi: 10.1016/j.neulet.2013.12.001. Epub 2013 Dec 9.
• [267] Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia.Schizophr Res. 2018 Dec;202:173-179. doi: 10.1016/j.schres.2018.07.003. Epub 2018 Jul 6.
• [268] Lower LINE-1 methylation in first-episode schizophrenia patients with the history of childhood trauma.Epigenomics. 2015;7(8):1275-85. doi: 10.2217/epi.15.68. Epub 2015 Jul 27.
• [269] BBOX1 is down-regulated in maternal immune-activated mice and implicated in genetic susceptibility to human schizophrenia.Psychiatry Res. 2018 Jan;259:197-202. doi: 10.1016/j.psychres.2017.10.018. Epub 2017 Oct 7.
• [270] Autophagy has a key role in the pathophysiology of schizophrenia.Mol Psychiatry. 2015 Feb;20(1):126-32. doi: 10.1038/mp.2013.174. Epub 2013 Dec 24.
• [271] Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophrenia.J Psychopharmacol. 2020 Jan;34(1):115-124. doi: 10.1177/0269881119874446. Epub 2019 Oct 3.
• [272] Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p.Genes Brain Behav. 2009 Nov;8(8):785-94. doi: 10.1111/j.1601-183X.2009.00523.x. Epub 2009 Jul 21.
• [273] Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia.Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15533-8. doi: 10.1073/pnas.0507666102. Epub 2005 Oct 13.
• [274] Association of C1QB gene polymorphism with schizophrenia in Armenian population.BMC Med Genet. 2011 Sep 28;12:126. doi: 10.1186/1471-2350-12-126.
• [275] Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia.Biochem Biophys Res Commun. 2018 Mar 4;497(2):683-688. doi: 10.1016/j.bbrc.2018.02.131. Epub 2018 Feb 16.
• [276] A further study of a possible locus for schizophrenia on the X chromosome.Biochem Biophys Res Commun. 2006 Jun 16;344(4):1241-5. doi: 10.1016/j.bbrc.2006.04.018. Epub 2006 May 2.
• [277] Genome-wide association study identifies five new schizophrenia loci.Nat Genet. 2011 Sep 18;43(10):969-76. doi: 10.1038/ng.940.
• [278] Voltage-gated calcium channel activity and complex related genes and schizophrenia: A systematic investigation based on Han Chinese population.J Psychiatr Res. 2018 Nov;106:99-105. doi: 10.1016/j.jpsychires.2018.09.020. Epub 2018 Oct 3.
• [279] Loss of Ca(2+)/Calmodulin Dependent Protein Kinase Kinase 2 Leads to Aberrant Transferrin Phosphorylation and Trafficking: A Potential Biomarker for Alzheimer's Disease.Front Mol Biosci. 2018 Nov 20;5:99. doi: 10.3389/fmolb.2018.00099. eCollection 2018.
• [280] Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia.Schizophr Res. 2010 Jul;120(1-3):150-8. doi: 10.1016/j.schres.2010.04.012. Epub 2010 May 23.
• [281] Caveolin-1 regulation of disrupted-in-schizophrenia-1 as a potential therapeutic target for schizophrenia.J Neurophysiol. 2017 Jan 1;117(1):436-444. doi: 10.1152/jn.00481.2016. Epub 2016 Nov 2.
• [282] The 844ins68 polymorphism of the cystathionine beta-synthase gene is associated with schizophrenia.Psychiatry Res. 2009 Dec 30;170(2-3):168-71. doi: 10.1016/j.psychres.2008.07.007. Epub 2009 Nov 10.
• [283] Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia.Mol Neurobiol. 2019 Oct;56(10):7056-7073. doi: 10.1007/s12035-019-1578-2. Epub 2019 Apr 10.
• [284] Increased peripheral levels of TARC/CCL17 in first episode psychosis patients.Schizophr Res. 2019 Aug;210:221-227. doi: 10.1016/j.schres.2018.12.033. Epub 2019 Jan 3.
• [285] Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluid.Eur Arch Psychiatry Clin Neurosci. 2020 Oct;270(7):933-938. doi: 10.1007/s00406-019-01042-9. Epub 2019 Jul 13.
• [286] Abnormalities in chemokine levels in schizophrenia and their clinical correlates.Schizophr Res. 2017 Mar;181:63-69. doi: 10.1016/j.schres.2016.09.019. Epub 2016 Sep 17.
• [287] Effects of schizophrenomimetics on the expression of the CCN1 (CYR 61) gene encoding a matricellular protein in the infant and adult neocortex of the mouse and rat.Int J Neuropsychopharmacol. 2007 Dec;10(6):717-25. doi: 10.1017/S1461145707007882. Epub 2007 Jul 4.
• [288] Schizophrenia susceptibility gene product dysbindin-1 regulates the homeostasis of cyclin D1.Biochim Biophys Acta. 2016 Aug;1862(8):1383-91. doi: 10.1016/j.bbadis.2016.04.016. Epub 2016 Apr 27.
• [289] Chemokine gene variants in schizophrenia.Nord J Psychiatry. 2016 Aug;70(6):407-12. doi: 10.3109/08039488.2016.1141981. Epub 2016 Feb 23.
• [290] Immunohistochemical localisation of the NK1 receptor in the human amygdala: preliminary investigation in schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1313-21. doi: 10.1016/j.pnpbp.2006.05.008. Epub 2006 Jul 11.
• [291] Study of the possible association of HLA class II, CD4, and CD3 polymorphisms with schizophrenia.Am J Med Genet. 1994 Dec 15;54(4):372-7. doi: 10.1002/ajmg.1320540417.
• [292] Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition.Brain. 2011 Aug;134(Pt 8):2408-21. doi: 10.1093/brain/awr155. Epub 2011 Jul 19.
• [293] A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects.Psychopharmacology (Berl). 2020 Feb;237(2):317-328. doi: 10.1007/s00213-019-05366-1. Epub 2019 Nov 26.
• [294] Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes.Neuropsychopharmacology. 2008 Nov;33(12):2993-3009. doi: 10.1038/npp.2008.19. Epub 2008 Mar 5.
• [295] Properdin factor B (Bf) types in schizophrenia.Hum Hered. 1984;34(5):331-3. doi: 10.1159/000153490.
• [296] GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia.Mol Psychiatry. 2018 Jun;23(6):1496-1505. doi: 10.1038/mp.2017.105. Epub 2017 May 9.
• [297] Association Study of N-Methyl-D-Aspartate Receptor Subunit 2B (GRIN2B) Polymorphisms and Schizophrenia Symptoms in the Han Chinese Population.PLoS One. 2015 May 28;10(5):e0125925. doi: 10.1371/journal.pone.0125925. eCollection 2015.
• [298] Choline acetyltransferase variants and their influence in schizophrenia and olanzapine response.Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 5;144B(7):849-53. doi: 10.1002/ajmg.b.30468.
• [299] Minds, Maps, Meanderings.J Am Acad Child Adolesc Psychiatry. 2019 Aug;58(8):827-828. doi: 10.1016/j.jaac.2019.05.017.
• [300] Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia.Neuropsychobiology. 2004;50(2):124-7. doi: 10.1159/000079102.
• [301] Impact of CHRNA5 polymorphisms on the risk of schizophrenia in the Chinese Han population.Mol Genet Genomic Med. 2019 Sep;7(9):e869. doi: 10.1002/mgg3.869. Epub 2019 Jul 24.
• [302] Relationship between Alzheimer's disease-associated SNPs within the CLU gene, local DNA methylation and episodic verbal memory in healthy and schizophrenia subjects.Psychiatry Res. 2019 Feb;272:380-386. doi: 10.1016/j.psychres.2018.12.134. Epub 2018 Dec 27.
• [303] Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk.Psychiatry Res. 2016 Dec 30;246:833-837. doi: 10.1016/j.psychres.2016.10.017. Epub 2016 Oct 17.
• [304] Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system.Arch Gen Psychiatry. 2011 Dec;68(12):1247-56. doi: 10.1001/archgenpsychiatry.2011.100. Epub 2011 Aug 1.
• [305] Association of HPA axis genes with suicidal behaviour in schizophrenia.J Psychopharmacol. 2010 May;24(5):677-82. doi: 10.1177/0269881108097817. Epub 2008 Oct 6.
• [306] Cryptochrome1 maybe a candidate gene of schizophrenia.Med Hypotheses. 2007;69(4):849-51. doi: 10.1016/j.mehy.2007.02.003. Epub 2007 Mar 21.
• [307] From eyeless to neurological diseases.Exp Eye Res. 2017 Mar;156:5-9. doi: 10.1016/j.exer.2015.11.006. Epub 2015 Nov 22.
• [308] Common SNPs in CSF2RB are associated with major depression and schizophrenia in the Chinese Han population.World J Biol Psychiatry. 2011 Apr;12(3):233-8. doi: 10.3109/15622975.2010.544328. Epub 2011 Jan 19.
• [309] Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2009 Apr;259(3):151-63. doi: 10.1007/s00406-008-0847-2. Epub 2009 Jan 22.
• [310] The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders.Mol Psychiatry. 2020 Feb;25(2):368-378. doi: 10.1038/s41380-019-0495-0. Epub 2019 Aug 27.
• [311] Cathepsin K generates enkephalin from beta-endorphin: a new mechanism with possible relevance for schizophrenia.Neurochem Int. 2009 Jun;54(7):410-7. doi: 10.1016/j.neuint.2009.01.011. Epub 2009 Feb 7.
• [312] Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses.Pharmacogenomics J. 2011 Feb;11(1):1-14. doi: 10.1038/tpj.2010.73. Epub 2010 Sep 28.
• [313] Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine.Comb Chem High Throughput Screen. 2018;21(5):374-380. doi: 10.2174/1386207321666180619164726.
• [314] Genome-wide expression analysis of peripheral blood identifies candidate biomarkers for schizophrenia.J Psychiatr Res. 2009 Sep;43(13):1073-7. doi: 10.1016/j.jpsychires.2009.03.005. Epub 2009 Apr 8.
• [315] Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia.Biol Psychiatry. 2012 Jan 15;71(2):114-9. doi: 10.1016/j.biopsych.2011.09.014. Epub 2011 Oct 28.
• [316] Sex differences in DEK expression in the anterior cingulate cortex and its association with dementia severity in schizophrenia.Schizophr Res. 2018 Dec;202:188-194. doi: 10.1016/j.schres.2018.07.010. Epub 2018 Jul 13.
• [317] Down-regulation of Dickkopf 3, a regulator of the Wnt signalling pathway, in elderly schizophrenic subjects.J Neurochem. 2005 Jul;94(2):520-30. doi: 10.1111/j.1471-4159.2005.03239.x.
• [318] Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells.Mol Psychiatry. 2012 Jul;17(8):827-40. doi: 10.1038/mp.2011.78. Epub 2011 Jul 5.
• [319] Potential synergistic action of 19 schizophrenia risk genes in the thalamus.Schizophr Res. 2017 Feb;180:64-69. doi: 10.1016/j.schres.2016.09.008. Epub 2016 Sep 16.
• [320] Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.Arch Gen Psychiatry. 2004 Jun;61(6):544-55. doi: 10.1001/archpsyc.61.6.544.
• [321] Expression of HSPF1 and LIM in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia.J Hum Genet. 2004;49(5):227-31. doi: 10.1007/s10038-004-0136-5.
• [322] De Novo Synonymous Mutations in Regulatory Elements Contribute to the Genetic Etiology of Autism and Schizophrenia.Neuron. 2016 Mar 2;89(5):940-7. doi: 10.1016/j.neuron.2016.02.024.
• [323] N-Phthalyl-l-Tryptophan (RG108), like Clozapine (CLO), Induces Chromatin Remodeling in Brains of Prenatally Stressed Mice.Mol Pharmacol. 2019 Jan;95(1):62-69. doi: 10.1124/mol.118.113415. Epub 2018 Nov 5.
• [324] Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients.Eur J Hum Genet. 2020 Apr;28(4):469-479. doi: 10.1038/s41431-019-0485-3. Epub 2019 Nov 4.
• [325] Disorganization at the stage of schizophrenia clinical outcome: Clinical-biological study.Eur Psychiatry. 2017 May;42:44-48. doi: 10.1016/j.eurpsy.2016.12.011. Epub 2016 Dec 30.
• [326] DNA methyl transferase (DNMT) gene polymorphisms could be a primary event in epigenetic susceptibility to schizophrenia.PLoS One. 2014 May 23;9(5):e98182. doi: 10.1371/journal.pone.0098182. eCollection 2014.
• [327] Impairment of chaperone-mediated autophagy affects neuronal homeostasis through altered expression of DJ-1 and CRMP-2 proteins.Mol Cell Neurosci. 2019 Mar;95:1-12. doi: 10.1016/j.mcn.2018.12.006. Epub 2018 Dec 15.
• [328] Analysis of association between dopamine receptor genes' methylation and their expression profile with the risk of schizophrenia.Psychiatr Genet. 2013 Oct;23(5):183-7. doi: 10.1097/YPG.0b013e328363d6e1.
• [329] Chitinase-3-like 1 (CHI3L1) gene and schizophrenia: genetic association and a potential functional mechanism.Biol Psychiatry. 2008 Jul 15;64(2):98-103. doi: 10.1016/j.biopsych.2007.12.012. Epub 2008 Feb 20.
• [330] Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis.Diabetes Obes Metab. 2019 Feb;21(2):293-302. doi: 10.1111/dom.13522. Epub 2018 Oct 7.
• [331] Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment.Pharmacogenet Genomics. 2014 Jun;24(6):314-9. doi: 10.1097/FPC.0000000000000052.
• [332] Context Dependence Signature, Stimulus Properties and Stimulus Probability as Predictors of ERP Amplitude Variability.Front Hum Neurosci. 2019 Feb 26;13:39. doi: 10.3389/fnhum.2019.00039. eCollection 2019.
• [333] Prenatal adverse environment is associated with epigenetic age deceleration at birth and hypomethylation at the hypoxia-responsive EP300 gene.Clin Epigenetics. 2019 May 9;11(1):73. doi: 10.1186/s13148-019-0674-5.
• [334] Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk.Hum Mol Genet. 2019 Oct 15;28(20):3498-3513. doi: 10.1093/hmg/ddz145.
• [335] Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status.Psychoneuroendocrinology. 2019 Feb;100:113-119. doi: 10.1016/j.psyneuen.2018.10.001. Epub 2018 Oct 4.
• [336] NURR1 and ERR1 Modulate the Expression of Genes of a DRD2 Coexpression Network Enriched for Schizophrenia Risk.J Neurosci. 2020 Jan 22;40(4):932-941. doi: 10.1523/JNEUROSCI.0786-19.2019. Epub 2019 Dec 6.
• [337] EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia.Neurobiol Dis. 2018 Nov;119:149-158. doi: 10.1016/j.nbd.2018.08.005. Epub 2018 Aug 9.
• [338] Mapping heritability and molecular genetic associations with cortical features using probabilistic brain atlases: methods and applications to schizophrenia.Neuroinformatics. 2006 Winter;4(1):5-19. doi: 10.1385/NI:4:1:5.
• [339] Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia.Mol Psychiatry. 2020 Nov;25(11):2860-2872. doi: 10.1038/s41380-019-0401-9. Epub 2019 Apr 3.
• [340] Dual activities of ritanserin and R59022 as DGK inhibitors and serotonin receptor antagonists.Biochem Pharmacol. 2017 Jan 1;123:29-39. doi: 10.1016/j.bcp.2016.10.011. Epub 2016 Oct 28.
• [341] Utility of Scalp Hair Follicles as a Novel Source of Biomarker Genes for Psychiatric Illnesses.Biol Psychiatry. 2015 Jul 15;78(2):116-25. doi: 10.1016/j.biopsych.2014.07.025. Epub 2014 Sep 11.
• [342] Elevated delta-6 desaturase (FADS2) expression in the postmortem prefrontal cortex of schizophrenic patients: relationship with fatty acid composition.Schizophr Res. 2009 Apr;109(1-3):113-20. doi: 10.1016/j.schres.2008.12.027. Epub 2009 Feb 4.
• [343] Gene expression analysis implicates a death receptor pathway in schizophrenia pathology.PLoS One. 2012;7(4):e35511. doi: 10.1371/journal.pone.0035511. Epub 2012 Apr 24.
• [344] Dysregulation of Fibroblast Growth Factor 10 in the Peripheral Blood of Patients with Schizophrenia.J Mol Neurosci. 2019 Sep;69(1):69-74. doi: 10.1007/s12031-019-01331-x. Epub 2019 Jun 29.
• [345] Intracellular Fibroblast Growth Factor 14: Emerging Risk Factor for Brain Disorders.Front Cell Neurosci. 2017 Apr 19;11:103. doi: 10.3389/fncel.2017.00103. eCollection 2017.
• [346] Increased serum FGF2 levels in first-episode, drug-free patients with schizophrenia.Neurosci Lett. 2018 Nov 1;686:28-32. doi: 10.1016/j.neulet.2018.08.046. Epub 2018 Aug 30.
• [347] Genome-wide association study of breakfast skipping links clock regulation with food timing.Am J Clin Nutr. 2019 Aug 1;110(2):473-484. doi: 10.1093/ajcn/nqz076.
• [348] Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder.Schizophr Res. 2019 Nov;213:87-95. doi: 10.1016/j.schres.2019.06.026. Epub 2019 Jul 8.
• [349] Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder.Transl Psychiatry. 2018 Mar 6;8(1):55. doi: 10.1038/s41398-018-0102-1.
• [350] Association between GABA-A receptor alpha 5 subunit gene locus and schizophrenia of a later age of onset.Neuropsychobiology. 2001;43(3):141-4. doi: 10.1159/000054882.
• [351] A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder.Schizophr Res. 2010 Dec;124(1-3):192-9. doi: 10.1016/j.schres.2010.09.002.
• [352] Variation at the GABAA receptor gene, Rho 1 (GABRR1) associated with susceptibility to bipolar schizoaffective disorder.Am J Med Genet B Neuropsychiatr Genet. 2010 Oct 5;153B(7):1347-9. doi: 10.1002/ajmg.b.31108.
• [353] Analysis of age-related changes in psychosine metabolism in the human brain.PLoS One. 2018 Feb 26;13(2):e0193438. doi: 10.1371/journal.pone.0193438. eCollection 2018.
• [354] Proteomic analysis of lymphoblastoid cell lines from schizophrenic patients.Transl Psychiatry. 2019 Apr 22;9(1):126. doi: 10.1038/s41398-019-0461-2.
• [355] Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.J Psychiatr Res. 2010 Aug;44(11):700-6. doi: 10.1016/j.jpsychires.2010.01.002. Epub 2010 Jan 29.
• [356] Voxel-Based Morphometry in Individuals at Genetic High Risk for Schizophrenia and Patients with Schizophrenia during Their First Episode of Psychosis.PLoS One. 2016 Oct 10;11(10):e0163749. doi: 10.1371/journal.pone.0163749. eCollection 2016.
• [357] GIPR Gene Polymorphism and Weight Gain in Patients With Schizophrenia Treated With Olanzapine.J Neuropsychiatry Clin Neurosci. 2015;27(2):162-4. doi: 10.1176/appi.neuropsych.13120389.
• [358] Connexin 50 gene on human chromosome 1q21 is associated with schizophrenia in matched case control and family-based studies.J Med Genet. 2007 Aug;44(8):532-6. doi: 10.1136/jmg.2006.047944. Epub 2007 Apr 5.
• [359] Evidence against dopamine D1/D2 receptor heteromers.Mol Psychiatry. 2015 Nov;20(11):1373-85. doi: 10.1038/mp.2014.166. Epub 2015 Jan 6.
• [360] GPR17 receptor modulators and their therapeutic implications: review of recent patents.Expert Opin Ther Pat. 2019 Feb;29(2):85-95. doi: 10.1080/13543776.2019.1568990. Epub 2019 Jan 24.
• [361] Effect of schizophrenia risk-associated alleles in SREB2 (GPR85) on functional MRI phenotypes in healthy volunteers.Neuropsychopharmacology. 2013 Jan;38(2):341-9. doi: 10.1038/npp.2012.184. Epub 2012 Sep 12.
• [362] Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.ACS Chem Neurosci. 2019 Jan 16;10(1):190-200. doi: 10.1021/acschemneuro.8b00572. Epub 2018 Dec 20.
• [363] The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?.Mol Cell Neurosci. 2009 Dec;42(4):438-47. doi: 10.1016/j.mcn.2009.09.007. Epub 2009 Sep 29.
• [364] Differential allosteric modulation within dopamine D(2)R - neurotensin NTS1R and D(2)R - serotonin 5-HT(2A)R receptor complexes gives bias to intracellular calcium signalling.Sci Rep. 2019 Nov 8;9(1):16312. doi: 10.1038/s41598-019-52540-8.
• [365] Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia.Front Psychiatry. 2019 Feb 14;10:49. doi: 10.3389/fpsyt.2019.00049. eCollection 2019.
• [366] Alterations in sleep, sleep spindle, and EEG power in mGluR5 knockout mice.J Neurophysiol. 2020 Jan 1;123(1):22-33. doi: 10.1152/jn.00532.2019. Epub 2019 Nov 20.
• [367] Glutathione S-transferase alpha 1 risk polymorphism and increased bilateral thalamus mean diffusivity in schizophrenia.Psychiatry Res. 2012 Aug-Sep;203(2-3):180-3. doi: 10.1016/j.pscychresns.2011.12.016. Epub 2012 Sep 5.
• [368] Early Development of Parvalbumin-, Somatostatin-, and Cholecystokinin-Expressing Neurons in Rat Brain following Prenatal Immune Activation and Maternal Iron Deficiency.Dev Neurosci. 2016;38(5):342-353. doi: 10.1159/000454677. Epub 2017 Feb 18.
• [369] The high-affinity niacin receptor HM74A is decreased in the anterior cingulate cortex of individuals with schizophrenia.Brain Res Bull. 2008 Sep 5;77(1):33-41. doi: 10.1016/j.brainresbull.2008.03.015. Epub 2008 Apr 22.
• [370] Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics.Int J Neuropsychopharmacol. 2019 Jan 1;22(1):28-36. doi: 10.1093/ijnp/pyy075.
• [371] Epigenetic Regulation of Glutamic Acid Decarboxylase 67 in a Hippocampal Circuit.Cereb Cortex. 2017 Nov 1;27(11):5284-5293. doi: 10.1093/cercor/bhw307.
• [372] Disruption to schizophrenia-associated gene Fez1 in the hippocampus of HDAC11 knockout mice.Sci Rep. 2017 Sep 19;7(1):11900. doi: 10.1038/s41598-017-11630-1.
• [373] Whole-genome-wide association study in the Bulgarian population reveals HHAT as schizophrenia susceptibility gene.Psychiatr Genet. 2013 Feb;23(1):11-9. doi: 10.1097/YPG.0b013e3283586343.
• [374] The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients.Neurochem Int. 2010 May-Jun;56(6-7):736-9. doi: 10.1016/j.neuint.2010.03.011. Epub 2010 Mar 27.
• [375] Schizotypal and paranoid personality disorder in the relatives of patients with schizophrenia and affective disorders: a review.Schizophr Res. 1993 Dec;11(1):81-92. doi: 10.1016/0920-9964(93)90041-g.
• [376] Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis.J Psychopharmacol. 2019 Oct;33(10):1199-1214. doi: 10.1177/0269881119845820. Epub 2019 Apr 30.
• [377] Genetic variant of the histamine-1 receptor (glu349asp) and body weight change during clozapine treatment.Psychiatr Genet. 2002 Sep;12(3):169-71. doi: 10.1097/00041444-200209000-00009.
• [378] A pharmacogenetic study of risperidone on histamine H3 receptor gene (HRH3) in Chinese Han schizophrenia patients.J Psychopharmacol. 2012 Jun;26(6):813-8. doi: 10.1177/0269881111405358. Epub 2011 Jun 7.
• [379] Histamine H4 receptor polymorphism: a potential predictor of risperidone efficacy.J Clin Psychopharmacol. 2013 Apr;33(2):221-5. doi: 10.1097/JCP.0b013e318283963b.
• [380] Investigating interactions between early life stress and two single nucleotide polymorphisms in HSD11B2 on the risk of schizophrenia.Psychoneuroendocrinology. 2015 Oct;60:18-27. doi: 10.1016/j.psyneuen.2015.05.013. Epub 2015 Jun 11.
• [381] Evaluation of association of common variants in HTR1A and HTR5A with schizophrenia and executive function.Sci Rep. 2016 Nov 29;6:38048. doi: 10.1038/srep38048.
• [382] Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients.Neurosci Lett. 2007 Feb 27;414(1):1-4. doi: 10.1016/j.neulet.2006.09.014. Epub 2007 Feb 6.
• [383] Abnormal levels of vascular endothelial biomarkers in schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2018 Dec;268(8):849-860. doi: 10.1007/s00406-017-0842-6. Epub 2017 Sep 23.
• [384] Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia.J Psychiatr Res. 2009 Sep;43(13):1095-105. doi: 10.1016/j.jpsychires.2009.03.006. Epub 2009 Apr 23.
• [385] IFNGR2 genetic polymorphism associated with sex-specific paranoid schizophrenia risk.Nord J Psychiatry. 2017 Jan;71(1):42-47. doi: 10.1080/08039488.2016.1216595. Epub 2016 Aug 26.
• [386] IL-28B genetic variant is associated with the risk of schizophrenia in the Chinese Han population.DNA Cell Biol. 2012 Jun;31(6):988-92. doi: 10.1089/dna.2011.1471. Epub 2012 Jan 25.
• [387] The value of interleukin-12B (p40) gene promoter polymorphism in patients with schizophrenia in a region of East Turkey.Psychiatry Clin Neurosci. 2008 Jun;62(3):307-12. doi: 10.1111/j.1440-1819.2008.01798.x.
• [388] Role of IL-6/RORC/IL-22 axis in driving Th17 pathway mediated immunopathogenesis of schizophrenia.Cytokine. 2018 Nov;111:112-118. doi: 10.1016/j.cyto.2018.08.016. Epub 2018 Aug 20.
• [389] Association analysis of putative cis-acting polymorphisms of interleukin-19 gene with schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:151-6. doi: 10.1016/j.pnpbp.2013.12.006. Epub 2013 Dec 19.
• [390] IL1R2, CCR2, and CXCR4 May Form Heteroreceptor Complexes with NMDAR and D2R: Relevance for Schizophrenia.Front Psychiatry. 2017 Feb 15;8:24. doi: 10.3389/fpsyt.2017.00024. eCollection 2017.
• [391] No evidence for a schizophrenia susceptibility gene in the vicinity of IL2RB on chromosome 22.Am J Med Genet. 1997 Jul 25;74(4):361-4. doi: 10.1002/(sici)1096-8628(19970725)74:4<361::aid-ajmg4>3.0.co;2-s.
• [392] A family-based study of the IL3RA gene on susceptibility to schizophrenia in a Chinese Han population.Brain Res. 2009 May 1;1268:13-16. doi: 10.1016/j.brainres.2009.02.071. Epub 2009 Mar 10.
• [393] Common variants of IRF3 conferring risk of schizophrenia.J Psychiatr Res. 2015 May;64:67-73. doi: 10.1016/j.jpsychires.2015.03.008. Epub 2015 Mar 20.
• [394] A missense mutation in the ITGA8 gene, a cell adhesion molecule gene, is associated with schizophrenia in Japanese female patients.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:347-52. doi: 10.1016/j.pnpbp.2012.11.002. Epub 2012 Nov 12.
• [395] RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients.Schizophr Res. 2013 Jun;147(1):24-31. doi: 10.1016/j.schres.2013.02.017. Epub 2013 Apr 6.
• [396] Genetic association analysis of ITGB3 polymorphisms with age at onset of schizophrenia.J Mol Neurosci. 2013 Oct;51(2):446-53. doi: 10.1007/s12031-013-0059-8. Epub 2013 Jul 17.
• [397] Analysis of coding-polymorphisms in NOTCH-related genes reveals NUMBL poly-glutamine repeat to be associated with schizophrenia in Brazilian and Danish subjects.Schizophr Res. 2006 Dec;88(1-3):275-82. doi: 10.1016/j.schres.2006.06.036. Epub 2006 Aug 8.
• [398] Brain expressed microRNAs implicated in schizophrenia etiology.PLoS One. 2007 Sep 12;2(9):e873. doi: 10.1371/journal.pone.0000873.
• [399] Prediction of causal genes and gene expression analysis of attention-deficit hyperactivity disorder in the different brain region, a comprehensive integrative analysis of ADHD.Behav Brain Res. 2019 May 17;364:183-192. doi: 10.1016/j.bbr.2019.02.010. Epub 2019 Feb 6.
• [400] AMIGO-Kv2.1 Potassium Channel Complex Is Associated With Schizophrenia-Related Phenotypes.Schizophr Bull. 2016 Jan;42(1):191-201. doi: 10.1093/schbul/sbv105. Epub 2015 Aug 3.
• [401] KCNH2-3.1 mediates aberrant complement activation and impaired hippocampal-medial prefrontal circuitry associated with working memory deficits.Mol Psychiatry. 2020 Jan;25(1):206-229. doi: 10.1038/s41380-019-0530-1. Epub 2019 Sep 30.
• [402] Association study of the KCNJ3 gene as a susceptibility candidate for schizophrenia in the Chinese population.Hum Genet. 2012 Mar;131(3):443-51. doi: 10.1007/s00439-011-1089-3. Epub 2011 Sep 17.
• [403] A Schizophrenia-Related Deletion Leads to KCNQ2-Dependent Abnormal Dopaminergic Modulation of Prefrontal Cortical Interneuron Activity.Cereb Cortex. 2018 Jun 1;28(6):2175-2191. doi: 10.1093/cercor/bhx123.
• [404] A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels.Psychopharmacology (Berl). 2008 Jul;199(1):47-54. doi: 10.1007/s00213-008-1095-x. Epub 2008 Jun 11.
• [405] Prenatal MAM administration affects histone H3 methylation in postnatal life in the rat medial prefrontal cortex.Eur Neuropsychopharmacol. 2014 Feb;24(2):271-89. doi: 10.1016/j.euroneuro.2013.05.013. Epub 2013 Aug 8.
• [406] Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophrenia.J Psychiatr Res. 2016 Nov;82:100-8. doi: 10.1016/j.jpsychires.2016.07.018. Epub 2016 Jul 25.
• [407] Higher blood MLL1 mRNA and BDNF promoter IV on histone H3K4me3 levels in patients with schizophrenia.Psychiatry Res. 2016 Sep 30;243:207-9. doi: 10.1016/j.psychres.2016.06.010. Epub 2016 Jun 16.
• [408] Analysis of schizophrenia and hepatocellular carcinoma genetic network with corresponding modularity and pathways: novel insights to the immune system.BMC Genomics. 2013;14 Suppl 5(Suppl 5):S10. doi: 10.1186/1471-2164-14-S5-S10. Epub 2013 Oct 16.
• [409] Identification and evolution of latrophilin receptor gene involved in Tribolium castaneum devolopment and female fecundity.Genesis. 2017 Dec;55(12). doi: 10.1002/dvg.23081. Epub 2017 Nov 2.
• [410] Association between promoter polymorphisms of the LIFR gene and schizophrenia with persecutory delusion in a Korean population.Mol Med Rep. 2012 Jan;5(1):270-4. doi: 10.3892/mmr.2011.618. Epub 2011 Oct 4.
• [411] Insulin-regulated aminopeptidase immunoreactivity is abundantly present in human hypothalamus and posterior pituitary gland, with reduced expression in paraventricular and suprachiasmatic neurons in chronic schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2017 Aug;267(5):427-443. doi: 10.1007/s00406-016-0757-7. Epub 2016 Dec 29.
• [412] Neurochemical changes in LPA1 receptor deficient mice--a putative model of schizophrenia.Neurochem Res. 2005 Mar;30(3):371-7. doi: 10.1007/s11064-005-2611-6.
• [413] Truncating variant burden in high-functioning autism and pleiotropic effects of LRP1 across psychiatric phenotypes.J Psychiatry Neurosci. 2019 Sep 1;44(5):350-359. doi: 10.1503/jpn.180184.
• [414] Genetic mapping and evolutionary analysisof human-expanded cognitive networks.Nat Commun. 2019 Oct 24;10(1):4839. doi: 10.1038/s41467-019-12764-8.
• [415] Exome sequencing supports a de novo mutational paradigm for schizophrenia.Nat Genet. 2011 Aug 7;43(9):864-8. doi: 10.1038/ng.902.
• [416] Searching for a schizophrenia susceptibility gene in the 22q11 region.Biomed Environ Sci. 2005 Feb;18(1):31-5.
• [417] Pallidin protein in neurodevelopment and its relation to the pathogenesis of schizophrenia.Mol Med Rep. 2017 Feb;15(2):665-672. doi: 10.3892/mmr.2016.6064. Epub 2016 Dec 21.
• [418] Recurrent deletions of ULK4 in schizophrenia: a gene crucial for neuritogenesis and neuronal motility.J Cell Sci. 2014 Feb 1;127(Pt 3):630-40. doi: 10.1242/jcs.137604. Epub 2013 Nov 27.
• [419] Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia.Schizophr Res. 2018 Nov;201:270-277. doi: 10.1016/j.schres.2018.04.042. Epub 2018 May 11.
• [420] Contrasting metacognitive, social cognitive and alexithymia profiles in adults with borderline personality disorder, schizophrenia and substance use disorder.Psychiatry Res. 2017 Nov;257:393-399. doi: 10.1016/j.psychres.2017.08.001. Epub 2017 Aug 1.
• [421] Differential expression of the ghrelin-related mRNAs GHS-R1a, GHS-R1b, and MBOAT4 in Japanese patients with schizophrenia.Psychiatry Res. 2019 Feb;272:334-339. doi: 10.1016/j.psychres.2018.12.135. Epub 2018 Dec 26.
• [422] Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene.Pharmacogenomics J. 2013 Jun;13(3):272-9. doi: 10.1038/tpj.2011.66. Epub 2012 Feb 7.
• [423] Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder.Schizophr Res. 2009 Sep;113(2-3):259-67. doi: 10.1016/j.schres.2009.05.014. Epub 2009 Jun 6.
• [424] The cell cycle-related genes as biomarkers for schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2016 Oct 3;70:85-91. doi: 10.1016/j.pnpbp.2016.05.005. Epub 2016 May 20.
• [425] MeCP2 Dysfunction in Rett Syndrome and Neuropsychiatric Disorders.Methods Mol Biol. 2019;2011:573-591. doi: 10.1007/978-1-4939-9554-7_33.
• [426] Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia.Biol Psychiatry. 2001 Nov 15;50(10):743-9. doi: 10.1016/s0006-3223(01)01209-4.
• [427] Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population.Neuropsychiatr Dis Treat. 2019 Apr 24;15:989-1000. doi: 10.2147/NDT.S194924. eCollection 2019.
• [428] Brain changes in a maternal immune activation model of neurodevelopmental brain disorders.Prog Neurobiol. 2019 Apr;175:1-19. doi: 10.1016/j.pneurobio.2018.12.002. Epub 2018 Dec 24.
• [429] Do schizophrenia and bipolar disorders share a common disease susceptibility variant at the MMP3 gene?.Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30;33(3):557-61. doi: 10.1016/j.pnpbp.2009.02.012. Epub 2009 Feb 23.
• [430] Sequence Variation Associated with SLC12A5 Gene Expression Is Linked to Brain Structure and Function in Healthy Adults.Cereb Cortex. 2019 Dec 17;29(11):4654-4661. doi: 10.1093/cercor/bhy344.
• [431] Up-regulation of ADM and SEPX1 in the lymphoblastoid cells of patients in monozygotic twins discordant for schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2008 Jul 5;147B(5):557-64. doi: 10.1002/ajmg.b.30643.
• [432] Association of polymorphism in the promoter of the melatonin receptor 1A gene with schizophrenia and with insomnia symptoms in schizophrenia patients.J Mol Neurosci. 2011 Oct;45(2):304-8. doi: 10.1007/s12031-011-9522-6. Epub 2011 Apr 28.
• [433] Withdrawn.CNS Neurol Disord Drug Targets. 2019 Mar 12. Online ahead of print.
• [434] MTHFD 1958G>A and MTR 2756A>G polymorphisms are associated with bipolar disorder and schizophrenia.Psychiatr Genet. 2007 Jun;17(3):177-81. doi: 10.1097/YPG.0b013e328029826f.
• [435] Auditory steady state response in the schizophrenia, first-degree relatives, and schizotypal personality disorder.Schizophr Res. 2012 Apr;136(1-3):143-9. doi: 10.1016/j.schres.2012.01.003. Epub 2012 Jan 28.
• [436] Association between polymorphism of the NEDD4 gene and cognitive dysfunction of schizophrenia patients in Chinese Han population.BMC Psychiatry. 2019 Dec 18;19(1):405. doi: 10.1186/s12888-019-2386-y.
• [437] Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association Study.JAMA Psychiatry. 2019 Oct 1;76(10):1026-1034. doi: 10.1001/jamapsychiatry.2019.1335.
• [438] Effect of lurasidone vs olanzapine on neurotrophic biomarkers in unmedicated schizophrenia: A randomized controlled trial.J Psychiatr Res. 2019 May;112:1-6. doi: 10.1016/j.jpsychires.2019.02.007. Epub 2019 Feb 12.
• [439] A large-scale integrative analysis of GWAS and common meQTLs across whole life course identifies genes, pathways and tissue/cell types for three major psychiatric disorders.Neurosci Biobehav Rev. 2018 Dec;95:347-352. doi: 10.1016/j.neubiorev.2018.10.005. Epub 2018 Oct 16.
• [440] Association study of arcuate nucleus neuropeptide Y neuron receptor gene variation and serum NPY levels in clozapine treated patients with schizophrenia.Eur Psychiatry. 2017 Feb;40:13-19. doi: 10.1016/j.eurpsy.2016.07.004. Epub 2016 Nov 10.
• [441] Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior.Neuropsychopharmacology. 2001 Jul;25(1):91-7. doi: 10.1016/S0893-133X(00)00231-1.
• [442] Correlation of metabolic parameters, neurotrophin-3, and neurotrophin-4 serum levels in women with schizophrenia and first-onset depression.Nord J Psychiatry. 2019 Feb;73(2):96-103. doi: 10.1080/08039488.2018.1563213. Epub 2019 Jan 17.
• [443] Neuregulin directed molecular mechanisms of visual cortical plasticity.J Comp Neurol. 2019 Feb 15;527(3):668-678. doi: 10.1002/cne.24414. Epub 2018 Mar 9.
• [444] Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia.Biol Psychiatry. 2011 May 15;69(10):980-8. doi: 10.1016/j.biopsych.2011.01.010. Epub 2011 Mar 11.
• [445] A systematic review of the role of the nociceptin receptor system in stress, cognition, and reward: relevance to schizophrenia.Transl Psychiatry. 2018 Feb 2;8(1):38. doi: 10.1038/s41398-017-0080-8.
• [446] Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia.Arch Gen Psychiatry. 2011 Jan;68(1):21-31. doi: 10.1001/archgenpsychiatry.2010.114. Epub 2010 Sep 6.
• [447] Distinct changes in chronic pain sensitivity and oxytocin receptor expression in a new rat model (Wisket) of schizophrenia.Neurosci Lett. 2020 Jan 1;714:134561. doi: 10.1016/j.neulet.2019.134561. Epub 2019 Oct 16.
• [448] Variation in the purinergic P2RX(7) receptor gene and schizophrenia.Schizophr Res. 2008 Sep;104(1-3):146-52. doi: 10.1016/j.schres.2008.05.026. Epub 2008 Jul 9.
• [449] Whole genome sequence study of cannabis dependence in two independent cohorts.Addict Biol. 2018 Jan;23(1):461-473. doi: 10.1111/adb.12489. Epub 2017 Jan 23.
• [450] Phosphodiesterase 10A Inhibitor Monotherapy Is Not an Effective Treatment of Acute Schizophrenia.J Clin Psychopharmacol. 2019 Nov/Dec;39(6):575-582. doi: 10.1097/JCP.0000000000001128.
• [451] Phosphodiesterase 2A Inhibitor TAK-915 Ameliorates Cognitive Impairments and Social Withdrawal in N-Methyl-d-Aspartate Receptor Antagonist-Induced Rat Models of Schizophrenia.J Pharmacol Exp Ther. 2018 Apr;365(1):179-188. doi: 10.1124/jpet.117.245506. Epub 2018 Feb 13.
• [452] Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide.Front Neurosci. 2019 Aug 23;13:837. doi: 10.3389/fnins.2019.00837. eCollection 2019.
• [453] Variants in the 1q21 risk region are associated with a visual endophenotype of autism and schizophrenia.Genes Brain Behav. 2014 Feb;13(2):144-51. doi: 10.1111/gbb.12096. Epub 2013 Nov 7.
• [454] Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis.J Neural Transm (Vienna). 2009 Mar;116(3):275-89. doi: 10.1007/s00702-008-0156-y. Epub 2008 Nov 26.
• [455] A Comprehensive Analysis of Nuclear-Encoded Mitochondrial Genes in Schizophrenia.Biol Psychiatry. 2018 May 1;83(9):780-789. doi: 10.1016/j.biopsych.2018.02.1175. Epub 2018 Mar 15.
• [456] Transcription of PIK3CD in human brain and schizophrenia: regulation by proinflammatory cytokines.Hum Mol Genet. 2019 Oct 1;28(19):3188-3198. doi: 10.1093/hmg/ddz144.
• [457] Identification of the Niacin-Blunted Subgroup of Schizophrenia Patients from Mood Disorders and Healthy Individuals in Chinese Population.Schizophr Bull. 2018 Jun 6;44(4):896-907. doi: 10.1093/schbul/sbx150.
• [458] TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA(A) receptor agonist mechanism: possible therapeutic target for cognitive deficit in schizophrenia.Neuropsychopharmacology. 2018 Nov;43(12):2468-2477. doi: 10.1038/s41386-018-0160-3. Epub 2018 Jul 23.
• [459] High-Frequency Neuronal Oscillatory Abnormalities in the Phospholipase C-1 Knockout Mouse Model of Schizophrenia.Int J Neuropsychopharmacol. 2019 Mar 1;22(3):221-231. doi: 10.1093/ijnp/pyy097.
• [460] Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo.Sci Adv. 2019 May 8;5(5):eaau9093. doi: 10.1126/sciadv.aau9093. eCollection 2019 May.
• [461] Genes in immune pathways associated with abnormal white matter integrity in first-episode and treatment-nave patients with schizophrenia.Br J Psychiatry. 2019 May;214(5):281-287. doi: 10.1192/bjp.2018.297. Epub 2019 Feb 6.
• [462] Altered subcellular localization of fragile X mental retardation signaling partners and targets in superior frontal cortex of individuals with schizophrenia.Neuroreport. 2017 Nov 8;28(16):1066-1070. doi: 10.1097/WNR.0000000000000880.
• [463] The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia.Eur Neuropsychopharmacol. 2017 Feb;27(2):180-191. doi: 10.1016/j.euroneuro.2016.11.016. Epub 2016 Dec 14.
• [464] Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.Hum Psychopharmacol. 2014 Jul;29(4):330-5. doi: 10.1002/hup.2407. Epub 2014 Apr 16.
• [465] Differential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophrenia.Psychiatry Res. 2012 Apr 30;196(2-3):201-6. doi: 10.1016/j.psychres.2011.09.026. Epub 2012 Mar 6.
• [466] Studies on Prostaglandin-Endoperoxide Synthase 1: Lower Levels in Schizophrenia and After Treatment with Antipsychotic Drugs in Conjunction with Aspirin.Int J Neuropsychopharmacol. 2018 Mar 1;21(3):216-225. doi: 10.1093/ijnp/pyx092.
• [467] Association studies of the CT repeat polymorphism in the 5' upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects.Am J Med Genet. 2001 Dec 8;105(8):779-82. doi: 10.1002/ajmg.10043.
• [468] Integration of expression quantitative trait loci and pleiotropy identifies a novel psoriasis susceptibility gene, PTPN1.J Gene Med. 2017 Jan;19(1-2). doi: 10.1002/jgm.2939.
• [469] The SHP-1 expression is associated with cytokines and psychopathological status in unmedicated first episode schizophrenia patients.Brain Behav Immun. 2014 Oct;41:251-60. doi: 10.1016/j.bbi.2014.04.008. Epub 2014 Apr 30.
• [470] Attenuated Notch signaling in schizophrenia and bipolar disorder.Sci Rep. 2018 Mar 28;8(1):5349. doi: 10.1038/s41598-018-23703-w.
• [471] Grey matter, an endophenotype for schizophrenia? A voxel-based morphometry study in siblings of patients with schizophrenia.J Psychiatry Neurosci. 2015 May;40(3):207-13. doi: 10.1503/jpn.140064.
• [472] Effect of Rhesus D incompatibility on schizophrenia depends on offspring sex.Schizophr Res. 2008 Sep;104(1-3):135-45. doi: 10.1016/j.schres.2008.06.022. Epub 2008 Aug 9.
• [473] Association of age-of-onset groups with GWAS significant schizophrenia and bipolar disorder loci in Romanian bipolar I patients.Psychiatry Res. 2015 Dec 30;230(3):964-7. doi: 10.1016/j.psychres.2015.11.008. Epub 2015 Nov 10.
• [474] Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia.Biol Psychiatry. 2012 Oct 15;72(8):620-8. doi: 10.1016/j.biopsych.2012.05.035. Epub 2012 Aug 9.
• [475] Mental imagery vividness as a trait marker across the schizophrenia spectrum.Psychiatry Res. 2009 May 15;167(1-2):1-11. doi: 10.1016/j.psychres.2007.12.008. Epub 2009 Apr 3.
• [476] Transcriptomic Analysis Shows Decreased Cortical Expression of NR4A1, NR4A2 and RXRB in Schizophrenia and Provides Evidence for Nuclear Receptor Dysregulation.PLoS One. 2016 Dec 16;11(12):e0166944. doi: 10.1371/journal.pone.0166944. eCollection 2016.
• [477] Racial Differences in S100b Levels in Persons with Schizophrenia.Psychiatr Q. 2020 Mar;91(1):137-145. doi: 10.1007/s11126-019-09687-4.
• [478] Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1.BMC Med Genet. 2014 Jan 4;15:2. doi: 10.1186/1471-2350-15-2.
• [479] Understanding the schizophrenia phenotype in the first patient with the full SCN2A phenotypic spectrum.Psychiatr Genet. 2019 Jun;29(3):91-94. doi: 10.1097/YPG.0000000000000219.
• [480] Multifaceted genomic risk for brain function in schizophrenia.Neuroimage. 2012 Jul 16;61(4):866-75. doi: 10.1016/j.neuroimage.2012.03.022. Epub 2012 Mar 13.
• [481] Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits.Biol Psychiatry. 2010 Jul 1;68(1):25-32. doi: 10.1016/j.biopsych.2010.02.016. Epub 2010 Apr 10.
• [482] Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots.Transl Psychiatry. 2017 Dec 18;7(12):1290. doi: 10.1038/s41398-017-0027-0.
• [483] Complement Gene Expression Correlates with Superior Frontal Cortical Thickness in Humans.Neuropsychopharmacology. 2018 Feb;43(3):525-533. doi: 10.1038/npp.2017.164. Epub 2017 Jul 31.
• [484] Cognitive performance of the MAM-E17 schizophrenia model rats in different age-periods.Behav Brain Res. 2020 Feb 3;379:112345. doi: 10.1016/j.bbr.2019.112345. Epub 2019 Nov 5.
• [485] Functional analysis of a potassium-chloride co-transporter 3 (SLC12A6) promoter polymorphism leading to an additional DNA methylation site. Neuropsychopharmacology. 2009 Jan;34(2):458-67.
• [486] Study on ceramide modulates EAAT-2 participation in the immunoinflammatory response in schizophrenia.Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):2263-2272. doi: 10.26355/eurrev_201903_17275.
• [487] Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons?.Mol Psychiatry. 2016 Jun;21(6):823-30. doi: 10.1038/mp.2015.148. Epub 2015 Sep 29.
• [488] Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):271-8. doi: 10.1002/ajmg.b.30351.
• [489] Oct-6 transcription factor.Int Rev Neurobiol. 2004;59:471-89. doi: 10.1016/S0074-7742(04)59018-9.
• [490] Systems Analysis of the 22q11.2 Microdeletion Syndrome Converges on a Mitochondrial Interactome Necessary for Synapse Function and Behavior.J Neurosci. 2019 May 1;39(18):3561-3581. doi: 10.1523/JNEUROSCI.1983-18.2019. Epub 2019 Mar 4.
• [491] Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia.Schizophr Res. 2008 Jul;102(1-3):283-94. doi: 10.1016/j.schres.2008.02.009. Epub 2008 Apr 8.
• [492] Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance.Schizophr Bull. 2015 Jan;41(1):180-91. doi: 10.1093/schbul/sbt178. Epub 2013 Dec 22.
• [493] Association between the SLC6A12 gene and negative symptoms of schizophrenia in a Korean population.Psychiatry Res. 2011 Oct 30;189(3):478-9. doi: 10.1016/j.psychres.2011.01.023. Epub 2011 Mar 2.
• [494] Transcriptional dysregulation of -aminobutyric acid transporter in parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia.Psychiatry Res. 2014 Dec 30;220(3):1155-9. doi: 10.1016/j.psychres.2014.09.016. Epub 2014 Oct 2.
• [495] Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders.Nat Commun. 2016 Feb 3;7:10594. doi: 10.1038/ncomms10594.
• [496] A Computer-Aided Diagnosis System With EEG Based on the P3b Wave During an Auditory Odd-Ball Task in Schizophrenia.IEEE Trans Biomed Eng. 2017 Feb;64(2):395-407. doi: 10.1109/TBME.2016.2558824.
• [497] Reward processing in certain versus uncertain contexts in schizophrenia: An event-related potential (ERP) study.J Abnorm Psychol. 2019 Nov;128(8):867-880. doi: 10.1037/abn0000469.
• [498] SRD5A2 is associated with increased cortisol metabolism in schizophrenia spectrum disorders.Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 1;34(8):1500-6. doi: 10.1016/j.pnpbp.2010.08.013. Epub 2010 Aug 25.
• [499] Enriched Environment Reverts Somatostatin Interneuron Loss in MK-801 Model of Schizophrenia.Mol Neurobiol. 2020 Jan;57(1):125-134. doi: 10.1007/s12035-019-01762-y. Epub 2019 Sep 10.
• [500] Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients.J Psychiatr Res. 2010 Oct;44(14):971-8. doi: 10.1016/j.jpsychires.2010.03.007. Epub 2010 Apr 15.
• [501] Investigation of manic and euthymic episodes identifies state- and trait-specific gene expression and STAB1 as a new candidate gene for bipolar disorder.Transl Psychiatry. 2014 Aug 19;4(8):e426. doi: 10.1038/tp.2014.71.
• [502] Genetic predictors of risk and resilience in psychiatric disorders: a cross-disorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2013 Dec;162B(8):779-88. doi: 10.1002/ajmg.b.32190. Epub 2013 Sep 13.
• [503] Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia.Schizophr Res. 2012 Nov;141(2-3):262-5. doi: 10.1016/j.schres.2012.08.027. Epub 2012 Sep 24.
• [504] Actions of Trace Amines in the Brain-Gut-Microbiome Axis via Trace Amine-Associated Receptor-1 (TAAR1).Cell Mol Neurobiol. 2020 Mar;40(2):191-201. doi: 10.1007/s10571-019-00772-7. Epub 2019 Dec 13.
• [505] Transporter associated with antigen processing and the chaperone tapasin: are non-classical HLA genes keys to the pathogenesis of schizophrenia?.Med Hypotheses. 2009 May;72(5):535-8. doi: 10.1016/j.mehy.2008.12.036. Epub 2009 Feb 12.
• [506] Genome-wide association analysis with gray matter volume as a quantitative phenotype in first-episode treatment-nave patients with schizophrenia.PLoS One. 2013 Sep 24;8(9):e75083. doi: 10.1371/journal.pone.0075083. eCollection 2013.
• [507] The common variants implicated in microstructural abnormality of first episode and drug-nave patients with schizophrenia.Sci Rep. 2017 Sep 18;7(1):11750. doi: 10.1038/s41598-017-10507-7.
• [508] Association of thrombospondin 1 gene with schizophrenia in Korean population.Mol Biol Rep. 2012 Jun;39(6):6875-80. doi: 10.1007/s11033-012-1513-3. Epub 2012 Feb 7.
• [509] Fast set-based association analysis using summary data from GWAS identifies novel gene loci for human complex traits.Sci Rep. 2016 Sep 8;6:32894. doi: 10.1038/srep32894.
• [510] Pattern of expression of Toll like receptor (TLR)-3 and -4 genes in drug-nave and antipsychotic treated patients diagnosed with schizophrenia.Psychiatry Res. 2020 Mar;285:112727. doi: 10.1016/j.psychres.2019.112727. Epub 2019 Dec 4.
• [511] Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia.Sci Rep. 2017 Jun 23;7(1):4147. doi: 10.1038/s41598-017-03736-3.
• [512] Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.Nat Genet. 2018 Mar;50(3):381-389. doi: 10.1038/s41588-018-0059-2. Epub 2018 Feb 26.
• [513] Polymorphism of bovine beta-casein and its potential effect on human health.J Appl Genet. 2007;48(3):189-98. doi: 10.1007/BF03195213.
• [514] Genetics of Aggression in Alzheimer's Disease (AD).Front Aging Neurosci. 2017 Apr 10;9:87. doi: 10.3389/fnagi.2017.00087. eCollection 2017.
• [515] Overlapping regional distribution of CCK and TPPII mRNAs in Cynomolgus monkey brain and correlated levels in human cerebral cortex (BA 10).Brain Res. 2006 Aug 9;1104(1):175-82. doi: 10.1016/j.brainres.2006.05.059. Epub 2006 Jul 5.
• [516] Prefrontal cortex alterations in glia gene expression in schizophrenia with and without suicide.J Psychiatr Res. 2020 Feb;121:31-38. doi: 10.1016/j.jpsychires.2019.11.002. Epub 2019 Nov 9.
• [517] Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia.Psychiatr Genet. 2012 Feb;22(1):1-14. doi: 10.1097/YPG.0b013e32834c0c33.
• [518] Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia.Mol Psychiatry. 2005 Apr;10(4):353-65. doi: 10.1038/sj.mp.4001586.
• [519] TRP's: links to schizophrenia?.Biochim Biophys Acta. 2007 Aug;1772(8):968-77. doi: 10.1016/j.bbadis.2007.05.003. Epub 2007 May 21.
• [520] Alterations of ubiquitin related proteins in the pathology and development of schizophrenia: Evidence from human and animal studies.J Psychiatr Res. 2017 Jul;90:31-39. doi: 10.1016/j.jpsychires.2017.01.009. Epub 2017 Jan 18.
• [521] Synergistic association of mitochondrial uncoupling protein (UCP) genes with schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 5;144B(2):250-3. doi: 10.1002/ajmg.b.30443.
• [522] Exome sequence analysis and follow up genotyping implicates rare ULK1 variants to be involved in susceptibility to schizophrenia.Ann Hum Genet. 2018 Mar;82(2):88-92. doi: 10.1111/ahg.12226. Epub 2017 Nov 17.
• [523] Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors.Curr Cancer Drug Targets. 2017;17(2):109-121. doi: 10.2174/1568009616666160621101248.
• [524] Genetic variation in the 3'-untranslated region of PAK1 influences schizophrenia susceptibility.Exp Ther Med. 2017 Mar;13(3):1101-1108. doi: 10.3892/etm.2017.4039. Epub 2017 Jan 12.
• [525] Wendan decoction (Traditional Chinese medicine) for schizophrenia.Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD012217. doi: 10.1002/14651858.CD012217.pub2.
• [526] Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study.Schizophr Res. 2019 Apr;206:291-299. doi: 10.1016/j.schres.2018.11.002. Epub 2018 Nov 23.
• [527] Adolescent (9)-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-B-Cyclooxygenase-2 Signaling to ImpairMemory in Adulthood.Biol Psychiatry. 2019 Jun 1;85(11):891-903. doi: 10.1016/j.biopsych.2018.07.024. Epub 2018 Aug 16.
• [528] Mutation analysis of the WNT7A gene in patients with schizophrenia.Psychiatry Res. 2018 Jul;265:246-248. doi: 10.1016/j.psychres.2018.04.057. Epub 2018 May 8.
• [529] Leucocyte arylsulphatase A activity and subtypes of chronic schizophrenia.Acta Psychiatr Scand. 1990 Jul;82(1):55-9. doi: 10.1111/j.1600-0447.1990.tb01355.x.
• [530] The mediating effect of family cohesion in reducing patient symptoms and family distress in a culturally informed family therapy for schizophrenia: A parallel-process latent-growth model.J Consult Clin Psychol. 2018 Jan;86(1):1-14. doi: 10.1037/ccp0000257. Epub 2017 Nov 27.
• [531] Strategic Timing of Glial HMOX1 Expression Results in Either Schizophrenia-Like or Parkinsonian Behavior in Mice.Antioxid Redox Signal. 2020 Jun 10;32(17):1259-1272. doi: 10.1089/ars.2019.7937. Epub 2020 Jan 23.
• [532] Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia.World J Biol Psychiatry. 2017 Apr;18(3):239-246. doi: 10.1080/15622975.2016.1224926. Epub 2016 Sep 22.
• [533] Elevation of plasma neutrophil gelatinase-associated lipocalin (NGAL) levels in schizophrenia patients.J Affect Disord. 2018 Jan 15;226:307-312. doi: 10.1016/j.jad.2017.10.002. Epub 2017 Oct 3.
• [534] Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.Lancet Psychiatry. 2018 Apr;5(4):327-338. doi: 10.1016/S2215-0366(18)30049-X. Epub 2018 Mar 1.
• [535] Gain-of-function missense variant in SLC12A2, encoding the bumetanide-sensitive NKCC1 cotransporter, identified in human schizophrenia. J Psychiatr Res. 2016 Jun;77:22-6. doi: 10.1016/j.jpsychires.2016.02.016. Epub 2016 Feb 27.
• [536] Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell. 2013 Aug 1;154(3):518-29. doi: 10.1016/j.cell.2013.06.049.
• [537] Genome-wide association study of schizophrenia using microsatellite markers in the Japanese population. Psychiatr Genet. 2013 Jun;23(3):117-23.
• [538] Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls.Transl Psychiatry. 2018 Apr 12;8(1):78. doi: 10.1038/s41398-018-0124-8.
• [539] Common variants in the chromosome 2p23 region containing the SLC30A3 (ZnT3) gene are associated with schizophrenia in female but not male individuals in a large collection of European samples.Psychiatry Res. 2016 Dec 30;246:335-340. doi: 10.1016/j.psychres.2016.09.052. Epub 2016 Sep 28.
• [540] Oxidative stress in drug-nave first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders.Eur Arch Psychiatry Clin Neurosci. 2018 Mar;268(2):129-143. doi: 10.1007/s00406-016-0749-7. Epub 2016 Dec 2.
• [541] Evidence for altered excitatory and inhibitory tone in the post-mortem substantia nigra in schizophrenia.World J Biol Psychiatry. 2020 Jun;21(5):339-356. doi: 10.1080/15622975.2019.1615638. Epub 2019 Jun 4.
• [542] Association of an UCP4 (SLC25A27) haplotype with ultra-resistant schizophrenia.Pharmacogenomics. 2011 Feb;12(2):185-93. doi: 10.2217/pgs.10.179.
• [543] Using phenome-wide association to investigate the function of a schizophrenia risk locus at SLC39A8.Transl Psychiatry. 2019 Jan 29;9(1):45. doi: 10.1038/s41398-019-0386-9.
• [544] GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.Am J Psychiatry. 2019 Aug 1;176(8):651-660. doi: 10.1176/appi.ajp.2019.18080957. Epub 2019 Jun 5.
• [545] Large-Scale Identification of Common Trait and Disease Variants Affecting Gene Expression.Am J Hum Genet. 2017 Jun 1;100(6):885-894. doi: 10.1016/j.ajhg.2017.04.016. Epub 2017 May 25.
• [546] Selective Loss of Smaller Spines in Schizophrenia.Am J Psychiatry. 2017 Jun 1;174(6):586-594. doi: 10.1176/appi.ajp.2017.16070814. Epub 2017 Mar 31.
• [547] Common variants on chromosome 6p22.1 are associated with schizophrenia.Nature. 2009 Aug 6;460(7256):753-7. doi: 10.1038/nature08192. Epub 2009 Jul 1.
• [548] Deletion of the vesicular monoamine transporter 1 (vmat1/slc18a1) gene affects dopamine signaling.Brain Res. 2019 Jun 1;1712:151-157. doi: 10.1016/j.brainres.2019.01.029. Epub 2019 Jan 24.
• [549] Dyslexia associated functional variants in Europeans are not associated with dyslexia in Chinese.Am J Med Genet B Neuropsychiatr Genet. 2019 Oct;180(7):488-495. doi: 10.1002/ajmg.b.32750. Epub 2019 Jul 2.
• [550] Glucose-6-phosphate dehydrogenase activity in bipolar disorder and schizophrenia: Relationship to mitochondrial impairment.J Psychiatr Res. 2019 May;112:99-103. doi: 10.1016/j.jpsychires.2019.03.004. Epub 2019 Mar 5.
• [551] Positive association between ALDH1A2 and schizophrenia in the Chinese population.Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1491-5. doi: 10.1016/j.pnpbp.2009.08.008. Epub 2009 Aug 22.
• [552] Independent Methylome-Wide Association Studies of Schizophrenia Detect Consistent Case-Control Differences.Schizophr Bull. 2020 Feb 26;46(2):319-327. doi: 10.1093/schbul/sbz056.
• [553] Female specific association between NNMT gene and schizophrenia in a Han Chinese population.Int J Med Sci. 2014 Sep 19;11(12):1234-9. doi: 10.7150/ijms.9426. eCollection 2014.
• [554] Variants in ACPP are associated with cerebrospinal fluid Prostatic Acid Phosphatase levels.BMC Genomics. 2016 Jun 29;17 Suppl 3(Suppl 3):439. doi: 10.1186/s12864-016-2787-y.
• [555] Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism.Hum Genet. 2013 Jul;132(7):735-43. doi: 10.1007/s00439-013-1277-4. Epub 2013 Mar 7.
• [556] Evidence of epistasis between the catechol-O-methyltransferase and aldehyde dehydrogenase 3B1 genes in paranoid schizophrenia.Biol Psychiatry. 2009 Jun 15;65(12):1048-54. doi: 10.1016/j.biopsych.2008.11.027. Epub 2009 Jan 21.
• [557] Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas.Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):72-9. doi: 10.1007/s00406-008-0837-4. Epub 2008 Sep 19.
• [558] Investigation of betaine as a novel psychotherapeutic for schizophrenia.EBioMedicine. 2019 Jul;45:432-446. doi: 10.1016/j.ebiom.2019.05.062. Epub 2019 Jun 26.
• [559] Wisconsin Card Sorting Test performance impairment in schizophrenia: An Indian study report.Indian J Psychiatry. 2017 Jan-Mar;59(1):88-93. doi: 10.4103/0019-5545.204440.
• [560] Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits.Hum Mol Genet. 2012 Oct 15;21(20):4406-18. doi: 10.1093/hmg/dds273. Epub 2012 Jul 13.
• [561] Interactive effect of cytochrome P450 17alpha-hydroxylase and dopamine D3 receptor gene polymorphisms on abnormal involuntary movements in chronic schizophrenia.Biol Psychiatry. 2002 Feb 1;51(3):261-3. doi: 10.1016/s0006-3223(01)01302-6.
• [562] The Emerging Role of Altered d-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies.Front Psychiatry. 2018 Nov 6;9:559. doi: 10.3389/fpsyt.2018.00559. eCollection 2018.
• [563] Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia.Schizophr Res. 2017 Apr;182:66-73. doi: 10.1016/j.schres.2016.10.024. Epub 2016 Oct 20.
• [564] Social isolation induces schizophrenia-like behavior potentially associated with HINT1, NMDA receptor 1, and dopamine receptor 2.Neuroreport. 2017 May 24;28(8):462-469. doi: 10.1097/WNR.0000000000000775.
• [565] Lateralization of 17beta-hydroxysteroid dehydrogenase type 10 in hippocampi of demented and psychotic people.Dement Geriatr Cogn Disord. 2008;26(3):193-8. doi: 10.1159/000151778. Epub 2008 Sep 3.
• [566] Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1).Brain Res. 2006 Aug 23;1106(1):205-210. doi: 10.1016/j.brainres.2006.05.082. Epub 2006 Jul 7.
• [567] Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.Biol Psychiatry. 2005 Mar 1;57(5):525-32. doi: 10.1016/j.biopsych.2004.11.041.
• [568] SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D(2) Receptor Mechanism of Action.J Pharmacol Exp Ther. 2019 Oct;371(1):1-14. doi: 10.1124/jpet.119.260281. Epub 2019 Aug 1.
• [569] Association between MTHFR C677T and A1298C, and MTRR A66G polymorphisms and susceptibility to schizophrenia in a Syrian study cohort.Asian J Psychiatr. 2012 Jun;5(2):144-9. doi: 10.1016/j.ajp.2012.03.002. Epub 2012 Apr 26.
• [570] The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples.BMC Med Genet. 2008 May 6;9:39. doi: 10.1186/1471-2350-9-39.
• [571] Association of interleukin 2 (IL-2), interleukin 6 (IL-6), and TNF-alpha (TNF) gene polymorphisms with paranoid schizophrenia in a Polish population.J Neuropsychiatry Clin Neurosci. 2013 Winter;25(1):72-82. doi: 10.1176/appi.neuropsych.12020021.
• [572] Association between PNPO and schizophrenia in the Japanese population.Schizophr Res. 2007 Dec;97(1-3):264-70. doi: 10.1016/j.schres.2007.08.004. Epub 2007 Sep 12.
• [573] A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder: altered l-serine level associated with disruption of PSAT1 gene expression.Neurosci Res. 2011 Feb;69(2):154-60. doi: 10.1016/j.neures.2010.10.003. Epub 2010 Oct 16.
• [574] Rheumatoid arthritis and schizophrenia: a negative association at a dimensional level.Schizophr Res. 2004 Jan 1;66(1):21-9. doi: 10.1016/s0920-9964(03)00017-3.
• [575] Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr-/- mice: relevance to schizophrenia.BMB Rep. 2010 Sep;43(9):593-8. doi: 10.5483/BMBRep.2010.43.9.593.
• [576] A tale of two steroids: The importance of the androgens DHEA and DHEAS for early neurodevelopment.J Steroid Biochem Mol Biol. 2019 Apr;188:77-85. doi: 10.1016/j.jsbmb.2018.12.007. Epub 2018 Dec 15.
• [577] De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample.Schizophr Res. 2015 Aug;166(1-3):119-24. doi: 10.1016/j.schres.2015.05.042. Epub 2015 Jun 16.
• [578] BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:181-8. doi: 10.1016/j.pnpbp.2013.07.008. Epub 2013 Jul 19.
• [579] Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial.Eur Neuropsychopharmacol. 2016 Oct;26(10):1683-9. doi: 10.1016/j.euroneuro.2016.08.006. Epub 2016 Aug 18.
• [580] Mutations of the glycine cleavage system genes possibly affect the negative symptoms of schizophrenia through metabolomic profile changes.Psychiatry Clin Neurosci. 2018 Mar;72(3):168-179. doi: 10.1111/pcn.12628. Epub 2018 Jan 31.
• [581] Damaging coding variants within kainate receptor channel genes are enriched in individuals with schizophrenia, autism and intellectual disabilities.Sci Rep. 2019 Dec 16;9(1):19215. doi: 10.1038/s41598-019-55635-4.
• [582] Whole Exome Sequencing of Patients from Multicase Families with Systemic Lupus Erythematosus Identifies Multiple Rare Variants. Sci Rep. 2018 Jun 8;8(1):8775. doi: 10.1038/s41598-018-26274-y.
• [583] Clec16a is Critical for Autolysosome Function and Purkinje Cell Survival. Sci Rep. 2016 Mar 18;6:23326. doi: 10.1038/srep23326.
• [584] Genomic duplication and overexpression of TJP2/ZO-2 leads to altered expression of apoptosis genes in progressive nonsyndromic hearing loss DFNA51. Am J Hum Genet. 2010 Jul 9;87(1):101-9. doi: 10.1016/j.ajhg.2010.05.011. Epub 2010 Jun 17.
• [585] Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genes. PLoS One. 2014 Nov 24;9(11):e112745. doi: 10.1371/journal.pone.0112745. eCollection 2014.
• [586] Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell. 2020 Feb 6;180(3):568-584.e23. doi: 10.1016/j.cell.2019.12.036. Epub 2020 Jan 23.
• [587] De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biol Psychiatry. 2010 Oct 1;68(7):649-56. doi: 10.1016/j.biopsych.2010.04.018. Epub 2010 Jun 19.
• [588] The contribution of de novo coding mutations to autism spectrum disorder. Nature. 2014 Nov 13;515(7526):216-21. doi: 10.1038/nature13908. Epub 2014 Oct 29.
• [589] Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family-based, Arab-Israeli sample. FASEB J. 2011 Nov;25(11):4011-23. doi: 10.1096/fj.11-184937. Epub 2011 Jul 27.
• [590] Double hits in schizophrenia. Hum Mol Genet. 2018 Aug 1;27(15):2755-2761. doi: 10.1093/hmg/ddy175.
• [591] Molecular genetic studies of schizophrenia. Eur J Hum Genet. 2006 Jun;14(6):669-80. doi: 10.1038/sj.ejhg.5201571.
• [592] Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017 Feb 23;542(7642):433-438. doi: 10.1038/nature21062. Epub 2017 Jan 25.
• [593] Identification of rare mutations of synaptogyrin 1 gene in patients with schizophrenia. J Psychiatr Res. 2007 Dec;41(12):1027-31. doi: 10.1016/j.jpsychires.2006.08.010. Epub 2006 Oct 17.
• [594] A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression. Am J Hum Genet. 2009 Dec;85(6):833-46. doi: 10.1016/j.ajhg.2009.11.003.
• [595] Genetic variations in the ADCK1 gene predict paliperidone palmitate efficacy in Han Chinese patients with schizophrenia.J Neural Transm (Vienna). 2019 Jan;126(1):19-25. doi: 10.1007/s00702-018-1953-6. Epub 2018 Nov 13.
• [596] Examining the structure of ideas of reference in clinical and community samples.Compr Psychiatry. 2019 Aug;93:48-55. doi: 10.1016/j.comppsych.2019.06.006. Epub 2019 Jul 3.
• [597] rs7968606 polymorphism of ANKS1B is associated with improvement in the PANSS general score of schizophrenia caused by amisulpride.Hum Psychopharmacol. 2017 Mar;32(2). doi: 10.1002/hup.2562. Epub 2017 Mar 23.
• [598] Association of ARHGAP18 polymorphisms with schizophrenia in the Chinese-Han population.PLoS One. 2017 Apr 6;12(4):e0175209. doi: 10.1371/journal.pone.0175209. eCollection 2017.
• [599] Common variants on Xq28 conferring risk of schizophrenia in Han Chinese.Schizophr Bull. 2014 Jul;40(4):777-86. doi: 10.1093/schbul/sbt104. Epub 2013 Sep 16.
• [600] A Bayesian model comparison approach to test the specificity of visual integration impairment in schizophrenia or psychosis.Psychiatry Res. 2018 Jul;265:271-278. doi: 10.1016/j.psychres.2018.04.061. Epub 2018 May 7.
• [601] The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies.Transl Psychiatry. 2019 Aug 27;9(1):205. doi: 10.1038/s41398-019-0532-4.
• [602] The effects of combined oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia.Psychol Med. 2019 Jul;49(10):1731-1739. doi: 10.1017/S0033291718002465. Epub 2018 Sep 5.
• [603] Influence of antipsychotic drugs on human endogenous retrovirus (HERV) transcription in brain cells.PLoS One. 2012;7(1):e30054. doi: 10.1371/journal.pone.0030054. Epub 2012 Jan 11.
• [604] Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat.Schizophr Res. 2019 Apr;206:263-270. doi: 10.1016/j.schres.2018.11.006. Epub 2018 Dec 3.
• [605] Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells.Mol Autism. 2018 Aug 15;9:44. doi: 10.1186/s13229-018-0227-3. eCollection 2018.
• [606] Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders.J Psychiatr Res. 2009 Sep;43(13):1078-85. doi: 10.1016/j.jpsychires.2009.03.010. Epub 2009 Apr 19.
• [607] Risperidone and NAP protect cognition and normalize gene expression in a schizophrenia mouse model.Sci Rep. 2015 Nov 10;5:16300. doi: 10.1038/srep16300.
• [608] Cux2 expression regulated by Lhx2 in the upper layer neurons of the developing cortex.Biochem Biophys Res Commun. 2020 Jan 22;521(4):874-879. doi: 10.1016/j.bbrc.2019.11.004. Epub 2019 Nov 8.
• [609] Unwell in hospital but not incapable: cross-sectional study on the dissociation of decision-making capacity for treatment and research in in-patients with schizophrenia and related psychoses.Br J Psychiatry. 2018 Aug;213(2):484-489. doi: 10.1192/bjp.2018.85. Epub 2018 Jun 18.
• [610] Dorsal Forebrain-Specific Deficiency of Reelin-Dab1 Signal Causes Behavioral Abnormalities Related to Psychiatric Disorders.Cereb Cortex. 2017 Jul 1;27(7):3485-3501. doi: 10.1093/cercor/bhv334.
• [611] Multivariate eQTL mapping uncovers functional variation on the X-chromosome associated with complex disease traits.Hum Genet. 2016 Jul;135(7):827-39. doi: 10.1007/s00439-016-1674-6. Epub 2016 May 7.
• [612] Electrodermal activation in first-episode psychotic patients and their first-degree relatives.Psychiatry Res. 1999 Oct 18;88(1):25-39. doi: 10.1016/s0165-1781(99)00071-2.
• [613] Association Between Polymorphisms of DNA Repair Genes and Risk of Schizophrenia.Genet Test Mol Biomarkers. 2016 Jan;20(1):11-7. doi: 10.1089/gtmb.2015.0168. Epub 2015 Nov 10.
• [614] A pilot study on commonality and specificity of copy number variants in schizophrenia and bipolar disorder.Transl Psychiatry. 2016 May 31;6(5):e824. doi: 10.1038/tp.2016.96.
• [615] Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders.CNS Neurol Disord Drug Targets. 2006 Apr;5(2):197-204. doi: 10.2174/187152706776359673.
• [616] Evidence for Association of Cell Adhesion Molecules Pathway and NLGN1 Polymorphisms with Schizophrenia in Chinese Han Population.PLoS One. 2015 Dec 16;10(12):e0144719. doi: 10.1371/journal.pone.0144719. eCollection 2015.
• [617] Chromatin profiling of cortical neurons identifies individual epigenetic signatures in schizophrenia.Transl Psychiatry. 2019 Oct 17;9(1):256. doi: 10.1038/s41398-019-0596-1.
• [618] Potential involvement of the interleukin-18 pathway in schizophrenia.J Psychiatr Res. 2016 Mar;74:10-6. doi: 10.1016/j.jpsychires.2015.12.013. Epub 2015 Dec 15.
• [619] Fronto-parietal hypo-activation during working memory independent of structural abnormalities: conjoint fMRI and sMRI analyses in adolescent offspring of schizophrenia patients.Neuroimage. 2011 Sep 1;58(1):234-41. doi: 10.1016/j.neuroimage.2011.06.033. Epub 2011 Jun 29.
• [620] Leveraging brain cortex-derived molecular data to elucidate epigenetic and transcriptomic drivers of complex traits and disease.Transl Psychiatry. 2019 Feb 28;9(1):105. doi: 10.1038/s41398-019-0437-2.
• [621] Schizophrenia and Nail Patella Syndrome: The Dopamine Connection.Isr Med Assoc J. 2018 Aug;20(8):496-498.
• [622] Altered Expression Profile of IgLON Family of Neural Cell Adhesion Molecules in the Dorsolateral Prefrontal Cortex of Schizophrenic Patients.Front Mol Neurosci. 2018 Jan 29;11:8. doi: 10.3389/fnmol.2018.00008. eCollection 2018.
• [623] Pilot study for family-based association analysis of schizophrenia in a Korean population: Analysis for candidate genes positionally on chromosome 18q21.Asia Pac Psychiatry. 2015 Sep;7(3):268-75. doi: 10.1111/appy.12167. Epub 2014 Dec 12.
• [624] Genetic association and functional characterization of MCPH1 gene variation in bipolar disorder and schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2019 Jun;180(4):258-265. doi: 10.1002/ajmg.b.32722. Epub 2019 Mar 11.
• [625] Handedness, language areas and neuropsychiatric diseases: insights from brain imaging and genetics.Brain. 2019 Oct 1;142(10):2938-2947. doi: 10.1093/brain/awz257.
• [626] Association study of myelin transcription factor 1-like polymorphisms with schizophrenia in Han Chinese population.Genes Brain Behav. 2012 Feb;11(1):87-93. doi: 10.1111/j.1601-183X.2011.00734.x. Epub 2011 Oct 19.
• [627] Current Understanding of the Role of Neuronal Calcium Sensor 1 in Neurological Disorders.Mol Neurobiol. 2019 Sep;56(9):6080-6094. doi: 10.1007/s12035-019-1497-2. Epub 2019 Feb 4.
• [628] Basic helix-loop-helix transcription factor NEUROG1 and schizophrenia: effects on illness susceptibility, MRI brain morphometry and cognitive abilities.Schizophr Res. 2008 Dec;106(2-3):192-9. doi: 10.1016/j.schres.2008.08.009. Epub 2008 Sep 16.
• [629] Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphisms in schizophrenia.Chronobiol Int. 2014 Aug;31(7):838-44. doi: 10.3109/07420528.2014.914034. Epub 2014 May 14.
• [630] The TLX-miR-219 cascade regulates neural stem cell proliferation in neurodevelopment and schizophrenia iPSC model.Nat Commun. 2016 Mar 11;7:10965. doi: 10.1038/ncomms10965.
• [631] Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet. 2011 Oct;130(4):563-73. doi: 10.1007/s00439-011-0975-z. Epub 2011 Mar 22.
• [632] A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia.Mol Brain. 2014 Jan 21;7:5. doi: 10.1186/1756-6606-7-5.
• [633] Schizophrenia is a later-onset feature of PCDH19 Girls Clustering Epilepsy.Epilepsia. 2019 Mar;60(3):429-440. doi: 10.1111/epi.14678. Epub 2019 Mar 3.
• [634] Sex-specific rates of transmission of psychosis in the New England high-risk family study.Schizophr Res. 2011 May;128(1-3):150-5. doi: 10.1016/j.schres.2011.01.019. Epub 2011 Feb 18.
• [635] Whole-exome sequencing of individuals from an isolated population implicates rare risk variants in bipolar disorder.Transl Psychiatry. 2017 Feb 14;7(2):e1034. doi: 10.1038/tp.2017.3.
• [636] Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease.Pharmacol Rev. 2018 Jul;70(3):446-474. doi: 10.1124/pr.117.015354.
• [637] Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia.Transl Psychiatry. 2017 Jun 20;7(6):e1155. doi: 10.1038/tp.2017.115.
• [638] Genome-Scale Transcriptional Regulatory Network Models of Psychiatric and Neurodegenerative Disorders.Cell Syst. 2019 Feb 27;8(2):122-135.e7. doi: 10.1016/j.cels.2019.01.002. Epub 2019 Feb 13.
• [639] The Weighting is the Hardest Part: On the Behavior of the Likelihood Ratio Test and the Score Test Under a Data-Driven Weighting Scheme in Sequenced Samples.Twin Res Hum Genet. 2017 Apr;20(2):108-118. doi: 10.1017/thg.2017.7. Epub 2017 Feb 27.
• [640] Mind Bomb-Binding Partner RanBP9 Plays a Contributory Role in Retinal Development.Mol Cells. 2017 Apr;40(4):271-279. doi: 10.14348/molcells.2017.2308. Epub 2017 Mar 28.
• [641] Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice.Neuropsychopharmacology. 2016 Feb;41(3):916-27. doi: 10.1038/npp.2015.228. Epub 2015 Jul 31.
• [642] Dysregulated Glial Differentiation in Schizophrenia May Be Relieved by Suppression of SMAD4- and REST-Dependent Signaling.Cell Rep. 2019 Jun 25;27(13):3832-3843.e6. doi: 10.1016/j.celrep.2019.05.088.
• [643] RIT2 Polymorphisms: Is There a Differential Association?.Mol Neurobiol. 2017 Apr;54(3):2234-2240. doi: 10.1007/s12035-016-9815-4. Epub 2016 Mar 3.
• [644] Reduced Efficacy of d-Amphetamine and 3,4-Methylenedioxymethamphetamine in Inducing Hyperactivity in Mice Lacking the Postsynaptic Scaffolding Protein SHANK1.Front Mol Neurosci. 2018 Nov 16;11:419. doi: 10.3389/fnmol.2018.00419. eCollection 2018.
• [645] Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness. Mol Psychiatry. 2016 Dec;21(12):1690-1695. doi: 10.1038/mp.2016.24. Epub 2016 Mar 22.
• [646] Synaptic and Gene Regulatory Mechanisms in Schizophrenia, Autism, and 22q11.2 Copy Number Variant-Mediated Risk for Neuropsychiatric Disorders.Biol Psychiatry. 2020 Jan 15;87(2):150-163. doi: 10.1016/j.biopsych.2019.06.029. Epub 2019 Jul 11.
• [647] CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formation.Neuron. 2013 Sep 18;79(6):1169-82. doi: 10.1016/j.neuron.2013.06.039.
• [648] Evidence for schizophrenia susceptibility alleles in the Indian population: An association of neurodevelopmental genes in case-control and familial samples.Schizophr Res. 2015 Mar;162(1-3):112-7. doi: 10.1016/j.schres.2014.12.031. Epub 2015 Jan 9.
• [649] Synaptotagmin-11 mediates a vesicle trafficking pathway that is essential for development and synaptic plasticity.Genes Dev. 2019 Mar 1;33(5-6):365-376. doi: 10.1101/gad.320077.118. Epub 2019 Feb 26.
• [650] Tet1 overexpression leads to anxiety-like behavior and enhanced fear memories via the activation of calcium-dependent cascade through Egr1 expression in mice.FASEB J. 2018 Jan;32(1):390-403. doi: 10.1096/fj.201601340RR. Epub 2017 Sep 12.
• [651] Transmembrane protein 108 involves in adult neurogenesis in the hippocampal dentate gyrus.Cell Biosci. 2019 Jan 11;9:9. doi: 10.1186/s13578-019-0272-4. eCollection 2019.
• [652] Trio Haploinsufficiency Causes Neurodevelopmental Disease-Associated Deficits.Cell Rep. 2019 Mar 5;26(10):2805-2817.e9. doi: 10.1016/j.celrep.2019.02.022.
• [653] Nipped-A regulates the Drosophila circadian clock via histone deubiquitination.EMBO J. 2020 Jan 2;39(1):e101259. doi: 10.15252/embj.2018101259. Epub 2019 Sep 19.
• [654] Study of the tetraspanin 18 association with schizophrenia in a Han Chinese population.Psychiatry Res. 2016 Jul 30;241:263-6. doi: 10.1016/j.psychres.2016.03.057. Epub 2016 May 11.
• [655] Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.Mol Psychiatry. 2014 Sep;19(9):1017-1024. doi: 10.1038/mp.2013.138. Epub 2013 Nov 26.
• [656] Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder.Schizophr Res. 2009 Oct;114(1-3):50-6. doi: 10.1016/j.schres.2009.07.008. Epub 2009 Jul 29.
• [657] Palmitoylation of cdc42 Promotes Spine Stabilization and Rescues Spine Density Deficit in a Mouse Model of 22q11.2 Deletion Syndrome.Cereb Cortex. 2017 Jul 1;27(7):3618-3629. doi: 10.1093/cercor/bhw183.
• [658] Functional gene-expression analysis shows involvement of schizophrenia-relevant pathways in patients with 22q11 deletion syndrome.PLoS One. 2012;7(3):e33473. doi: 10.1371/journal.pone.0033473. Epub 2012 Mar 22.
• [659] A genome-wide supported psychiatric risk variant in NCAN influences brain function and cognitive performance in healthy subjects.Hum Brain Mapp. 2015 Jan;36(1):378-90. doi: 10.1002/hbm.22635. Epub 2014 Sep 13.
• [660] Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment.Cogn Neuropsychiatry. 2017 Jul;22(4):280-297. doi: 10.1080/13546805.2017.1322502. Epub 2017 May 4.
• [661] Functional variants of the genes involved in neurodevelopment and susceptibility to schizophrenia in an Armenian population.Hum Immunol. 2011 Sep;72(9):746-8. doi: 10.1016/j.humimm.2011.05.018. Epub 2011 May 24.
• [662] No evidence for excess runs of homozygosity in bipolar disorder.Psychiatr Genet. 2009 Aug;19(4):165-70. doi: 10.1097/YPG.0b013e32832a4faa.
• [663] Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study.Transl Psychiatry. 2017 Oct 24;7(10):e1249. doi: 10.1038/tp.2017.210.
• [664] Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.Mol Psychiatry. 2012 Sep;17(9):880-6. doi: 10.1038/mp.2012.73. Epub 2012 Jun 12.
• [665] Neurodevelopmental Disorders: Functional Role of Ambra1 in Autism and Schizophrenia.Mol Neurobiol. 2019 Oct;56(10):6716-6724. doi: 10.1007/s12035-019-1557-7. Epub 2019 Mar 26.
• [666] Association study of BCL9 gene polymorphism rs583583 with schizophrenia and negative symptoms in Japanese population.Sci Rep. 2015 Oct 23;5:15705. doi: 10.1038/srep15705.
• [667] An association study of the Hermansky-Pudlak syndrome type 4 gene in schizophrenic patients.Psychiatr Genet. 2013 Aug;23(4):163-73. doi: 10.1097/YPG.0b013e32836130a9.
• [668] Evaluation of voltage-dependent calcium channel gene families identified several novel potential susceptible genes to schizophrenia.Sci Rep. 2016 Apr 22;6:24914. doi: 10.1038/srep24914.
• [669] Hyperactive mice show elevated D2(High) receptors, a model for schizophrenia: Calcium/calmodulin-dependent kinase II alpha knockouts.Synapse. 2010 Oct;64(10):794-800. doi: 10.1002/syn.20786.
• [670] ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure.PLoS One. 2011;6(12):e28790. doi: 10.1371/journal.pone.0028790. Epub 2011 Dec 20.
• [671] Association between chromogranin A gene polymorphism and schizophrenia in the Japanese population.Schizophr Res. 2006 Apr;83(2-3):179-83. doi: 10.1016/j.schres.2005.12.854. Epub 2006 Feb 28.
• [672] Gender-Specific Associations between CHGB Genetic Variants and Schizophrenia in a Korean Population.Yonsei Med J. 2017 May;58(3):619-625. doi: 10.3349/ymj.2017.58.3.619.
• [673] Roles of interferon-gamma and its target genes in schizophrenia: Proteomics-based reverse genetics from mouse to human.Proteomics. 2012 Jun;12(11):1815-29. doi: 10.1002/pmic.201100184.
• [674] A current view on contactin-4, -5, and -6: Implications in neurodevelopmental disorders.Mol Cell Neurosci. 2017 Jun;81:72-83. doi: 10.1016/j.mcn.2016.12.004. Epub 2017 Jan 5.
• [675] Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.J Psychopharmacol. 2015 Aug;29(8):884-91. doi: 10.1177/0269881115584469. Epub 2015 May 5.
• [676] Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis.Ann N Y Acad Sci. 2006 Aug;1074:90-6. doi: 10.1196/annals.1369.008.
• [677] Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.J Neurosci. 2016 Apr 27;36(17):4859-75. doi: 10.1523/JNEUROSCI.4632-15.2016.
• [678] Transmission disequilibrium test provides evidence of association between promoter polymorphisms in 22q11 gene DGCR14 and schizophrenia.J Neural Transm (Vienna). 2006 Oct;113(10):1551-61. doi: 10.1007/s00702-005-0420-3. Epub 2006 Jan 25.
• [679] Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets.Eur Neuropsychopharmacol. 2013 Oct;23(10):1182-9. doi: 10.1016/j.euroneuro.2012.12.002. Epub 2013 Jan 16.
• [680] Protein-interaction-network-based analysis for genome-wide association analysis of schizophrenia in Han Chinese population.J Psychiatr Res. 2014 Mar;50:73-8. doi: 10.1016/j.jpsychires.2013.11.014. Epub 2013 Dec 13.
• [681] Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach.BMC Psychiatry. 2007 May 23;7:22. doi: 10.1186/1471-244X-7-22.
• [682] Polymorphisms in MicroRNA Genes And Genes Involving in NMDAR Signaling and Schizophrenia: A Case-Control Study in Chinese Han Population.Sci Rep. 2015 Aug 10;5:12984. doi: 10.1038/srep12984.
• [683] A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patients.Eur Neuropsychopharmacol. 2010 Jun;20(6):414-20. doi: 10.1016/j.euroneuro.2010.02.012. Epub 2010 Mar 30.
• [684] Associations between SNPs and immune-related circulating proteins in schizophrenia.Sci Rep. 2017 Oct 3;7(1):12586. doi: 10.1038/s41598-017-12986-0.
• [685] Genetic and functional study of the IPO5 gene in schizophrenia.Psychiatry Res. 2011 May 30;187(3):460-1. doi: 10.1016/j.psychres.2010.05.010. Epub 2010 Jun 12.
• [686] Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia.Am J Psychiatry. 2014 Jan;171(1):62-71. doi: 10.1176/appi.ajp.2013.13040468.
• [687] KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders.CNS Neurosci Ther. 2019 Jul;25(7):887-902. doi: 10.1111/cns.13156.
• [688] Genetic association of LMAN2L gene in schizophrenia and bipolar disorder and its interaction with ANK3 gene polymorphism.Prog Neuropsychopharmacol Biol Psychiatry. 2014 Oct 3;54:157-62. doi: 10.1016/j.pnpbp.2014.05.017. Epub 2014 Jun 8.
• [689] 6p25 interstitial deletion in two dizygotic twins with gyral pattern anomaly and speech and language disorder.Eur J Paediatr Neurol. 2013 May;17(3):225-31. doi: 10.1016/j.ejpn.2012.09.008. Epub 2012 Oct 12.
• [690] Genetic association study between methyl-CpG-binding domain genes and schizophrenia among Chinese family trios.Psychiatr Genet. 2014 Oct;24(5):221-4. doi: 10.1097/YPG.0000000000000042.
• [691] A de novo 1.5Mb microdeletion on chromosome 14q23.2-23.3 in a patient with autism and spherocytosis.Autism Res. 2011 Jun;4(3):221-7. doi: 10.1002/aur.186. Epub 2011 Feb 28.
• [692] Genetic variant in NDUFS1 gene is associated with schizophrenia and negative symptoms in Han Chinese.J Hum Genet. 2015 Jan;60(1):11-6. doi: 10.1038/jhg.2014.94. Epub 2014 Oct 30.
• [693] Further evidence supporting the association of NKAPL with schizophrenia.Neurosci Lett. 2015 Sep 25;605:49-52. doi: 10.1016/j.neulet.2015.08.023. Epub 2015 Aug 18.
• [694] The Schizophrenia Susceptibility Gene OPCML Regulates Spine Maturation and Cognitive Behaviors through Eph-Cofilin Signaling.Cell Rep. 2019 Oct 1;29(1):49-61.e7. doi: 10.1016/j.celrep.2019.08.091.
• [695] Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation.BMC Psychiatry. 2009 Apr 30;9:17. doi: 10.1186/1471-244X-9-17.
• [696] Synaptic NMDA Receptor Activation Induces Ubiquitination and Degradation of STEP(61).Mol Neurobiol. 2018 Apr;55(4):3096-3111. doi: 10.1007/s12035-017-0555-x. Epub 2017 May 2.
• [697] Recapitulation and Reversal of Schizophrenia-Related Phenotypes in Setd1a-Deficient Mice.Neuron. 2019 Nov 6;104(3):471-487.e12. doi: 10.1016/j.neuron.2019.09.014. Epub 2019 Oct 9.
• [698] A direct regulatory link between microRNA-137 and SHANK2: implications for neuropsychiatric disorders.J Neurodev Disord. 2018 Apr 17;10(1):15. doi: 10.1186/s11689-018-9233-1.
• [699] SIRPB1 copy-number polymorphism as candidate quantitative trait locus for impulsive-disinhibited personality.Genes Brain Behav. 2014 Sep;13(7):653-62. doi: 10.1111/gbb.12154. Epub 2014 Jul 23.
• [700] Molecular signatures associated with cognitive deficits in schizophrenia: a study of biopsied olfactory neural epithelium.Transl Psychiatry. 2016 Oct 11;6(10):e915. doi: 10.1038/tp.2016.154.
• [701] SPG11 mutations cause Kjellin syndrome, a hereditary spastic paraplegia with thin corpus callosum and central retinal degeneration.Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):984-92. doi: 10.1002/ajmg.b.30928.
• [702] The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing.Mol Psychiatry. 2014 Apr;19(4):486-94. doi: 10.1038/mp.2013.45. Epub 2013 Apr 30.
• [703] Cortical surface area correlates with STON2 gene Ser307Pro polymorphism in first-episode treatment-nave patients with schizophrenia.PLoS One. 2013 Jun 13;8(6):e64090. doi: 10.1371/journal.pone.0064090. Print 2013.
• [704] The C allele of synonymous SNP (rs1142636, Asn170Asn) in SYN1 is a risk factor for the susceptibility of Korean female schizophrenia.Synapse. 2012 Nov;66(11):979-83. doi: 10.1002/syn.21583. Epub 2012 Aug 6.
• [705] Exome Sequencing Identifies TENM4 as a Novel Candidate Gene for Schizophrenia in the SCZD2 Locus at 11q14-21.Front Genet. 2019 Jan 28;9:725. doi: 10.3389/fgene.2018.00725. eCollection 2018.
• [706] Functional variants of TSPAN8 are associated with bipolar disorder and schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2010 Jun 5;153B(4):967-72. doi: 10.1002/ajmg.b.31057.
• [707] A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes.PLoS One. 2012;7(6):e39498. doi: 10.1371/journal.pone.0039498. Epub 2012 Jun 27.
• [708] Genetic association of ACSM1 variation with schizophrenia and major depressive disorder in the Han Chinese population.Am J Med Genet B Neuropsychiatr Genet. 2015 Mar;168B(2):144-9. doi: 10.1002/ajmg.b.32291. Epub 2015 Feb 5.
• [709] Dysregulated Prefrontal Cortical RhoA Signal Transduction in Bipolar Disorder with Psychosis: New Implications for Disease Pathophysiology.Cereb Cortex. 2020 Jan 10;30(1):59-71. doi: 10.1093/cercor/bhz070.
• [710] No evidence for linkage between schizophrenia and markers at chromosome 15q13-14.Am J Med Genet. 1999 Apr 16;88(2):109-12. doi: 10.1002/(sici)1096-8628(19990416)88:2<109::aid-ajmg1>3.0.co;2-3.
• [711] A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology.Neuropsychopharmacology. 2013 Nov;38(12):2532-44. doi: 10.1038/npp.2013.160. Epub 2013 Jul 3.
• [712] Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia.World J Biol Psychiatry. 2010 Apr;11(3):556-66. doi: 10.3109/15622970903497936.
• [713] Subcortical association with memory performance in schizophrenia: a structural magnetic resonance imaging study.Transl Psychiatry. 2018 Jan 10;8(1):20. doi: 10.1038/s41398-017-0069-3.
• [714] Genetic variations in the ADAMTS12 gene are associated with schizophrenia in Puerto Rican patients of Spanish descent.Neuromolecular Med. 2012 Mar;14(1):53-64. doi: 10.1007/s12017-012-8169-y. Epub 2012 Feb 10.
• [715] ADDing a piece to the puzzle of cognition in schizophrenia.Eur J Med Genet. 2016 Jan;59(1):26-31. doi: 10.1016/j.ejmg.2015.12.012. Epub 2015 Dec 24.
• [716] The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.Transl Psychiatry. 2019 Jan 15;9(1):2. doi: 10.1038/s41398-018-0357-6.
• [717] Association analyses of the interaction between the ADSS and ATM genes with schizophrenia in a Chinese population.BMC Med Genet. 2008 Dec 30;9:119. doi: 10.1186/1471-2350-9-119.
• [718] Potential linkage disequilibrium between schizophrenia and locus D22S278 on the long arm of chromosome 22.Am J Med Genet. 1995 Oct 9;60(5):465-7. doi: 10.1002/ajmg.1320600521.
• [719] Family study of schizophrenia: exploratory analysis for relevant factors.Schizophr Bull. 1986;12(1):120-8. doi: 10.1093/schbul/12.1.120.
• [720] Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression.Mol Psychiatry. 2020 Jul;25(7):1420-1429. doi: 10.1038/s41380-018-0336-6. Epub 2019 Jan 9.
• [721] Tyrosine hydroxylase down-regulation after loss of Abelson helper integration site 1 (AHI1) promotes depression via the circadian clock pathway in mice.J Biol Chem. 2018 Apr 6;293(14):5090-5101. doi: 10.1074/jbc.RA117.000618. Epub 2018 Feb 15.
• [722] Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility.J Psychiatr Res. 2015 Jul-Aug;66-67:38-44. doi: 10.1016/j.jpsychires.2015.04.013. Epub 2015 Apr 22.
• [723] Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia: a novel strategy for complex disorders.Mol Psychiatry. 2004 May;9(5):510-21. doi: 10.1038/sj.mp.4001472.
• [724] Applying vinpocetine to reverse synaptic ultrastructure by regulating BDNF-related PSD-95 in alleviating schizophrenia-like deficits in rat.Compr Psychiatry. 2019 Oct;94:152122. doi: 10.1016/j.comppsych.2019.152122. Epub 2019 Aug 20.
• [725] Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.PLoS One. 2018 Jan 8;13(1):e0190991. doi: 10.1371/journal.pone.0190991. eCollection 2018.
• [726] A mannosyltransferase gene at 11q23 is disrupted by a translocation breakpoint that co-segregates with bipolar affective disorder in a small family.Neurogenetics. 2002 Mar;4(1):43-53. doi: 10.1007/s10048-001-0129-x.
• [727] An evaluation of lumateperone tosylate for the treatment of schizophrenia. Expert Opin Pharmacother. 2019 Nov 30:1-7. doi: 10.1080/14656566.2019.1695778.
• [728] Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia.Schizophr Res. 2017 Apr;182:90-97. doi: 10.1016/j.schres.2016.10.027. Epub 2016 Oct 24.
• [729] Statistical Binning for Barcoded Reads Improves Downstream Analyses.Cell Syst. 2018 Aug 22;7(2):219-226.e5. doi: 10.1016/j.cels.2018.07.005.
• [730] DNA methylation of ANKK1 and response to aripiprazole in patients with acute schizophrenia: A preliminary study.J Psychiatr Res. 2018 May;100:84-87. doi: 10.1016/j.jpsychires.2018.02.018. Epub 2018 Feb 23.
• [731] The difference in serum proteomes in schizophrenia and bipolar disorder.BMC Genomics. 2019 Jul 11;20(Suppl 7):535. doi: 10.1186/s12864-019-5848-1.
• [732] Kallmann syndrome gene (KAL-X) is not mutated in schizophrenia.Am J Med Genet. 1999 Feb 5;88(1):34-7. doi: 10.1002/(sici)1096-8628(19990205)88:1<34::aid-ajmg6>3.0.co;2-6.
• [733] Reduced Annexin A3 in schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2020 Jun;270(4):489-494. doi: 10.1007/s00406-019-01048-3. Epub 2019 Aug 1.
• [734] Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia.Hum Mol Genet. 2008 Feb 1;17(3):458-65. doi: 10.1093/hmg/ddm323. Epub 2007 Nov 6.
• [735] The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia.Mol Psychiatry. 2005 Jul;10(7):669-77. doi: 10.1038/sj.mp.4001653.
• [736] Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.Pharmacogenomics J. 2008 Jun;8(3):228-36. doi: 10.1038/sj.tpj.6500474. Epub 2007 Aug 28.
• [737] The p250GAP gene is associated with risk for schizophrenia and schizotypal personality traits.PLoS One. 2012;7(4):e35696. doi: 10.1371/journal.pone.0035696. Epub 2012 Apr 18.
• [738] De novo single-nucleotide and copy number variation in discordant monozygotic twins reveals disease-related genes. Eur J Hum Genet. 2019 Jul;27(7):1121-1133. doi: 10.1038/s41431-019-0376-7. Epub 2019 Mar 18.
• [739] Human Rho guanine nucleotide exchange factor 11 gene is associated with schizophrenia in a Japanese population.Hum Psychopharmacol. 2014 Nov;29(6):552-8. doi: 10.1002/hup.2435. Epub 2014 Oct 15.
• [740] Selective attention and mismatch negativity in antipsychotic-nave, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy.Psychol Med. 2017 Sep;47(12):2155-2165. doi: 10.1017/S0033291717000599. Epub 2017 Apr 26.
• [741] Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population.Mol Psychiatry. 2017 Jul;22(7):954-960. doi: 10.1038/mp.2016.212. Epub 2016 Dec 6.
• [742] Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.Schizophr Res. 2008 Sep;104(1-3):108-20. doi: 10.1016/j.schres.2008.06.012. Epub 2008 Aug 3.
• [743] Comprehensive analysis of polymorphisms throughout GAD1 gene: a family-based association study in schizophrenia.J Neural Transm (Vienna). 2008;115(3):513-9. doi: 10.1007/s00702-007-0844-z. Epub 2008 Mar 12.
• [744] The maternal immune activation model uncovers a role for the Arx gene in GABAergic dysfunction in schizophrenia.Brain Behav Immun. 2019 Oct;81:161-171. doi: 10.1016/j.bbi.2019.06.009. Epub 2019 Jun 5.
• [745] Identification of the N-acylsphingosine amidohydrolase 1 gene (ASAH1) for susceptibility to schizophrenia in a Han Chinese population.World J Biol Psychiatry. 2012 Feb;13(2):106-13. doi: 10.3109/15622975.2011.559273. Epub 2011 Mar 4.
• [746] The Potential Role of Regulatory Genes (DNMT3A, HDAC5, and HDAC9) in Antipsychotic Treatment Response in South African Schizophrenia Patients.Front Genet. 2019 Jul 10;10:641. doi: 10.3389/fgene.2019.00641. eCollection 2019.
• [747] ASTN1 and alcohol dependence: family-based association analysis in multiplex alcohol dependence families.Am J Med Genet B Neuropsychiatr Genet. 2012 Jun;159B(4):445-55. doi: 10.1002/ajmg.b.32048. Epub 2012 Apr 9.
• [748] mRNA expression of the P5 ATPase ATP13A4 is increased in Broca's area from subjects with schizophrenia.World J Biol Psychiatry. 2020 Jun;21(5):402-408. doi: 10.1080/15622975.2018.1548781. Epub 2019 Jan 14.
• [749] Myelin, myelin-related disorders, and psychosis.Schizophr Res. 2015 Jan;161(1):85-93. doi: 10.1016/j.schres.2014.09.040. Epub 2014 Oct 23.
• [750] Transcriptomic analysis reveals oxidative phosphorylation activation in an adolescent social isolation rat model.Brain Res Bull. 2018 Sep;142:304-312. doi: 10.1016/j.brainresbull.2018.08.013. Epub 2018 Aug 22.
• [751] Association study identifying a new susceptibility gene (AUTS2) for schizophrenia.Int J Mol Sci. 2014 Oct 24;15(11):19406-16. doi: 10.3390/ijms151119406.
• [752] Candidate gene analysis of the human natural killer-1 carbohydrate pathway and perineuronal nets in schizophrenia: B3GAT2 is associated with disease risk and cortical surface area.Biol Psychiatry. 2011 Jan 1;69(1):90-6. doi: 10.1016/j.biopsych.2010.07.035. Epub 2010 Oct 15.
• [753] Transcriptome study of differential expression in schizophrenia.Hum Mol Genet. 2013 Dec 15;22(24):5001-14. doi: 10.1093/hmg/ddt350. Epub 2013 Jul 30.
• [754] DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia.Transl Psychiatry. 2017 Feb 14;7(2):e1032. doi: 10.1038/tp.2016.297.
• [755] Recruitment of PCM1 to the centrosome by the cooperative action of DISC1 and BBS4: a candidate for psychiatric illnesses.Arch Gen Psychiatry. 2008 Sep;65(9):996-1006. doi: 10.1001/archpsyc.65.9.996.
• [756] Mice lacking BCAS1, a novel myelin-associated protein, display hypomyelination, schizophrenia-like abnormal behaviors, and upregulation of inflammatory genes in the brain.Glia. 2017 May;65(5):727-739. doi: 10.1002/glia.23129. Epub 2017 Feb 23.
• [757] Preliminary assessment of intrahemispheric QEEG measures in bipolar mood disorders.Can J Psychiatry. 2002 May;47(4):368-74. doi: 10.1177/070674370204700408.
• [758] Growth arrest specific gene 7 is associated with schizophrenia and regulates neuronal migration and morphogenesis.Mol Brain. 2016 May 18;9(1):54. doi: 10.1186/s13041-016-0238-y.
• [759] Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia.Int J Dev Neurosci. 2011 May;29(3):351-8. doi: 10.1016/j.ijdevneu.2010.07.234. Epub 2010 Aug 5.
• [760] Gene dosage in the dysbindin schizophrenia susceptibility network differentially affect synaptic function and plasticity.J Neurosci. 2015 Jan 7;35(1):325-38. doi: 10.1523/JNEUROSCI.3542-14.2015.
• [761] Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia.Transl Psychiatry. 2018 Nov 23;8(1):252. doi: 10.1038/s41398-018-0304-6.
• [762] A two-stage association study suggests BRAP as a susceptibility gene for schizophrenia.PLoS One. 2014 Jan 15;9(1):e86037. doi: 10.1371/journal.pone.0086037. eCollection 2014.
• [763] Decreased parvalbumin and somatostatin neurons in medial prefrontal cortex in BRINP1-KO mice.Neurosci Lett. 2018 Sep 14;683:82-88. doi: 10.1016/j.neulet.2018.06.050. Epub 2018 Jun 28.
• [764] The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia.Hum Psychopharmacol. 2013 Mar;28(2):117-23. doi: 10.1002/hup.2287. Epub 2013 Jan 30.
• [765] Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study.Transl Psychiatry. 2018 Jul 19;8(1):134. doi: 10.1038/s41398-018-0181-z.
• [766] Expression of Ca?dependent activator protein for secretion 2 is increased in the brains of schizophrenic patients.Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1738-43. doi: 10.1016/j.pnpbp.2011.05.004. Epub 2011 May 12.
• [767] Effect of pre- and post-treatment with Bacopa monnieri (Brahmi) on phencyclidine-induced disruptions in object recognition memory and cerebral calbindin, parvalbumin, and calretinin immunoreactivity in rats.Neuropsychiatr Dis Treat. 2019 May 1;15:1103-1117. doi: 10.2147/NDT.S193222. eCollection 2019.
• [768] Two-stage replication of previous genome-wide association studies of AS3MT-CNNM2-NT5C2 gene cluster region in a large schizophrenia case-control sample from Han Chinese population.Schizophr Res. 2016 Oct;176(2-3):125-130. doi: 10.1016/j.schres.2016.07.004. Epub 2016 Jul 8.
• [769] Amphetamine sensitization elevates CaMKIIbeta mRNA.Synapse. 2007 Oct;61(10):827-34. doi: 10.1002/syn.20429.
• [770] Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.Mol Psychiatry. 2011 Mar;16(3):286-92. doi: 10.1038/mp.2010.7. Epub 2010 Feb 16.
• [771] Genome-wide investigation of schizophrenia associated plasma Ndel1 enzyme activity.Schizophr Res. 2016 Apr;172(1-3):60-7. doi: 10.1016/j.schres.2016.01.043. Epub 2016 Feb 2.
• [772] Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.Nature. 2009 Aug 6;460(7256):748-52. doi: 10.1038/nature08185. Epub 2009 Jul 1.
• [773] A genome-wide association study in 574 schizophrenia trios using DNA pooling.Mol Psychiatry. 2009 Aug;14(8):796-803. doi: 10.1038/mp.2008.33. Epub 2008 Mar 11.
• [774] Expression and differential response to haloperidol treatment of Cyclon/CCDC86 mRNA in schizophrenia patients.Neurochem Int. 2013 May;62(6):870-2. doi: 10.1016/j.neuint.2013.02.017. Epub 2013 Feb 21.
• [775] Common variants on 8p12 and 1q24.2 confer risk of schizophrenia.Nat Genet. 2011 Oct 30;43(12):1224-7. doi: 10.1038/ng.980.
• [776] Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia. Pharmacogenet Genomics. 2010 Apr;20(4):274-6. doi: 10.1097/FPC.0b013e328337ce3e.
• [777] Ten-year follow up of patients with first-episode schizophrenia spectrum disorder from an early intervention service: Predictors of clinical remission and functional recovery.Schizophr Res. 2019 Feb;204:65-71. doi: 10.1016/j.schres.2018.08.022. Epub 2018 Aug 17.
• [778] Reduced neonatal brain-derived neurotrophic factor is associated with autism spectrum disorders.Transl Psychiatry. 2019 Oct 7;9(1):252. doi: 10.1038/s41398-019-0587-2.
• [779] Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci.Mol Psychiatry. 2014 Mar;19(3):325-33. doi: 10.1038/mp.2013.2. Epub 2013 Jan 29.
• [780] Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.Synapse. 2011 Mar;65(3):234-48. doi: 10.1002/syn.20839.
• [781] Association between cerebral dopamine neurotrophic factor (CDNF) 2 polymorphisms and schizophrenia susceptibility and symptoms in the Han Chinese population.Behav Brain Funct. 2018 Jan 3;14(1):1. doi: 10.1186/s12993-017-0133-4.
• [782] DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population.Int J Neuropsychopharmacol. 2012 May;15(4):459-69. doi: 10.1017/S1461145711000903. Epub 2011 Jun 20.
• [783] A molecular pathway analysis informs the genetic risk for arrhythmias during antipsychotic treatment.Int Clin Psychopharmacol. 2018 Jan;33(1):1-14. doi: 10.1097/YIC.0000000000000198.
• [784] Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia.J Neurogenet. 2014 Mar-Jun;28(1-2):70-85. doi: 10.3109/01677063.2013.878339. Epub 2014 Mar 17.
• [785] Possible genetic and epigenetic links between human inner speech, schizophrenia and altruism.Brain Res. 2012 Oct 2;1476:38-57. doi: 10.1016/j.brainres.2012.02.074. Epub 2012 Mar 6.
• [786] CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1.Hum Mol Genet. 2014 Mar 15;23(6):1669-76. doi: 10.1093/hmg/ddt540. Epub 2013 Oct 26.
• [787] A de novo frameshift mutation in chromodomain helicase DNA-binding domain 8 (CHD8): A case report and literature review.Am J Med Genet A. 2016 May;170A(5):1225-35. doi: 10.1002/ajmg.a.37566. Epub 2016 Jan 20.
• [788] Increased temporal discounting after chronic stress in CHL1-deficient mice is reversed by 5-HT2C agonist Ro 60-0175.Neuroscience. 2017 Aug 15;357:110-118. doi: 10.1016/j.neuroscience.2017.05.047. Epub 2017 Jun 3.
• [789] Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated Task.Neuropsychopharmacology. 2017 May;42(6):1338-1348. doi: 10.1038/npp.2016.268. Epub 2016 Dec 5.
• [790] A Frameshift Variant in the CHST9 Gene Identified by Family-Based Whole Genome Sequencing Is Associated with Schizophrenia in Chinese Population.Sci Rep. 2019 Sep 3;9(1):12717. doi: 10.1038/s41598-019-49052-w.
• [791] Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders.Mol Autism. 2016 Nov 29;7:49. doi: 10.1186/s13229-016-0110-z. eCollection 2016.
• [792] Claudin-5: gatekeeper of neurological function.Fluids Barriers CNS. 2019 Jan 29;16(1):3. doi: 10.1186/s12987-019-0123-z.
• [793] New Dopamine D2 Receptor Agonist, [(3)H]MCL-536, for Detecting Dopamine D2high Receptors in Vivo.ACS Chem Neurosci. 2018 Jun 20;9(6):1283-1289. doi: 10.1021/acschemneuro.8b00096. Epub 2018 Apr 16.
• [794] Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:23-29. doi: 10.1016/j.pnpbp.2018.08.023. Epub 2018 Aug 24.
• [795] 22q11.2 deletion carriers and schizophrenia-associated novel variants.Br J Psychiatry. 2014;204:398-9. doi: 10.1192/bjp.bp.113.138420. Epub 2014 Jan 30.
• [796] Deficiency of sterol regulatory element-binding protein-1c induces schizophrenia-like behavior in mice.Genes Brain Behav. 2019 Apr;18(4):e12540. doi: 10.1111/gbb.12540. Epub 2018 Dec 5.
• [797] Upregulation of cornichon transcripts in the dorsolateral prefrontal cortex in schizophrenia.Neuroreport. 2012 Dec 5;23(17):1031-4. doi: 10.1097/WNR.0b013e32835ad229.
• [798] Genome-wide association study in two populations to determine genetic variants associated with Toxoplasma gondii infection and relationship to schizophrenia risk.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:133-147. doi: 10.1016/j.pnpbp.2018.12.019. Epub 2019 Jan 2.
• [799] Elevated mRNA expression of CASPR3 in patients with schizophrenia.Nord J Psychiatry. 2017 May;71(4):312-314. doi: 10.1080/08039488.2017.1291720. Epub 2017 Feb 23.
• [800] Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia.J Hum Genet. 2013 Feb;58(2):91-7. doi: 10.1038/jhg.2012.140. Epub 2012 Dec 13.
• [801] Coping and psychopathology in children with malignancy and bronchiectasis.Pediatr Pulmonol. 2020 Jan;55(1):214-220. doi: 10.1002/ppul.24534. Epub 2019 Dec 9.
• [802] Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.Neuropsychopharmacology. 2019 Apr;44(5):837-849. doi: 10.1038/s41386-018-0090-0. Epub 2018 May 16.
• [803] Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia.Schizophr Res. 2006 Sep;86(1-3):167-71. doi: 10.1016/j.schres.2006.05.027. Epub 2006 Jul 13.
• [804] Complexin2 modulates working memory-related neural activity in patients with schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2015 Mar;265(2):137-45. doi: 10.1007/s00406-014-0550-4. Epub 2014 Oct 9.
• [805] Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure.Molecules. 2019 Oct 12;24(20):3672. doi: 10.3390/molecules24203672.
• [806] Crybb2 Mutations Consistently Affect Schizophrenia Endophenotypes in Mice.Mol Neurobiol. 2019 Jun;56(6):4215-4230. doi: 10.1007/s12035-018-1365-5. Epub 2018 Oct 6.
• [807] Polymorphism in schizophrenia risk gene MIR137 is associated with the posterior cingulate Cortex's activation and functional and structural connectivity in healthy controls.Neuroimage Clin. 2018 Apr 3;19:160-166. doi: 10.1016/j.nicl.2018.03.039. eCollection 2018.
• [808] A genetic association study of CSMD1 and CSMD2 with cognitive function.Brain Behav Immun. 2017 Mar;61:209-216. doi: 10.1016/j.bbi.2016.11.026. Epub 2016 Nov 25.
• [809] Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes.Nat Commun. 2018 Feb 26;9(1):838. doi: 10.1038/s41467-018-03247-3.
• [810] The X-linked intellectual disability protein PHF6 associates with the PAF1 complex and regulates neuronal migration in the mammalian brain.Neuron. 2013 Jun 19;78(6):986-93. doi: 10.1016/j.neuron.2013.04.021.
• [811] Functional genomics reveal gene regulatory mechanisms underlying schizophrenia risk.Nat Commun. 2019 Feb 8;10(1):670. doi: 10.1038/s41467-019-08666-4.
• [812] Identifying the genetic risk factors for treatment response to lurasidone by genome-wide association study: A meta-analysis of samples from three independent clinical trials.Schizophr Res. 2018 Sep;199:203-213. doi: 10.1016/j.schres.2018.04.006. Epub 2018 May 2.
• [813] Further confirmation of the association between anxiety and CTNND2: replication in humans.Genes Brain Behav. 2014 Feb;13(2):195-201. doi: 10.1111/gbb.12095. Epub 2013 Nov 21.
• [814] Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects.Mol Psychiatry. 2020 Apr;25(4):776-790. doi: 10.1038/s41380-019-0359-7. Epub 2019 Jan 25.
• [815] Association between 5q23.2-located polymorphism of CTXN3 gene (Cortexin 3) and schizophrenia in European-Caucasian males; implications for the aetiology of schizophrenia.Behav Brain Funct. 2015 Mar 17;11:10. doi: 10.1186/s12993-015-0057-9.
• [816] Combining CDP-choline and galantamine, an optimized 7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia.Int J Psychophysiol. 2019 Nov;145:70-82. doi: 10.1016/j.ijpsycho.2019.02.005. Epub 2019 Feb 18.
• [817] Autism and Schizophrenia-Associated CYFIP1 Regulates the Balance of Synaptic Excitation and Inhibition.Cell Rep. 2019 Feb 19;26(8):2037-2051.e6. doi: 10.1016/j.celrep.2019.01.092.
• [818] Support for "Disease-Only" Genotypes and Excess of Homozygosity at the CYTH4 Primate-Specific GTTT-Repeat in Schizophrenia.Genet Test Mol Biomarkers. 2017 Aug;21(8):485-490. doi: 10.1089/gtmb.2016.0422. Epub 2017 Jul 19.
• [819] Maternal stress induces epigenetic signatures of psychiatric and neurological diseases in the offspring.PLoS One. 2013;8(2):e56967. doi: 10.1371/journal.pone.0056967. Epub 2013 Feb 22.
• [820] Genetic influences of cortical gray matter in language-related regions in healthy controls and schizophrenia.Schizophr Res. 2011 Jul;129(2-3):141-8. doi: 10.1016/j.schres.2011.03.027. Epub 2011 Apr 20.
• [821] Associations of common copy number variants in glutathione S-transferase mu 1 and D-dopachrome tautomerase-like protein genes with risk of schizophrenia in a Japanese population.Am J Med Genet B Neuropsychiatr Genet. 2015 Oct;168(7):630-6. doi: 10.1002/ajmg.b.32347. Epub 2015 Jul 14.
• [822] DEGS2 polymorphism associated with cognition in schizophrenia is associated with gene expression in brain.Transl Psychiatry. 2015 Apr 14;5(4):e550. doi: 10.1038/tp.2015.45.
• [823] Antipsychotic drug actions on gene modulation and signaling mechanisms.Pharmacol Ther. 2009 Oct;124(1):74-85. doi: 10.1016/j.pharmthera.2009.06.001. Epub 2009 Jun 21.
• [824] Evidence for association between novel polymorphisms in the PRODH gene and schizophrenia in a Chinese population.Am J Med Genet B Neuropsychiatr Genet. 2004 Aug 15;129B(1):13-5. doi: 10.1002/ajmg.b.30049.
• [825] Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models.Science. 2014 Jun 6;344(6188):1178-82. doi: 10.1126/science.1253895.
• [826] Differential expression of synaptic markers regulated during neurodevelopment in a rat model of schizophrenia-like behavior.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Dec 20;95:109669. doi: 10.1016/j.pnpbp.2019.109669. Epub 2019 Jun 20.
• [827] DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt/-catenin signaling.Mol Psychiatry. 2018 Feb;23(2):467-475. doi: 10.1038/mp.2016.184. Epub 2016 Oct 18.
• [828] Positional pathway screen of wnt signaling genes in schizophrenia: association with DKK4.Biol Psychiatry. 2008 Jan 1;63(1):13-6. doi: 10.1016/j.biopsych.2007.03.014. Epub 2007 Jun 5.
• [829] Exonic resequencing of the DLGAP3 gene as a candidate gene for schizophrenia.Psychiatry Res. 2013 Jun 30;208(1):84-7. doi: 10.1016/j.psychres.2012.12.015. Epub 2013 Feb 13.
• [830] Decreased thalamic expression of the homeobox gene DLX1 in psychosis.Arch Gen Psychiatry. 2003 Sep;60(9):869-74. doi: 10.1001/archpsyc.60.9.869.
• [831] Molecular evolution in the CREB1 signal pathway and a rare haplotype in CREB1 with genetic predisposition to schizophrenia.J Psychiatr Res. 2014 Oct;57:84-9. doi: 10.1016/j.jpsychires.2014.06.008. Epub 2014 Jun 24.
• [832] Drug Abuse and Psychosis: New Insights into Drug-induced Psychosis.Exp Neurobiol. 2017 Feb;26(1):11-24. doi: 10.5607/en.2017.26.1.11. Epub 2017 Feb 7.
• [833] Whole-genome sequencing of monozygotic twins discordant for schizophrenia indicates multiple genetic risk factors for schizophrenia.J Genet Genomics. 2017 Jun 20;44(6):295-306. doi: 10.1016/j.jgg.2017.05.005. Epub 2017 Jun 8.
• [834] Microtubule and microtubule associated protein anomalies in psychiatric disease.Cytoskeleton (Hoboken). 2016 Oct;73(10):596-611. doi: 10.1002/cm.21300. Epub 2016 May 20.
• [835] Schizophrenia and the HLA-DRB1 gene in the Japanese population.Am J Psychiatry. 1999 May;156(5):771-3. doi: 10.1176/ajp.156.5.771.
• [836] Evidence of association of the DISC1 interactome gene set with schizophrenia from GWAS.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Dec 20;95:109729. doi: 10.1016/j.pnpbp.2019.109729. Epub 2019 Aug 6.
• [837] Association of EPHB1 rs11918092 and EFNB2 rs9520087 with psychopathological symptoms of schizophrenia in Chinese Zhuang and Han populations.Asia Pac Psychiatry. 2016 Dec;8(4):306-308. doi: 10.1111/appy.12241. Epub 2016 Mar 29.
• [838] Genetic and functional analyses of early growth response (EGR) family genes in schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):149-55. doi: 10.1016/j.pnpbp.2012.06.004. Epub 2012 Jun 9.
• [839] Dopaminergic mechanisms in the pathogenesis of schizophrenia.FASEB J. 1992 Apr;6(7):2413-21.
• [840] Time dependent expression of the blood biomarkers EIF2D and TOX in patients with schizophrenia.Brain Behav Immun. 2019 Aug;80:909-915. doi: 10.1016/j.bbi.2019.05.015. Epub 2019 May 9.
• [841] Thalamic transcriptome screening in three psychiatric states.J Hum Genet. 2009 Nov;54(11):665-75. doi: 10.1038/jhg.2009.93. Epub 2009 Oct 16.
• [842] Systematic association analysis of microRNA machinery genes with schizophrenia informs further study.Neurosci Lett. 2012 Jun 27;520(1):47-50. doi: 10.1016/j.neulet.2012.05.028. Epub 2012 May 15.
• [843] Identification of relevant hub genes for early intervention at gene coexpression modules with altered predicted expression in schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2020 Mar 2;98:109815. doi: 10.1016/j.pnpbp.2019.109815. Epub 2019 Nov 9.
• [844] The effect of implementation intentions on prospective memory performance in patients with schizophrenia: A multinomial modeling approach.Schizophr Res. 2020 Jan;215:120-125. doi: 10.1016/j.schres.2019.11.003. Epub 2019 Nov 26.
• [845] Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia.Schizophr Res. 2011 Sep;131(1-3):43-51. doi: 10.1016/j.schres.2011.06.023. Epub 2011 Jul 14.
• [846] Model-based gene selection shows engrailed 1 is associated with antipsychotic response.Pharmacogenet Genomics. 2008 Sep;18(9):751-9. doi: 10.1097/FPC.0b013e32830162bc.
• [847] Analysis of t(9;17)(q33.2;q25.3) chromosomal breakpoint regions and genetic association reveals novel candidate genes for bipolar disorder.Bipolar Disord. 2015 Mar;17(2):205-11. doi: 10.1111/bdi.12239. Epub 2014 Jul 23.
• [848] HERV-W env regulates calcium influx via activating TRPC3 channel together with depressing DISC1 in human neuroblastoma cells.J Neurovirol. 2019 Feb;25(1):101-113. doi: 10.1007/s13365-018-0692-7. Epub 2018 Nov 5.
• [849] Genetic markers in schizophrenia: ACP1, ESD, TF and GC polymorphisms.Hum Hered. 1990;40(3):136-40. doi: 10.1159/000153920.
• [850] Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples.Adv Ther. 2017 Jun;34(6):1482-1497. doi: 10.1007/s12325-017-0555-2. Epub 2017 May 16.
• [851] Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial.Nicotine Tob Res. 2017 Jan;19(1):68-76. doi: 10.1093/ntr/ntw190. Epub 2016 Aug 3.
• [852] Evaluation of the role of fatty acid-binding protein 7 in controlling schizophrenia-relevant phenotypes using newly established knockout mice.Schizophr Res. 2020 Mar;217:52-59. doi: 10.1016/j.schres.2019.02.002. Epub 2019 Feb 11.
• [853] Oxidative Stress and Accelerated Aging in Neurodegenerative and Neuropsychiatric Disorder.Curr Pharm Des. 2018;24(40):4711-4725. doi: 10.2174/1381612825666190115121018.
• [854] A kernel machine method for detecting higher order interactions in multimodal datasets: Application to schizophrenia.J Neurosci Methods. 2018 Nov 1;309:161-174. doi: 10.1016/j.jneumeth.2018.08.027. Epub 2018 Sep 2.
• [855] Novel rare variants in F-box protein 45 (FBXO45) in schizophrenia.Schizophr Res. 2014 Aug;157(1-3):149-56. doi: 10.1016/j.schres.2014.04.032. Epub 2014 May 28.
• [856] A Case-Control Study of the Association between Polymorphisms in the Fibrinogen Alpha Chain Gene and Schizophrenia.Dis Markers. 2017;2017:3104180. doi: 10.1155/2017/3104180. Epub 2017 Jan 19.
• [857] Anomalous self-experiences are strongly associated with negative symptoms in a clinical high-risk for psychosis sample.Compr Psychiatry. 2019 Aug;93:65-72. doi: 10.1016/j.comppsych.2019.07.003. Epub 2019 Jul 13.
• [858] Chromosome conformation elucidates regulatory relationships in developing human brain.Nature. 2016 Oct 27;538(7626):523-527. doi: 10.1038/nature19847. Epub 2016 Oct 19.
• [859] Possibility of a sex-specific role for a genetic variant in FRMPD4 in schizophrenia, but not cognitive function.Neuroreport. 2016 Jan 6;27(1):33-8. doi: 10.1097/WNR.0000000000000491.
• [860] Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex.Arch Gen Psychiatry. 2002 Jul;59(7):631-40. doi: 10.1001/archpsyc.59.7.631.
• [861] Wnt receptor gene FZD1 was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohort.Aust N Z J Psychiatry. 2020 Sep;54(9):902-908. doi: 10.1177/0004867419885443. Epub 2019 Nov 16.
• [862] Functional analysis of haplotypes and promoter activity at the 5' region of the human GABRB3 gene and associations with schizophrenia.Mol Genet Genomic Med. 2019 May;7(5):e652. doi: 10.1002/mgg3.652. Epub 2019 Mar 25.
• [863] GABRB2 in schizophrenia and bipolar disorder: disease association, gene expression and clinical correlations.Biochem Soc Trans. 2009 Dec;37(Pt 6):1415-8. doi: 10.1042/BST0371415.
• [864] Solution NMR structure and ligand identification of human Gas7 SH3 domain reveal a typical SH3 fold but a non-canonical ligand-binding mode.Biochem Biophys Res Commun. 2019 Sep 3;516(4):1190-1195. doi: 10.1016/j.bbrc.2019.07.004. Epub 2019 Jul 9.
• [865] Genes regulated by SATB2 during neurodevelopment contribute to schizophrenia and educational attainment.PLoS Genet. 2018 Jul 24;14(7):e1007515. doi: 10.1371/journal.pgen.1007515. eCollection 2018 Jul.
• [866] Inflammation-related genes up-regulated in schizophrenia brains.BMC Psychiatry. 2007 Sep 6;7:46. doi: 10.1186/1471-244X-7-46.
• [867] Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity.Mol Psychiatry. 2017 Mar;22(3):417-429. doi: 10.1038/mp.2016.98. Epub 2016 Jul 26.
• [868] Glutamate Dehydrogenase-Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction.Schizophr Bull. 2019 Jan 1;45(1):127-137. doi: 10.1093/schbul/sby011.
• [869] GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons.Mol Psychiatry. 2018 Mar;23(3):691-700. doi: 10.1038/mp.2017.137. Epub 2017 Jul 11.
• [870] Genome-wide association analysis links multiple psychiatric liability genes to oscillatory brain activity.Hum Brain Mapp. 2018 Nov;39(11):4183-4195. doi: 10.1002/hbm.24238. Epub 2018 Jun 26.
• [871] Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways.Front Psychiatry. 2019 Nov 29;10:885. doi: 10.3389/fpsyt.2019.00885. eCollection 2019.
• [872] The role of genes affected by human evolution marker GNA13 in schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2020 Mar 2;98:109764. doi: 10.1016/j.pnpbp.2019.109764. Epub 2019 Oct 30.
• [873] Alternative transcripts and evidence of imprinting of GNAL on 18p11.2.Mol Psychiatry. 2005 Nov;10(11):1017-25. doi: 10.1038/sj.mp.4001713.
• [874] The T393C polymorphism of the GNAS1 gene is associated with deficit schizophrenia in an Italian population sample.Neurosci Lett. 2006 Apr 10-17;397(1-2):159-63. doi: 10.1016/j.neulet.2005.12.028. Epub 2006 Jan 6.
• [875] Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatments.Eur Neuropsychopharmacol. 2012 Aug;22(8):596-606. doi: 10.1016/j.euroneuro.2011.12.007. Epub 2012 Jan 20.
• [876] A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: Association with impairment of sustained attention.Biol Psychiatry. 2006 Sep 15;60(6):554-62. doi: 10.1016/j.biopsych.2006.04.024.
• [877] Blood-based dynamic genomic signature for obsessive-compulsive disorder.Am J Med Genet B Neuropsychiatr Genet. 2018 Dec;177(8):709-716. doi: 10.1002/ajmg.b.32675. Epub 2018 Oct 23.
• [878] Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls.Mol Psychiatry. 2019 Nov;24(11):1685-1695. doi: 10.1038/s41380-018-0059-8. Epub 2018 May 8.
• [879] Fatty acid composition and fatty acid binding protein expression in the postmortem frontal cortex of patients with schizophrenia: A case-control study.Schizophr Res. 2016 Mar;171(1-3):225-32. doi: 10.1016/j.schres.2016.01.014. Epub 2016 Jan 17.
• [880] Abnormal ER quality control of neural GPI-anchored proteins via dysfunction in ER export processing in the frontal cortex of elderly subjects with schizophrenia.Transl Psychiatry. 2019 Jan 16;9(1):6. doi: 10.1038/s41398-018-0359-4.
• [881] Tuning GABAergic Inhibition: Gephyrin Molecular Organization and Functions.Neuroscience. 2020 Jul 15;439:125-136. doi: 10.1016/j.neuroscience.2019.07.036. Epub 2019 Jul 26.
• [882] Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor.Mol Psychiatry. 2005 May;10(5):470-8. doi: 10.1038/sj.mp.4001593.
• [883] FTBMT, a Novel and Selective GPR52 Agonist, Demonstrates Antipsychotic-Like and Procognitive Effects in Rodents, Revealing a Potential Therapeutic Agent for Schizophrenia.J Pharmacol Exp Ther. 2017 Nov;363(2):253-264. doi: 10.1124/jpet.117.242925. Epub 2017 Aug 29.
• [884] Association analysis of the chromosome 4p-located G protein-coupled receptor 78 (GPR78) gene in bipolar affective disorder and schizophrenia.Mol Psychiatry. 2006 Apr;11(4):384-94. doi: 10.1038/sj.mp.4001786.
• [885] A genetic locus in 7p12.2 associated with treatment resistant schizophrenia.Schizophr Res. 2014 Nov;159(2-3):333-9. doi: 10.1016/j.schres.2014.08.018. Epub 2014 Sep 13.
• [886] Somatostatin Interneurons Facilitate Hippocampal-Prefrontal Synchrony and Prefrontal Spatial Encoding.Neuron. 2018 Nov 21;100(4):926-939.e3. doi: 10.1016/j.neuron.2018.09.029. Epub 2018 Oct 11.
• [887] A naturally occurring null variant of the NMDA type glutamate receptor NR3B subunit is a risk factor of schizophrenia.PLoS One. 2015 Mar 13;10(3):e0116319. doi: 10.1371/journal.pone.0116319. eCollection 2015.
• [888] Genetic Polymorphisms of Glutathione-Related Enzymes (GSTM1, GSTT1, and GSTP1) and Schizophrenia Risk: A Meta-Analysis.Int J Mol Sci. 2015 Aug 19;16(8):19602-11. doi: 10.3390/ijms160819602.
• [889] Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia.Mol Psychiatry. 2010 Oct;15(10):1023-33. doi: 10.1038/mp.2009.53. Epub 2009 Jun 16.
• [890] Novel polymorphisms of the AP-2 gene (6p24): analysis of association with schizophrenia.J Hum Genet. 2000;45(1):24-30. doi: 10.1007/s100380050005.
• [891] A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.J Neurosci. 2017 Apr 12;37(15):4093-4102. doi: 10.1523/JNEUROSCI.0827-16.2017. Epub 2017 Mar 10.
• [892] Bi-directional Mendelian randomization of epithelial ovarian cancer and schizophrenia and uni-directional Mendelian randomization of schizophrenia on circulating 1- or 2-glycerophosphocholine metabolites.Mol Genet Metab Rep. 2019 Nov 6;21:100539. doi: 10.1016/j.ymgmr.2019.100539. eCollection 2019 Dec.
• [893] Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia.Mol Psychiatry. 2015 Apr;20(4):424-32. doi: 10.1038/mp.2014.63. Epub 2014 Jul 22.
• [894] Evidence of aberrant DNA damage response signalling but normal rates of DNA repair in dividing lymphoblasts from patients with schizophrenia.World J Biol Psychiatry. 2012 Feb;13(2):114-25. doi: 10.3109/15622975.2011.565073. Epub 2011 Aug 11.
• [895] Association study of H2AFZ with schizophrenia in a Japanese case-control sample.J Neural Transm (Vienna). 2015 Jun;122(6):915-23. doi: 10.1007/s00702-014-1332-x. Epub 2014 Nov 13.
• [896] Validation of a microRNA target site polymorphism in H3F3B that is potentially associated with a broad schizophrenia phenotype.PLoS One. 2018 Mar 12;13(3):e0194233. doi: 10.1371/journal.pone.0194233. eCollection 2018.
• [897] Exercise-induced modulation of histone H4 acetylation status and cytokines levels in patients with schizophrenia.Physiol Behav. 2017 Jan 1;168:84-90. doi: 10.1016/j.physbeh.2016.10.021. Epub 2016 Oct 31.
• [898] Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample.PLoS One. 2012;7(1):e29228. doi: 10.1371/journal.pone.0029228. Epub 2012 Jan 11.
• [899] Hapln2 in Neurological Diseases and Its Potential as Therapeutic Target.Front Aging Neurosci. 2019 Mar 21;11:60. doi: 10.3389/fnagi.2019.00060. eCollection 2019.
• [900] Simplifying the human serum proteome for discriminating patients with bipolar disorder of other psychiatry conditions.Clin Biochem. 2017 Dec;50(18):1118-1125. doi: 10.1016/j.clinbiochem.2017.06.009. Epub 2017 Jun 27.
• [901] Hemoencephalography self-regulation training and its impact on cognition: A study with schizophrenia and healthy participants.Schizophr Res. 2018 May;195:591-593. doi: 10.1016/j.schres.2017.08.044. Epub 2017 Sep 5.
• [902] Attenuated bidirectional short-term synaptic plasticity in the dentate gyrus of Schnurri-2 knockout mice, a model of schizophrenia.Mol Brain. 2018 Oct 1;11(1):56. doi: 10.1186/s13041-018-0400-9.
• [903] Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by Schizophrenia and Bipolar Disorder and controls.Psychiatry Res. 2015 Aug 30;228(3):945-9. doi: 10.1016/j.psychres.2015.06.013. Epub 2015 Jun 26.
• [904] Altering the expression balance of hnRNP C1 and C2 changes the expression of myelination-related genes.Psychiatry Res. 2011 Dec 30;190(2-3):364-6. doi: 10.1016/j.psychres.2011.05.043.
• [905] A postmortem analysis of NMDA ionotropic and group 1 metabotropic glutamate receptors in the nucleus accumbens in schizophrenia.J Psychiatry Neurosci. 2018 Mar;43(2):102-110. doi: 10.1503/jpn.170077. Epub 2017 Oct 6.
• [906] Replicated genetic evidence supports a role for HOMER2 in schizophrenia.Neurosci Lett. 2010 Jan 14;468(3):229-33. doi: 10.1016/j.neulet.2009.11.003. Epub 2009 Nov 13.
• [907] MeCP2 AT-Hook1 mutations in patients with intellectual disability and/or schizophrenia disrupt DNA binding and chromatin compaction in vitro.Hum Mutat. 2018 May;39(5):717-728. doi: 10.1002/humu.23409. Epub 2018 Mar 8.
• [908] Heat shock protein 12A shows reduced expression in the prefrontal cortex of subjects with schizophrenia.Biol Psychiatry. 2004 Dec 15;56(12):943-50. doi: 10.1016/j.biopsych.2004.09.005.
• [909] Assessing psychopathy in forensic schizophrenia spectrum disorders: Validating the Comprehensive Assessment of the Psychopathic Personality-Institutional Rating Scale (CAPP-IRS).Psychiatry Res. 2018 Jul;265:303-308. doi: 10.1016/j.psychres.2018.05.019. Epub 2018 May 16.
• [910] Immune system disturbances in schizophrenia.Biol Psychiatry. 2014 Feb 15;75(4):316-23. doi: 10.1016/j.biopsych.2013.06.010. Epub 2013 Jul 25.
• [911] Common variants conferring risk of schizophrenia.Nature. 2009 Aug 6;460(7256):744-7. doi: 10.1038/nature08186. Epub 2009 Jul 1.
• [912] The type 2 diabetes mellitus susceptibility gene IGF2BP2 is associated with schizophrenia in a Han Chinese population.J Clin Psychiatry. 2013 Apr;74(4):e287-92. doi: 10.4088/JCP.12m07846.
• [913] Human serine racemase structure/activity relationship studies provide mechanistic insight and point to position 84 as a hot spot for -elimination function.J Biol Chem. 2017 Aug 25;292(34):13986-14002. doi: 10.1074/jbc.M117.777904. Epub 2017 Jul 10.
• [914] Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia.Transl Psychiatry. 2013 Oct 29;3(10):e321. doi: 10.1038/tp.2013.94.
• [915] Chronic schizophrenia is associated with over-expression of the interleukin-2 receptor gamma gene.Psychiatry Res. 2014 Jul 30;217(3):158-62. doi: 10.1016/j.psychres.2014.03.020. Epub 2014 Mar 25.
• [916] Interleukin-3, symptoms and cognitive deficits in first-episode drug-nave and chronic medicated schizophrenia.Psychiatry Res. 2018 May;263:147-153. doi: 10.1016/j.psychres.2018.02.054. Epub 2018 Mar 6.
• [917] Pseudoautosomal gene: possible association with bipolar males but not with schizophrenia.Psychiatr Genet. 1999 Sep;9(3):129-34.
• [918] Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.Hum Psychopharmacol. 2010 Apr;25(3):253-9. doi: 10.1002/hup.1111.
• [919] Investigating the potential genetic association between RANBP9 polymorphisms and the risk of schizophrenia.Mol Med Rep. 2015 Apr;11(4):2975-80. doi: 10.3892/mmr.2014.3045. Epub 2014 Dec 4.
• [920] Polish Adult Reading Test (PART) - construction of Polish test for estimating the level of premorbid intelligence in schizophrenia.Psychiatr Pol. 2017 Aug 29;51(4):673-685. doi: 10.12740/PP/OnlineFirst/63207. Epub 2017 Aug 29.
• [921] LPS-induced cortical kynurenic acid and neurogranin-NFAT signaling is associated with deficits in stimulus processing during Pavlovian conditioning.J Neuroimmunol. 2017 Dec 15;313:1-9. doi: 10.1016/j.jneuroim.2017.09.010. Epub 2017 Sep 28.
• [922] PDLIM5 and susceptibility to bipolar disorder: a family-based association study and meta-analysis.Psychiatr Genet. 2008 Jun;18(3):116-21. doi: 10.1097/YPG.0b013e3282fa184b.
• [923] A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia.Int Clin Psychopharmacol. 2018 Mar;33(2):79-87. doi: 10.1097/YIC.0000000000000203.
• [924] Genome-wide association study with the risk of schizophrenia in a Korean population.Am J Med Genet B Neuropsychiatr Genet. 2016 Mar;171B(2):257-65. doi: 10.1002/ajmg.b.32400. Epub 2015 Nov 4.
• [925] Rare variant analysis in multiply affected families, association studies and functional analysis suggest a role for the ITG4 gene in schizophrenia and bipolar disorder.Schizophr Res. 2018 Sep;199:181-188. doi: 10.1016/j.schres.2018.03.001. Epub 2018 Mar 9.
• [926] A multimodal attempt to follow-up linkage regions using RNA expression, SNPs and CpG methylation in schizophrenia and bipolar disorder kindreds.Eur J Hum Genet. 2020 Apr;28(4):499-507. doi: 10.1038/s41431-019-0526-y. Epub 2019 Nov 6.
• [927] Genetic Overlap Between Schizophrenia and Volumes of Hippocampus, Putamen, and Intracranial Volume Indicates Shared Molecular Genetic Mechanisms.Schizophr Bull. 2018 Jun 6;44(4):854-864. doi: 10.1093/schbul/sbx148.
• [928] Schizotypy and personality profiles of Cluster A in a group of schizophrenic patients and their siblings.BMC Psychiatry. 2013 Oct 4;13:245. doi: 10.1186/1471-244X-13-245.
• [929] Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia.J Biomed Biotechnol. 2009;2009:536918. doi: 10.1155/2009/536918. Epub 2009 Oct 27.
• [930] An association between the BanI polymorphism of the PLA2G4A gene for calcium-dependent phospholipase A2 and plasma glucose levels among females with schizophrenia.Prostaglandins Leukot Essent Fatty Acids. 2018 Aug;135:39-41. doi: 10.1016/j.plefa.2018.06.007. Epub 2018 Jun 30.
• [931] Two four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study.Behav Brain Funct. 2010 May 28;6:27. doi: 10.1186/1744-9081-6-27.
• [932] Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders.Transl Psychiatry. 2015 Feb 17;5(2):e510. doi: 10.1038/tp.2015.8.
• [933] CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells.Mol Neurobiol. 2020 Feb;57(2):616-634. doi: 10.1007/s12035-019-01727-1. Epub 2019 Aug 11.
• [934] Genetic influences of resting state fMRI activity in language-related brain regions in healthy controls and schizophrenia patients: a pilot study.Brain Imaging Behav. 2013 Mar;7(1):15-27. doi: 10.1007/s11682-012-9168-1.
• [935] Characterization of KIAA0513, a novel signaling molecule that interacts with modulators of neuroplasticity, apoptosis, and the cytoskeleton.Brain Res. 2006 Nov 22;1121(1):1-11. doi: 10.1016/j.brainres.2006.08.099. Epub 2006 Sep 29.
• [936] Deficits in the identification of pleasant odors predict the transition of an at-risk mental state to psychosis.Schizophr Res. 2017 Mar;181:49-54. doi: 10.1016/j.schres.2016.10.019. Epub 2016 Oct 17.
• [937] Identification of the human KIF13A gene homologous to Drosophila kinesin-73 and candidate for schizophrenia.Genomics. 2001 May 15;74(1):36-44. doi: 10.1006/geno.2001.6535.
• [938] A family-based association study of kinesin heavy chain member 2 gene (KIF2) and schizophrenia.Neurosci Lett. 2006 Oct 23;407(2):151-5. doi: 10.1016/j.neulet.2006.08.025. Epub 2006 Sep 7.
• [939] Kinesin Kif3b mutation reduces NMDAR subunit NR2A trafficking and causes schizophrenia-like phenotypes in mice.EMBO J. 2020 Jan 2;39(1):e101090. doi: 10.15252/embj.2018101090. Epub 2019 Nov 20.
• [940] Expression of Kruppel-like factor 5 gene in human brain and association of the gene with the susceptibility to schizophrenia.Schizophr Res. 2008 Mar;100(1-3):291-301. doi: 10.1016/j.schres.2007.11.042. Epub 2008 Jan 15.
• [941] Gene expression in superior temporal cortex of schizophrenia patients.Eur Arch Psychiatry Clin Neurosci. 2014 Jun;264(4):297-309. doi: 10.1007/s00406-013-0473-5. Epub 2013 Nov 28.
• [942] KPNA3 variation is associated with schizophrenia, major depression, opiate dependence and alcohol dependence. Dis Markers. 2012;33(4):163-70. doi: 10.3233/DMA-2012-0921.
• [943] Genetic association study of KREMEN1 and DKK1 and schizophrenia in a Japanese population.Schizophr Res. 2010 May;118(1-3):113-7. doi: 10.1016/j.schres.2010.01.014. Epub 2010 Feb 11.
• [944] An Association Study Between Genetic Polymorphisms in Functional Regions of Five Genes and the Risk of Schizophrenia.J Mol Neurosci. 2016 Jul;59(3):366-75. doi: 10.1007/s12031-016-0751-6. Epub 2016 Apr 7.
• [945] Implementing the Latvian Early Intervention Program (LAT-EIP) for Patients With Schizophrenia Spectrum First-Episode Psychosis: Study Protocol.Front Psychiatry. 2019 Nov 13;10:829. doi: 10.3389/fpsyt.2019.00829. eCollection 2019.
• [946] Thought, language, and communication deficits and association with everyday functional outcomes among community-dwelling middle-aged and older adults with schizophrenia.Schizophr Res. 2018 Jun;196:29-34. doi: 10.1016/j.schres.2017.07.017. Epub 2017 Aug 1.
• [947] Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism.Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):343-8. doi: 10.1073/pnas.1309475110. Epub 2013 Dec 16.
• [948] Developmentally regulated and thalamus-selective induction of leiomodin2 gene by a schizophrenomimetic, phencyclidine, in the rat.Int J Neuropsychopharmacol. 2009 Sep;12(8):1111-26. doi: 10.1017/S1461145709009997. Epub 2009 Mar 2.
• [949] Late electrophysiological potentials and emotion in schizophrenia: A meta-analytic review.Schizophr Res. 2019 Sep;211:21-31. doi: 10.1016/j.schres.2019.07.013. Epub 2019 Jul 17.
• [950] Autism-like behaviours and enhanced memory formation and synaptic plasticity in Lrfn2/SALM1-deficient mice.Nat Commun. 2017 Jun 12;8:15800. doi: 10.1038/ncomms15800.
• [951] NGL-2 Deletion Leads to Autistic-like Behaviors Responsive to NMDAR Modulation.Cell Rep. 2018 Jun 26;23(13):3839-3851. doi: 10.1016/j.celrep.2018.05.087.
• [952] Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders.Genome Biol. 2018 Nov 12;19(1):194. doi: 10.1186/s13059-018-1567-1.
• [953] The imprinted gene LRRTM1 mediates schizotypy and handedness in a nonclinical population.J Hum Genet. 2014 Jun;59(6):332-6. doi: 10.1038/jhg.2014.30. Epub 2014 May 1.
• [954] MACF1 Mutations Encoding Highly Conserved Zinc-Binding Residues of the GAR Domain Cause Defects in Neuronal Migration and Axon Guidance. Am J Hum Genet. 2018 Dec 6;103(6):1009-1021. doi: 10.1016/j.ajhg.2018.10.019. Epub 2018 Nov 21.
• [955] MAGI1 copy number variation in bipolar affective disorder and schizophrenia.Biol Psychiatry. 2012 May 15;71(10):922-30. doi: 10.1016/j.biopsych.2012.01.020. Epub 2012 Feb 28.
• [956] The Societal Cost of Schizophrenia: A Systematic Review.Pharmacoeconomics. 2017 Jan;35(1):25-42. doi: 10.1007/s40273-016-0444-6.
• [957] Hyperactivation of left inferior parietal lobule and left temporal gyri shortens resting EEG microstate in schizophrenia.Schizophr Res. 2018 Nov;201:204-207. doi: 10.1016/j.schres.2018.06.020. Epub 2018 Jun 18.
• [958] Deletion of the microtubule-associated protein 6 (MAP6) results in skeletal muscle dysfunction.Skelet Muscle. 2018 Sep 19;8(1):30. doi: 10.1186/s13395-018-0176-8.
• [959] Fine mapping of AHI1 as a schizophrenia susceptibility gene: from association to evolutionary evidence.FASEB J. 2010 Aug;24(8):3066-82. doi: 10.1096/fj.09-152611. Epub 2010 Apr 6.
• [960] Neurochemical changes and neurotoxic effects of an acute treatment with sydnocarb, a novel psychostimulant: comparison with D-amphetamine.Ann N Y Acad Sci. 2002 Jun;965:180-92. doi: 10.1111/j.1749-6632.2002.tb04160.x.
• [961] Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis.JAMA Psychiatry. 2018 Apr 1;75(4):396-404. doi: 10.1001/jamapsychiatry.2017.4607.
• [962] Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness.Cochrane Database Syst Rev. 2017 Jan 24;1(1):CD011464. doi: 10.1002/14651858.CD011464.pub2.
• [963] Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia.Cochrane Database Syst Rev. 2018 Dec 20;12(12):CD007964. doi: 10.1002/14651858.CD007964.pub2.
• [964] Advancing drug discovery for schizophrenia.Ann N Y Acad Sci. 2011 Oct;1236:30-43. doi: 10.1111/j.1749-6632.2011.06216.x.
• [965] Fragile early visual percepts mark genetic liability specific to schizophrenia.Schizophr Bull. 2013 Jul;39(4):839-47. doi: 10.1093/schbul/sbs041. Epub 2012 Mar 23.
• [966] High-resolution copy number variation analysis of schizophrenia in Japan.Mol Psychiatry. 2017 Mar;22(3):430-440. doi: 10.1038/mp.2016.88. Epub 2016 May 31.
• [967] Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia.Aust N Z J Psychiatry. 2007 Apr;41(4):308-20. doi: 10.1080/00048670701213245.
• [968] The Effect of Reducing the "Jumping to Conclusions" Bias on Treatment Decision-Making Capacity in Psychosis: A Randomized Controlled Trial With Mediation Analysis.Schizophr Bull. 2019 Jun 18;45(4):784-793. doi: 10.1093/schbul/sby136.
• [969] Allele-specific expression of mutated in colorectal cancer (MCC) gene and alternative susceptibility to colorectal cancer in schizophrenia.Sci Rep. 2016 May 26;6:26688. doi: 10.1038/srep26688.
• [970] Association of MCTP2 gene variants with schizophrenia in three independent samples of Scandinavian origin (SCOPE).Psychiatry Res. 2009 Aug 15;168(3):256-8. doi: 10.1016/j.psychres.2008.08.007. Epub 2009 Feb 15.
• [971] MDGA1-deficiency attenuates prepulse inhibition with alterations of dopamine and serotonin metabolism: An ex vivo HPLC-ECD analysis.Neurosci Lett. 2020 Jan 18;716:134677. doi: 10.1016/j.neulet.2019.134677. Epub 2019 Dec 5.
• [972] Malic enzyme 2 and susceptibility to psychosis and mania.Psychiatry Res. 2007 Feb 28;150(1):1-11. doi: 10.1016/j.psychres.2006.06.001. Epub 2007 Jan 29.
• [973] Emerging roles for MEF2 in brain development and mental disorders.Curr Opin Neurobiol. 2019 Dec;59:49-58. doi: 10.1016/j.conb.2019.04.008. Epub 2019 May 23.
• [974] Modelling schizophrenia using human induced pluripotent stem cells.Nature. 2011 May 12;473(7346):221-5. doi: 10.1038/nature09915. Epub 2011 Apr 13.
• [975] DNA methylation analyses of the candidate genes identified by a methylome-wide association study revealed common epigenetic alterations in schizophrenia and bipolar disorder.Psychiatry Clin Neurosci. 2018 Apr;72(4):245-254. doi: 10.1111/pcn.12645. Epub 2018 Mar 11.
• [976] The Interaction of TXNIP and AFq1 Genes Increases the Susceptibility of Schizophrenia.Mol Neurobiol. 2017 Aug;54(6):4806-4812. doi: 10.1007/s12035-016-9954-7. Epub 2016 Aug 10.
• [977] Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder.Neuropathol Appl Neurobiol. 2011 Feb;37(2):206-19. doi: 10.1111/j.1365-2990.2010.01128.x.
• [978] Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia.Am J Hum Genet. 2004 Oct;75(4):624-38. doi: 10.1086/424887. Epub 2004 Aug 24.
• [979] Novel putative nonprotein-coding RNA gene from 11q14 displays decreased expression in brains of patients with schizophrenia.J Neurosci Res. 2003 Oct 1;74(1):111-22. doi: 10.1002/jnr.10752.
• [980] MPZL1/PZR, a novel candidate predisposing schizophrenia in Han Chinese.Mol Psychiatry. 2006 Aug;11(8):748-51. doi: 10.1038/sj.mp.4001841. Epub 2006 May 9.
• [981] Synaptic localisation of SRF coactivators, MKL1 and MKL2, and their role in dendritic spine morphology.Sci Rep. 2018 Jan 15;8(1):727. doi: 10.1038/s41598-017-18905-7.
• [982] ANXA7, PPP3CB, DNAJC9, and ZMYND17 genes at chromosome 10q22 associated with the subgroup of schizophrenia with deficits in attention and executive function.Biol Psychiatry. 2011 Jul 1;70(1):51-8. doi: 10.1016/j.biopsych.2011.02.033. Epub 2011 Apr 30.
• [983] Fine mapping on chromosome 13q32-34 and brain expression analysis implicates MYO16 in schizophrenia.Neuropsychopharmacology. 2014 Mar;39(4):934-43. doi: 10.1038/npp.2013.293. Epub 2013 Oct 21.
• [984] Myosin Vb gene is associated with schizophrenia in Chinese Han population.Psychiatry Res. 2013 May 15;207(1-2):13-8. doi: 10.1016/j.psychres.2013.02.026. Epub 2013 Apr 3.
• [985] Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells.J Neurogenet. 2011 Oct;25(3):88-103. doi: 10.3109/01677063.2011.597908. Epub 2011 Jul 29.
• [986] Interaction of NOS1AP with the NOS-I PDZ domain: Implications for schizophrenia-related alterations in dendritic morphology.Eur Neuropsychopharmacol. 2016 Apr;26(4):741-55. doi: 10.1016/j.euroneuro.2016.01.008. Epub 2016 Jan 28.
• [987] Decreased DNA Methylation in the Shati/Nat8l Promoter in Both Patients with Schizophrenia and a Methamphetamine-Induced Murine Model of Schizophrenia-Like Phenotype.PLoS One. 2016 Jun 27;11(6):e0157959. doi: 10.1371/journal.pone.0157959. eCollection 2016.
• [988] Lack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients.Biol Psychiatry. 2011 Jan 1;69(1):71-9. doi: 10.1016/j.biopsych.2010.09.036.
• [989] Schizophrenia in the National Academy of Sciences-National Research Council Twin Registry: a 16-year update.Am J Psychiatry. 1983 Dec;140(12):1551-63. doi: 10.1176/ajp.140.12.1551.
• [990] Loss of Nicastrin from Oligodendrocytes Results in Hypomyelination and Schizophrenia with Compulsive Behavior.J Biol Chem. 2016 May 27;291(22):11647-56. doi: 10.1074/jbc.M116.715078. Epub 2016 Mar 23.
• [991] Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study.Biol Psychiatry. 2004 Apr 1;55(7):676-84. doi: 10.1016/j.biopsych.2003.12.012.
• [992] A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress.Schizophr Res. 2003 Dec 1;65(1):33-8. doi: 10.1016/s0920-9964(03)00011-2.
• [993] Systematic association studies of mitochondrial DNA variations in schizophrenia: focus on the ND5 gene.Schizophr Bull. 2008 May;34(3):458-65. doi: 10.1093/schbul/sbm100. Epub 2007 Sep 26.
• [994] A quantitative review of the postmortem evidence for decreased cortical N-methyl-D-aspartate receptor expression levels in schizophrenia: How can we link molecular abnormalities to mismatch negativity deficits?.Biol Psychol. 2016 Apr;116:57-67. doi: 10.1016/j.biopsycho.2015.10.013. Epub 2015 Nov 10.
• [995] Investigating association of four gene regions (GABRB3, MAOB, PAH, and SLC6A4) with five symptoms in schizophrenia.Psychiatry Res. 2012 Jul 30;198(2):202-6. doi: 10.1016/j.psychres.2011.12.035. Epub 2012 Mar 12.
• [996] Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2.PLoS One. 2007 Sep 5;2(9):e817. doi: 10.1371/journal.pone.0000817.
• [997] NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia.Mol Psychiatry. 2020 Apr;25(4):805-820. doi: 10.1038/s41380-018-0309-9. Epub 2018 Dec 10.
• [998] Pathology of white matter integrity in three major white matter fasciculi: A post-mortem study of schizophrenia and treatment status.Br J Pharmacol. 2019 Apr;176(8):1143-1155. doi: 10.1111/bph.14612. Epub 2019 Mar 18.
• [999] Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.J Neuroimmunol. 2014 Apr 15;269(1-2):68-75. doi: 10.1016/j.jneuroim.2014.02.008. Epub 2014 Feb 25.
• [1000] A case control association study and cognitive function analysis of neuropilin and tolloid-like 1 gene and schizophrenia in the Japanese population.PLoS One. 2011;6(12):e28929. doi: 10.1371/journal.pone.0028929. Epub 2011 Dec 20.
• [1001] The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring.Transl Psychiatry. 2017 Jan 10;7(1):e998. doi: 10.1038/tp.2016.268.
• [1002] Inhibition of STEP(61) ameliorates deficits in mouse and hiPSC-based schizophrenia models.Mol Psychiatry. 2018 Feb;23(2):271-281. doi: 10.1038/mp.2016.163. Epub 2016 Oct 18.
• [1003] Using data linkage to electronic patient records to assess the validity of selected mental health diagnoses in English Hospital Episode Statistics (HES).PLoS One. 2018 Mar 26;13(3):e0195002. doi: 10.1371/journal.pone.0195002. eCollection 2018.
• [1004] Microduplications at the 15q11.2 BP1-BP2 locus are enriched in patients with anorexia nervosa.J Psychiatr Res. 2019 Jun;113:34-38. doi: 10.1016/j.jpsychires.2019.01.021. Epub 2019 Jan 29.
• [1005] Synaptic deficits in iPSC-derived cortical interneurons in schizophrenia are mediated by NLGN2 and rescued by N-acetylcysteine.Transl Psychiatry. 2019 Nov 28;9(1):321. doi: 10.1038/s41398-019-0660-x.
• [1006] Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity.Am J Med Genet A. 2017 Jan;173(1):213-216. doi: 10.1002/ajmg.a.37977. Epub 2016 Nov 16.
• [1007] Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis.Cell. 2018 May 31;173(6):1356-1369.e22. doi: 10.1016/j.cell.2018.03.051. Epub 2018 May 31.
• [1008] Neuronal PAS Domain Proteins 1 and 3 Are Master Regulators of Neuropsychiatric Risk Genes.Biol Psychiatry. 2017 Aug 1;82(3):213-223. doi: 10.1016/j.biopsych.2017.03.021. Epub 2017 Apr 6.
• [1009] Downregulation of Npas4 in parvalbumin interneurons and cognitive deficits after neonatal NMDA receptor blockade: relevance for schizophrenia.Transl Psychiatry. 2019 Feb 21;9(1):99. doi: 10.1038/s41398-019-0436-3.
• [1010] The multidimensionality of schizotypy in nonpsychotic relatives of patients with schizophrenia and its applications in ordered subsets linkage analysis of schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):1-9. doi: 10.1002/ajmg.b.30948.
• [1011] The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) influences age at onset of obsessive-compulsive disorder.Int J Neuropsychopharmacol. 2013 Oct;16(9):1951-8. doi: 10.1017/S1461145713000382. Epub 2013 May 17.
• [1012] Genetically Induced Retrograde Amnesia of Associative Memories After Neuroplastin Ablation.Biol Psychiatry. 2017 Jan 15;81(2):124-135. doi: 10.1016/j.biopsych.2016.03.2107. Epub 2016 Apr 11.
• [1013] Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders.Mol Psychiatry. 2018 May;23(5):1233-1243. doi: 10.1038/mp.2017.22. Epub 2017 Mar 21.
• [1014] Detection and sequence analysis of borna disease virus p24 RNA from peripheral blood mononuclear cells of patients with mood disorders or schizophrenia and of blood donors.J Virol. 1998 Dec;72(12):10044-9. doi: 10.1128/JVI.72.12.10044-10049.1998.
• [1015] Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer's disease.Alzheimers Res Ther. 2019 Mar 21;11(1):28. doi: 10.1186/s13195-019-0475-2.
• [1016] Identification by nano-LC-MS/MS of NT5DC2 as a protein binding to tyrosine hydroxylase: Down-regulation of NT5DC2 by siRNA increases catecholamine synthesis in PC12D cells.Biochem Biophys Res Commun. 2019 Sep 3;516(4):1060-1065. doi: 10.1016/j.bbrc.2019.06.156. Epub 2019 Jul 3.
• [1017] Replication of NTNG1 association in schizophrenia.Psychiatr Genet. 2014 Dec;24(6):266-8. doi: 10.1097/YPG.0000000000000061.
• [1018] The association of serum nesfatin-1 and ghrelin levels with metabolic syndrome in patients with schizophrenia.Psychiatry Res. 2018 Mar;261:45-49. doi: 10.1016/j.psychres.2017.12.041. Epub 2017 Dec 20.
• [1019] Rare Risk Variants Identification by Identity-by-Descent Mapping and Whole-Exome Sequencing Implicates Neuronal Development Pathways in Schizophrenia and Bipolar Disorder.Mol Neurobiol. 2018 Sep;55(9):7366-7376. doi: 10.1007/s12035-018-0922-2. Epub 2018 Feb 6.
• [1020] The NVL gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population.Prog Neuropsychopharmacol Biol Psychiatry. 2015 Oct 1;62:7-13. doi: 10.1016/j.pnpbp.2015.04.001. Epub 2015 Apr 17.
• [1021] No association of TAP2 polymorphisms in Korean patients with schizophrenia.Psychiatr Genet. 2004 Sep;14(3):173-6. doi: 10.1097/00041444-200409000-00011.
• [1022] Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia.Front Pharmacol. 2018 Aug 21;9:901. doi: 10.3389/fphar.2018.00901. eCollection 2018.
• [1023] Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions.Neuropsychopharmacology. 2008 Dec;33(13):3237-45. doi: 10.1038/npp.2008.29. Epub 2008 Mar 19.
• [1024] Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials.J Psychiatr Res. 2019 Jun;113:27-33. doi: 10.1016/j.jpsychires.2019.02.024. Epub 2019 Mar 5.
• [1025] Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients.Front Psychiatry. 2019 Apr 10;10:217. doi: 10.3389/fpsyt.2019.00217. eCollection 2019.
• [1026] Invariance of factor structure of the 21-item Peters et al. Delusions Inventory (PDI-21) over time and across samples.Psychiatry Res. 2017 Aug;254:190-197. doi: 10.1016/j.psychres.2017.04.053. Epub 2017 Apr 24.
• [1027] Sequencing and expression analyses of the synaptic lipid raft adapter gene PAG1 in schizophrenia.J Neural Transm (Vienna). 2015 Mar;122(3):477-85. doi: 10.1007/s00702-014-1269-0. Epub 2014 Jul 9.
• [1028] Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree.Int J Neuropsychopharmacol. 2012 Apr;15(3):309-19. doi: 10.1017/S1461145711001374. Epub 2011 Sep 7.
• [1029] The role of Pannexin gene variants in schizophrenia: systematic analysis of phenotypes.Eur Arch Psychiatry Clin Neurosci. 2016 Aug;266(5):433-7. doi: 10.1007/s00406-015-0619-8. Epub 2015 Jul 30.
• [1030] No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population.Am J Med Genet. 2000 Dec 4;96(6):778-80.
• [1031] Screening the human protocadherin 8 (PCDH8) gene in schizophrenia.Genes Brain Behav. 2002 Aug;1(3):187-91. doi: 10.1034/j.1601-183x.2002.10307.x.
• [1032] Analysis of protocadherin alpha gene deletion variant in bipolar disorder and schizophrenia.Psychiatr Genet. 2008 Jun;18(3):110-5. doi: 10.1097/YPG.0b013e3282fa1838.
• [1033] Systematic screening of the LDL-PLA2 gene for polymorphic variants and case-control analysis in schizophrenia.Biochem Biophys Res Commun. 1997 Dec 29;241(3):630-5. doi: 10.1006/bbrc.1997.7741.
• [1034] Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects.Schizophr Bull. 2013 Mar;39(2):464-71. doi: 10.1093/schbul/sbr161. Epub 2012 Jan 10.
• [1035] Selective knockout of the casein kinase 2 in d1 medium spiny neurons controls dopaminergic function.Biol Psychiatry. 2013 Jul 15;74(2):113-21. doi: 10.1016/j.biopsych.2012.11.013. Epub 2013 Jan 3.
• [1036] Gly(247)-->Asp proenkephalin A mutation is rare in schizophrenia populations.Am J Med Genet. 1997 Apr 18;74(2):213-5. doi: 10.1002/(sici)1096-8628(19970418)74:2<213::aid-ajmg21>3.0.co;2-k.
• [1037] The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia. Ther Drug Monit. 2006 Oct;28(5):668-72.
• [1038] RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia.Mol Psychiatry. 2001 Jul;6(4):373-9. doi: 10.1038/sj.mp.4000920.
• [1039] Association analysis between the rs11136000 single nucleotide polymorphism in clusterin gene, rs3851179 single nucleotide polymorphism in clathrin assembly lymphoid myeloid protein gene and the patients with schizophrenia in the Chinese population.DNA Cell Biol. 2010 Dec;29(12):745-51. doi: 10.1089/dna.2010.1075. Epub 2010 Aug 25.
• [1040] Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.Int J Neuropsychopharmacol. 2014 Dec 28;18(6):pyu098. doi: 10.1093/ijnp/pyu098.
• [1041] Single nucleotide polymorphisms in piRNA-pathway genes: an insight into genetic determinants of human diseases.Mol Genet Genomics. 2020 Jan;295(1):1-12. doi: 10.1007/s00438-019-01612-5. Epub 2019 Oct 14.
• [1042] Association between social functioning and prefrontal cortex function during a verbal fluency task in schizophrenia: A near-infrared spectroscopic study.Psychiatry Clin Neurosci. 2017 Nov;71(11):769-779. doi: 10.1111/pcn.12548. Epub 2017 Jul 31.
• [1043] A Upf3b-mutant mouse model with behavioral and neurogenesis defects.Mol Psychiatry. 2018 Aug;23(8):1773-1786. doi: 10.1038/mp.2017.173. Epub 2017 Sep 26.
• [1044] Lack of association between schizophrenia and the phospholipase-A(2) genes cPLA2 and sPLA2.Am J Med Genet. 2001 Apr 8;105(3):246-9.
• [1045] Association between PLA2G12A polymorphism and patients with schizophrenia in a southern Chinese Han population.Hum Psychopharmacol. 2018 Mar;33(2):e2654. doi: 10.1002/hup.2654. Epub 2018 Mar 11.
• [1046] Association between PLA2G6 gene polymorphism for calcium-independent phospholipase A2 and nicotine dependence among males with schizophrenia.Prostaglandins Leukot Essent Fatty Acids. 2019 Sep;148:9-15. doi: 10.1016/j.plefa.2019.07.005. Epub 2019 Jul 3.
• [1047] Co-treatment of buspirone with atypical antipsychotic drugs (AAPDs) improved neurocognitive function in chronic schizophrenia.Schizophr Res. 2019 Jul;209:135-140. doi: 10.1016/j.schres.2019.05.006. Epub 2019 May 14.
• [1048] Microarray analysis of postmortem temporal cortex from patients with schizophrenia.J Neurosci Res. 2004 Sep 15;77(6):858-66. doi: 10.1002/jnr.20208.
• [1049] PlexinA2 Forward Signaling through Rap1 GTPases Regulates Dentate Gyrus Development and Schizophrenia-like Behaviors.Cell Rep. 2018 Jan 9;22(2):456-470. doi: 10.1016/j.celrep.2017.12.044.
• [1050] Plexin B3 is genetically associated with verbal performance and white matter volume in human brain.Mol Psychiatry. 2007 Feb;12(2):190-4, 115. doi: 10.1038/sj.mp.4001903. Epub 2006 Oct 10.
• [1051] Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients.Neurobiol Dis. 2006 Mar;21(3):531-40. doi: 10.1016/j.nbd.2005.08.012. Epub 2005 Oct 5.
• [1052] Schizophrenia and Hereditary Polyneuropathy: PMP22 Deletion as a Common Pathophysiological Link?.Front Psychiatry. 2019 May 2;10:270. doi: 10.3389/fpsyt.2019.00270. eCollection 2019.
• [1053] Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia.PLoS One. 2012;7(6):e38211. doi: 10.1371/journal.pone.0038211. Epub 2012 Jun 1.
• [1054] Altered prefrontal cortical MARCKS and PPP1R9A mRNA expression in schizophrenia and bipolar disorder.Schizophr Res. 2015 May;164(1-3):100-8. doi: 10.1016/j.schres.2015.02.005. Epub 2015 Mar 7.
• [1055] Comparative Analysis of Gene Expression Profiles Involved in Calcium Signaling Pathways Using the NLVH Animal Model of Schizophrenia.J Mol Neurosci. 2018 Jan;64(1):111-116. doi: 10.1007/s12031-017-1013-y. Epub 2017 Dec 6.
• [1056] Calcineurin knockout mice show a selective loss of small spines.Neurosci Lett. 2018 Apr 3;671:99-102. doi: 10.1016/j.neulet.2018.02.006. Epub 2018 Feb 7.
• [1057] Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial.Schizophr Bull. 2020 Apr 10;46(3):661-669. doi: 10.1093/schbul/sbz091.
• [1058] Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia.Neurosci Biobehav Rev. 2019 Dec;107:795-827. doi: 10.1016/j.neubiorev.2019.08.019. Epub 2019 Aug 25.
• [1059] Deficit Versus Nondeficit Schizophrenia: An MEG-EEG Investigation of Resting State and Source Coherence-Preliminary Data.Clin EEG Neurosci. 2020 Jan;51(1):34-44. doi: 10.1177/1550059419867561. Epub 2019 Aug 4.
• [1060] Loss-of-function of PTPR and , observed in sporadic schizophrenia, causes brain region-specific deregulation of monoamine levels and altered behavior in mice.Psychopharmacology (Berl). 2017 Feb;234(4):575-587. doi: 10.1007/s00213-016-4490-8. Epub 2016 Dec 26.
• [1061] How a poliovirus might cause schizophrenia: a commentary on Eagles' hypothesis.Neurochem Res. 1997 May;22(5):647-56. doi: 10.1023/a:1022486423238.
• [1062] Motor cortical plasticity in schizophrenia: A meta-analysis of Transcranial Magnetic Stimulation - Electromyography studies.Schizophr Res. 2019 May;207:37-47. doi: 10.1016/j.schres.2018.10.027. Epub 2018 Nov 6.
• [1063] Comprehensive gene-based association study of a chromosome 20 linked region implicates novel risk loci for depressive symptoms in psychotic illness.PLoS One. 2011;6(12):e21440. doi: 10.1371/journal.pone.0021440. Epub 2011 Dec 29.
• [1064] Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia.Mol Psychiatry. 2000 Jan;5(1):85-90. doi: 10.1038/sj.mp.4000580.
• [1065] Rapgef2, a guanine nucleotide exchange factor for Rap1 small GTPases, plays a crucial role in adherence junction (AJ) formation in radial glial cells through ERK-mediated upregulation of the AJ-constituent protein expression.Biochem Biophys Res Commun. 2017 Nov 4;493(1):139-145. doi: 10.1016/j.bbrc.2017.09.062. Epub 2017 Sep 14.
• [1066] A Schizophrenia-Linked KALRN Coding Variant Alters Neuron Morphology, Protein Function, and Transcript Stability.Biol Psychiatry. 2018 Mar 15;83(6):499-508. doi: 10.1016/j.biopsych.2017.10.024. Epub 2017 Nov 7.
• [1067] Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study.Front Psychiatry. 2018 Mar 8;9:74. doi: 10.3389/fpsyt.2018.00074. eCollection 2018.
• [1068] Duplications in RB1CC1 are associated with schizophrenia; identification in large European sample sets.Transl Psychiatry. 2013 Nov 26;3(11):e326. doi: 10.1038/tp.2013.101.
• [1069] Convergent Evidence That ZNF804A Is a Regulator of Pre-messenger RNA Processing and Gene Expression.Schizophr Bull. 2019 Oct 24;45(6):1267-1278. doi: 10.1093/schbul/sby183.
• [1070] Truncating mutations in RBM12 are associated with psychosis.Nat Genet. 2017 Aug;49(8):1251-1254. doi: 10.1038/ng.3894. Epub 2017 Jun 19.
• [1071] Variants of the RELA gene are associated with schizophrenia and their startle responses.Neuropsychopharmacology. 2011 Aug;36(9):1921-31. doi: 10.1038/npp.2011.78. Epub 2011 May 18.
• [1072] Disturbances of sleep quality, timing and structure and their relationship with other neuropsychiatric symptoms in Alzheimer's disease and schizophrenia: Insights from studies in patient populations and animal models.Neurosci Biobehav Rev. 2019 Feb;97:112-137. doi: 10.1016/j.neubiorev.2018.09.027. Epub 2018 Oct 9.
• [1073] Putative Astroglial Dysfunction in Schizophrenia: A Meta-Analysis of (1)H-MRS Studies of Medial Prefrontal Myo-Inositol.Front Psychiatry. 2018 Sep 21;9:438. doi: 10.3389/fpsyt.2018.00438. eCollection 2018.
• [1074] Association of RGS2 and RGS5 variants with schizophrenia symptom severity.Schizophr Res. 2008 Apr;101(1-3):67-75. doi: 10.1016/j.schres.2008.01.006. Epub 2008 Feb 11.
• [1075] Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2009 Mar 5;150B(2):239-42. doi: 10.1002/ajmg.b.30796.
• [1076] Investigation of the expression of genes affecting cytomatrix active zone function in the amygdala in schizophrenia: effects of antipsychotic drugs.J Psychiatr Res. 2009 Jan;43(3):282-90. doi: 10.1016/j.jpsychires.2008.04.001. Epub 2008 May 19.
• [1077] Gene expression in blood is associated with risperidone response in children with autism spectrum disorders.Pharmacogenomics J. 2012 Oct;12(5):368-71. doi: 10.1038/tpj.2011.23. Epub 2011 Jun 7.
• [1078] The application of strand invasion phenomenon, directed by peptide nucleic acid (PNA) and single-stranded DNA binding protein (SSB) for the recognition of specific sequences of human endogenous retroviral HERV-W family.J Mol Recognit. 2017 May;30(5). doi: 10.1002/jmr.2600. Epub 2016 Dec 6.
• [1079] Innate immune response is differentially dysregulated between bipolar disease and schizophrenia.Schizophr Res. 2015 Feb;161(2-3):215-21. doi: 10.1016/j.schres.2014.10.055. Epub 2014 Dec 6.
• [1080] Genes encoding SATB2-interacting proteins in adult cerebral cortex contribute to human cognitive ability.PLoS Genet. 2019 Feb 6;15(2):e1007890. doi: 10.1371/journal.pgen.1007890. eCollection 2019 Feb.
• [1081] Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression.BMC Bioinformatics. 2011;12 Suppl 13(Suppl 13):S20. doi: 10.1186/1471-2105-12-S13-S20. Epub 2011 Nov 30.
• [1082] Brain-behaviour relationships in people at high genetic risk of schizophrenia.Neuroimage. 2006 Oct 15;33(1):275-85. doi: 10.1016/j.neuroimage.2006.06.031. Epub 2006 Aug 22.
• [1083] A two-stage case-control association study of the dihydropyrimidinase-like 2 gene (DPYSL2) with schizophrenia in Japanese subjects.J Hum Genet. 2010 Jul;55(7):469-72. doi: 10.1038/jhg.2010.38. Epub 2010 Apr 23.
• [1084] Possible association of the semaphorin 3D gene (SEMA3D) with schizophrenia.J Psychiatr Res. 2011 Jan;45(1):47-53. doi: 10.1016/j.jpsychires.2010.05.004. Epub 2010 Jun 1.
• [1085] Quality of life and self-esteem in 7-year-old children with familial high risk of schizophrenia or bipolar disorder: the Danish High Risk and Resilience Study-VIA 7-a population-based cohort study.Eur Child Adolesc Psychiatry. 2020 Jun;29(6):849-860. doi: 10.1007/s00787-019-01397-3. Epub 2019 Sep 7.
• [1086] Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3.Arch Gen Psychiatry. 2011 May;68(5):477-88. doi: 10.1001/archgenpsychiatry.2011.43.
• [1087] Modeling and Predicting Developmental Trajectories of Neuropsychiatric Dimensions Associated With Copy Number Variations.Int J Neuropsychopharmacol. 2019 Aug 1;22(8):488-500. doi: 10.1093/ijnp/pyz026.
• [1088] Prefrontal Coexpression of Schizophrenia Risk Genes Is Associated With Treatment Response in Patients.Biol Psychiatry. 2019 Jul 1;86(1):45-55. doi: 10.1016/j.biopsych.2019.03.981. Epub 2019 Apr 3.
• [1089] Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia.Neurochem Res. 2004 Jun;29(6):1245-55. doi: 10.1023/b:nere.0000023611.99452.47.
• [1090] Direct measure of the de novo mutation rate in autism and schizophrenia cohorts.Am J Hum Genet. 2010 Sep 10;87(3):316-24. doi: 10.1016/j.ajhg.2010.07.019.
• [1091] The methyltransferase SETDB1 regulates a large neuron-specific topological chromatin domain.Nat Genet. 2017 Aug;49(8):1239-1250. doi: 10.1038/ng.3906. Epub 2017 Jul 3.
• [1092] Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation.Sci Rep. 2018 Feb 1;8(1):2158. doi: 10.1038/s41598-018-20538-3.
• [1093] Investigation of the involvement of MIR185 and its target genes in the development of schizophrenia.J Psychiatry Neurosci. 2014 Nov;39(6):386-96. doi: 10.1503/jpn.130189.
• [1094] Analysis of strain-dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia.J Neurochem. 2010 Dec;115(6):1374-85. doi: 10.1111/j.1471-4159.2010.07039.x. Epub 2010 Oct 26.
• [1095] Dietary patterns and physical activity in people with schizophrenia and increased waist circumference.Schizophr Res. 2018 Sep;199:109-115. doi: 10.1016/j.schres.2018.03.016. Epub 2018 Mar 16.
• [1096] Exploring Transcription Factors-microRNAs Co-regulation Networks in Schizophrenia.Schizophr Bull. 2016 Jul;42(4):1037-45. doi: 10.1093/schbul/sbv170. Epub 2015 Nov 24.
• [1097] Validating reference genes using minimally transformed qpcr data: findings in human cortex and outcomes in schizophrenia.BMC Psychiatry. 2016 May 20;16:154. doi: 10.1186/s12888-016-0855-0.
• [1098] Genetic structure adds power to detect schizophrenia susceptibility at SLIT3 in the Chinese Han population.Genome Res. 2004 Jul;14(7):1345-9. doi: 10.1101/gr.1758204.
• [1099] Genome-wide association study results for educational attainment aid in identifying genetic heterogeneity of schizophrenia.Nat Commun. 2018 Aug 6;9(1):3078. doi: 10.1038/s41467-018-05510-z.
• [1100] Correlation of reduced social communicational and interactional skills with regional grey matter volumes in schizophrenia patients.Acta Neuropsychiatr. 2017 Dec;29(6):374-381. doi: 10.1017/neu.2017.9. Epub 2017 Apr 10.
• [1101] Alpha- and beta-synucleins mRNA expression in lymphocytes of schizophrenia patients.Genet Test Mol Biomarkers. 2010 Oct;14(5):725-9. doi: 10.1089/gtmb.2010.0050. Epub 2010 Sep 20.
• [1102] Linkage disequilibrium on the COMT gene in French schizophrenics and controls.Am J Med Genet. 1999 Oct 15;88(5):452-7. doi: 10.1002/(sici)1096-8628(19991015)88:5<452::aid-ajmg2>3.3.co;2-s.
• [1103] Increased sensorimotor network connectivity associated with clozapine eligibility in people with schizophrenia.Psychiatry Res Neuroimaging. 2018 May 30;275:36-42. doi: 10.1016/j.pscychresns.2018.02.008. Epub 2018 Mar 6.
• [1104] Schizophrenia risk variants influence multiple classes of transcripts of sorting nexin 19 (SNX19).Mol Psychiatry. 2020 Apr;25(4):831-843. doi: 10.1038/s41380-018-0293-0. Epub 2019 Jan 11.
• [1105] Dopaminergic activity and behaviour in SOCS2 transgenic mice: Revealing a potential drug target for schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 2;56:247-53. doi: 10.1016/j.pnpbp.2014.09.009. Epub 2014 Oct 5.
• [1106] Genome-wide association study of behavioural and psychiatric features in human prion disease.Transl Psychiatry. 2015 Apr 21;5(4):e552. doi: 10.1038/tp.2015.42.
• [1107] MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients.Neurobiol Dis. 2013 Jul;55:1-10. doi: 10.1016/j.nbd.2013.03.011. Epub 2013 Mar 29.
• [1108] Synaptic Interactome Mining Reveals p140Cap as a New Hub for PSD Proteins Involved in Psychiatric and Neurological Disorders.Front Mol Neurosci. 2017 Jun 30;10:212. doi: 10.3389/fnmol.2017.00212. eCollection 2017.
• [1109] Loss of serum response factor in mature neurons in the dentate gyrus alters the morphology of dendritic spines and hippocampus-dependent behavioral tasks.Brain Struct Funct. 2019 Nov;224(8):2691-2701. doi: 10.1007/s00429-019-01925-6. Epub 2019 Aug 2.
• [1110] Quantitative Subcellular Proteomics of the Orbitofrontal Cortex of Schizophrenia Patients.J Proteome Res. 2019 Dec 6;18(12):4240-4253. doi: 10.1021/acs.jproteome.9b00398. Epub 2019 Oct 28.
• [1111] The complex relationship between self-reported 'personal recovery' and clinical recovery in schizophrenia.Schizophr Res. 2018 Feb;192:108-112. doi: 10.1016/j.schres.2017.04.040. Epub 2017 May 9.
• [1112] Decrease in olfactory and taste receptor expression in the dorsolateral prefrontal cortex in chronic schizophrenia.J Psychiatr Res. 2015 Jan;60:109-16. doi: 10.1016/j.jpsychires.2014.09.012. Epub 2014 Oct 2.
• [1113] Family-based association study of lithium-related and other candidate genes in bipolar disorder.Arch Gen Psychiatry. 2008 Jan;65(1):53-61. doi: 10.1001/archgenpsychiatry.2007.15.
• [1114] Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder.Hum Mol Genet. 2011 Dec 15;20(24):4786-96. doi: 10.1093/hmg/ddr416. Epub 2011 Sep 9.
• [1115] Initial genome-wide scan for linkage with schizophrenia in the Japanese Schizophrenia Sib-Pair Linkage Group (JSSLG) families.Am J Med Genet B Neuropsychiatr Genet. 2003 Jul 1;120B(1):22-8. doi: 10.1002/ajmg.b.20022.
• [1116] COMT and STH polymorphisms interaction on cognition in schizophrenia.Neurol Sci. 2015 Feb;36(2):215-20. doi: 10.1007/s10072-014-1936-9. Epub 2014 Oct 5.
• [1117] Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.Transl Psychiatry. 2013 Jan 22;3(1):e221. doi: 10.1038/tp.2012.149.
• [1118] Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia.J Psychiatry Neurosci. 2007 Nov;32(6):412-6.
• [1119] A model-based approach to characterize the population pharmacokinetics and the relationship between the pharmacokinetic and safety profiles of RBP-7000, a new, long-acting, sustained-released formulation of risperidone.J Clin Pharmacol. 2013 Oct;53(10):1010-9. doi: 10.1002/jcph.141. Epub 2013 Jul 19.
• [1120] Genetic variants in the bipolar disorder risk locus SYNE1 that affect CPG2 expression and protein function.Mol Psychiatry. 2021 Feb;26(2):508-523. doi: 10.1038/s41380-018-0314-z. Epub 2019 Jan 4.
• [1121] Comprehensive functional annotation of susceptibility SNPs prioritized 10 genes for schizophrenia.Transl Psychiatry. 2019 Jan 31;9(1):56. doi: 10.1038/s41398-019-0398-5.
• [1122] Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk.Schizophr Bull. 2016 Mar;42(2):288-300. doi: 10.1093/schbul/sbv135. Epub 2015 Sep 24.
• [1123] Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia. Eur J Neurosci. 2005 Mar;21(6):1712-8. doi: 10.1111/j.1460-9568.2005.04002.x.
• [1124] Expression of human neuronal protein 22, a novel cytoskeleton-associated protein, was decreased in the anterior cingulate cortex of schizophrenia.Neurosci Lett. 2005 Apr 22;378(3):125-30. doi: 10.1016/j.neulet.2004.12.079.
• [1125] Association of schizophrenia with the phenylthiocarbamide taste receptor haplotype on chromosome 7q.Psychiatr Genet. 2012 Dec;22(6):286-9. doi: 10.1097/YPG.0b013e32835863f0.
• [1126] Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain.Hum Psychopharmacol. 2013 Mar;28(2):183-7. doi: 10.1002/hup.2288. Epub 2013 Jan 30.
• [1127] Common variants on 17q25 and gene-gene interactions conferring risk of schizophrenia in Han Chinese population and regulating gene expressions in human brain.Mol Psychiatry. 2016 Sep;21(9):1244-50. doi: 10.1038/mp.2015.204. Epub 2016 Jan 5.
• [1128] A new risk locus in the ZEB2 gene for schizophrenia in the Han Chinese population.Prog Neuropsychopharmacol Biol Psychiatry. 2016 Apr 3;66:97-103. doi: 10.1016/j.pnpbp.2015.12.001. Epub 2015 Dec 3.
• [1129] BCL9 and C9orf5 are associated with negative symptoms in schizophrenia: meta-analysis of two genome-wide association studies.PLoS One. 2013;8(1):e51674. doi: 10.1371/journal.pone.0051674. Epub 2013 Jan 29.
• [1130] TOP3B: A Novel Candidate Gene in Juvenile Myoclonic Epilepsy?.Cytogenet Genome Res. 2018;154(1):1-5. doi: 10.1159/000486945. Epub 2018 Feb 28.
• [1131] Genetic variation in human 5-HT receptors: potential pathogenetic and pharmacological role.Ann N Y Acad Sci. 1998 Dec 15;861:26-30. doi: 10.1111/j.1749-6632.1998.tb10169.x.
• [1132] HTF9C gene of 22q11.21 region associates with schizophrenia having deficit-sustained attention.Psychiatr Genet. 2007 Dec;17(6):333-8. doi: 10.1097/YPG.0b013e328133f321.
• [1133] Replication of rs300774, a genetic biomarker near ACP1, associated with suicide attempts in patients with schizophrenia: Relation to brain cholesterol biosynthesis.J Psychiatr Res. 2017 Nov;94:54-61. doi: 10.1016/j.jpsychires.2017.06.005. Epub 2017 Jun 16.
• [1134] Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study.J Psychiatry Neurosci. 2019 Jul 1;44(4):269-276. doi: 10.1503/jpn.180174.
• [1135] Cognitive and behavioral precursors of schizophrenia.Dev Psychopathol. 1999 Summer;11(3):487-508. doi: 10.1017/s0954579499002175.
• [1136] Off-Label Use of Bumetanide for Brain Disorders: An Overview.Front Neurosci. 2019 Apr 24;13:310. doi: 10.3389/fnins.2019.00310. eCollection 2019.
• [1137] Schizophrenia and epilepsy as a result of maternally inherited CNTN6 copy number variant.Schizophr Res. 2018 Dec;202:111-112. doi: 10.1016/j.schres.2018.06.062. Epub 2018 Jul 6.
• [1138] Molecular identification of hydroxylysine kinase and of ammoniophospholyases acting on 5-phosphohydroxy-L-lysine and phosphoethanolamine.J Biol Chem. 2012 Mar 2;287(10):7246-55. doi: 10.1074/jbc.M111.323485. Epub 2012 Jan 12.
• [1139] Polymorphisms of dopamine pathway genes NRG1 and LMX1A are associated with cognitive performance in bipolar disorder.Bipolar Disord. 2015 Dec;17(8):859-68. doi: 10.1111/bdi.12347. Epub 2015 Nov 3.
• [1140] RSRC1 mutation affects intellect and behaviour through aberrant splicing and transcription, downregulating IGFBP3.Brain. 2018 Apr 1;141(4):961-970. doi: 10.1093/brain/awy045.
• [1141] Short tandem repeat (STR) replacements in UTRs and introns suggest an important role for certain STRs in gene expression and disease.Gene. 2005 Jan 3;344:203-11. doi: 10.1016/j.gene.2004.09.034. Epub 2004 Dec 7.
• [1142] Srgap3??mice present a neurodevelopmental disorder with schizophrenia-related intermediate phenotypes.FASEB J. 2012 Nov;26(11):4418-28. doi: 10.1096/fj.11-202317. Epub 2012 Jul 20.
• [1143] Cortical Development Requires Mesodermal Expression of Tbx1, a Gene Haploinsufficient in 22q11.2 Deletion Syndrome.Cereb Cortex. 2017 Mar 1;27(3):2210-2225. doi: 10.1093/cercor/bhw076.
• [1144] Comparison of neurocognitive domains in patients with schizophrenia with and without co-morbid obsessive compulsive disorder.Schizophr Res. 2018 Nov;201:151-158. doi: 10.1016/j.schres.2018.05.029. Epub 2018 May 29.